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Abstract 
Mass spectrometric fingerprint identification and structural elucidation of natural 
and synthetic compounds can be accomplished via the use of mass spectrometry 
techniques namely, electrospray ionization tandem mass spectrometry (ESI-MS/MS) and 
matrix assisted laser desorption ionization tandem mass spectrometry (MALDI-MS/MS). 
In this work, it was opted to use ESI-MS and MALDI-MS, since these are the softest 
ionization methods which do not require excessive manipulation of the analytes. The 
identification of MS fingerprints can be effectively used for any quantitative or 
qualitative studies. 
Lipopolysaccarides (LPS) are poly-sugars enriched on the outer membrane of all 
gram-negative bacteria, most of which are pathogenic. These sugar complexes are 
potential candidates with relevance to bacterial vaccine developments. This study 
established the fragmentation pattern of native LPS extracts isolated from Aeromonas 
salmonicida, which infects various fish species. The exact molecular structure of lipid A 
portion and the core region of this bacterium have been precisely established providing 
evidence for the unreported presence of the reactive phosphate group at the reducing end 
of the core oligosaccharide. 
LPS moieties (vaccines) have limited antigenic properties when injected alone . 
due to their small size. Therefore a synthetic conjugate of LPS with a protein carrier or 
the encapsulation of LPS within liposomal carrier will result in the desired antigenic 
activity. One major limitation for the usage of liposomes is their tendency to aggregate 
as well as rapid clearance in the circulation system. Synthetic neoglycolipids have been 
successfully incorporated into liposomal formulations to prolong their half lives as 
alternative to pegylated liposomes (PEG-liposomes). 
The fragmentation routes of a series of synthetic amphiphilic cholesteryl 
polyethoxy neoglycolipids were established with the aid of electrospray ionization mass 
spectrometry with a QqTOF-MS hybrid instrument. The results have shown the unique 
presence of specific common fingerprints such as [Cholestenet, [(Sugar-spacer-
OH)+Ht, [oxoniumt, [oxonium-H20t and, in some cases, [(Cholesterol-spacer-
OB:)+Ht. In addition, the "in situ" formation of an unexpected and unique [C-
glycosidet product ion, resulting from an ion-molecule reaction, was observed. This 
reaction occurs in the collision cell and the ESI interface of the tandem mass 
spectrometer. Interestingly, this product ion was absent in the case of 0-acetylated sugar 
species. 
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CHAPTER 1: Introduction 
1.1. Mass Spectrometry 
1.1.1. Mass spectrometry; a historic perspective: 
Mass spectrometry (MS) has rapidly evolved during the past 20 years with its 
various applications invading every discipline within the-life and health sciences (Banoub 
et a/., 2005b; Henderson & Mcindoe, 2005; Korfmacher, 2005). Mass spectrometry 
relies on the formation of gas phase ions (positively or negatively charged) that can be 
isolated electrically (or magnetically) based on their mass-to-charge ratio (mlz). In a MS 
spectrum, the x-coordinate represents m/z values while the y-axis indicates the relative 
abundances "quantity". Mass spectrometric analysis can provide important information 
about the analytes including their structure, purity and composition. 
Mass spectrometry was first described by physicists in the late 1880s. Wilhelm 
Wien, for example, was the first to demonstrate in 1898 that superimposed electric and 
magnetic fields can deflect positive ions and his work was preceded by the work of 
physicist, Eugen · Goldstein who in 1886 discovered a new kind of radiation, 
"Kanalstrahlen", and reached the conclusion that these "new" rays were merely 
positively charged particles (Grayson, 2002). Inspired by these findings, Sir Joseph John 
Thomson, a professor of experimental physics at Cambridge University, invented the first 
mass spectrometry instrumentation and in 1913 illustrated the value of his novel 
discovery within the field of analytical chemistry (Thomson, 1913). Mass spectrometry 
was critical for stable isotope/radionucleotide studies (Aston, 1942) and, eventually, 
commercial mass spectrometric instrumentation, that can diagnostically detect organic 
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substances, appeared on the market in the 1940s, as a response to the demands from the 
oil industry (Grayson, 2002). 
The "marriage" between gas chromatography and mass spectrometry expanded 
the interest in this powerful technique to include biochemistry. Gas chromatography is 
capable of separating thermally stable biological compounds, such as fatty acids, steroids, 
and carbohydrates. This analytical tool was invented in 1952 (James &Martin, 1952) and 
coupling it to a mass spectrometer (i.e. GC-MS) was pioneered by Holmes and Morrell in 
1957 (Holmes & Morrell, 1957). Ear1y mass spectrometric instrumentation was limited 
to volatile compounds with a low molecule weight range (> 1000 Da). This was due to 
the fact that the conventional ionization technique, namely electron impact (EI), is harsh 
and will result in the destruction of complex biomolecules (e.g. proteins, nucleotides, 
complex carbohydrates). In addition, the usage of mass spectrometry within biochemistry 
labs was limited to GC-MS instrumentation that separates volatile mixtures. Under such 
conditions, complex biological substances cannot be transmitted to the gas phase without 
significant destruction and degradation. It was only after the introduction of soft 
ionization techniques that mass spectrometry was used for structural biology. Mass 
spectrometry can now be interfaced with other separation techniques, such as high 
pressure liquid chromatography (HPLC-MS) and capillary electrophoresis (CE-MS). 
However, it is common to perform MS analysis for purified materials or synthetic 
conjugates, without the use of a separation procedure. 
2 
1.1.2. Soft ionization techniques: 
Regardless of the method by which a sample is introduced into a mass 
spectrometer (i.e. GC, HPLC, direct injection), the ion source is the compartment where 
charged species are produced and is the "gate" to other sections of the instrument, namely 
the analyzer and the detector. Many ionization techniques are currently used with mass 
spectrometric instrumentations. The traditional ionization method, namely EI, utilizes 
energetic electron beams during the ionization process and operates only under vacuum 
while the analytes are already in the gas phase. A beam of electrons (negative charges) 
are formed from a heated metallic filament (e.g. tungsten) and these electrons are 
electrically accelerated and directed to collide with a vaporized sample, causing electron 
expulsion from the analytes and subsequent formation of positively charged radical-
cations. These conditions are not suitable for large molecules or many biological 
materials. EI along with chemical ionization (introduced below) are, however, still the 
methods of choice for GC-MS equipment (Kitson et al., 1996). Figure 1-1 illustrates the 
process by which ions are formed during EI ionization and it should be noted that with 
specific compounds, negatively charged species can be observed (Herbert & Johnstone, 
2003) (Figure 1-1B). 
Due to the limitations associated with EI ionization, chemical ionization (CI) and 
plasma desorption (PD) methods were introduced in 1966 (Munson & Field, 1966) and 
1974 (Torgerson et al., 1974), respectively. Both techniques will result predominantly in 
the formation of protonated (or deprotonated) ions which are more stable than the radical 
ions formed during El-MS analysis. CI depends on the interaction between energetic 
electrons and neutral molecules, such as methane, resulting in the formation of charged 
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Figure 1-1: Conventional electron impact (EI) ionization process. (A) Formation of 
positively charged ions. (B) Formation of negatively charged ions. 
ions that will interact with the analytes producing protonated species. Similar to EI 
ionization, this method poses some limitations in terms of mass range ( <1 000) and 
requires specific sample characteristics with regard to thermal stability and volatility. CI 
is, however, better than EI with respect to the production of the molecular ion. 
Nevertheless, both EI and CI were not capable of analyzing the most valuable, thermally 
instable, polar biological compounds. 
PD ionization, on the other hand, is one of the early "soft" ionization techniques 
which were capable of analyzing biomolecules, up to a molecular weight (MW) of 
100,000 Daltons (Da). The term "soft" indicates that minimum internal energy is 
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transmitted to the analytes during the ionization process. PD ionization was introduced 
after the design of field ionization and field desorption methods (Beckey, 1969; Inghram 
& Gomer, 1954). Subsequently, additional soft ionization methods were developed and 
replaced older techniques. These include fast atom bombardment (FAB) (Barber et al., 
1981; Morris et al., 1981 ), liquid secondary ion mass spectrometry (LSIMS) (Shackleton 
& Straub, 1982), matrix assisted laser desorption ionization (MALDI) (Tanaka et al., 
1988) and electrospray ionization (ESI) (Yamashita & Fenn, 1984a; Yamashita & Fenn, 
1984b ). The last two ionization techniques, in particular, have revolutionized the usage 
of mass spectrometers and enabled researchers to easily study biological substances, such 
as glycoconjugates, proteins and DNA. The significance of the development of MALDI 
and ESI was globally recognized when the "inventors", Koichi Tanaka of the Shimadzu 
Corp in Kyoto, Japan and John Fenn of the Virginia Commonwealth University, 
Richmond, USA shared the 2002 Nobel Prize in chemistry. Table 1-1 compares different 
commonly used ionization methods, summarizing their various characteristics; 
information in Table 1-1 is extracted from Herbert & Johnstone, (2003) and Henderson & 
Mcindoe, (2005). 
1.1.2.1. Electrospray ionization-Mass spectrometry (ESI-MS): 
Development of electrospray ionization started in the late 1960s with the work of 
Dole and co-workers who successfully introduced a polystyrene polymer (average 
MW=51,000 Da) into the gas-phase as a charged species (Dole et al., 1968). This 
technique was then linked to a quadrupole mass analyzer and was significantly optimized 
in the early 1980s (Yamashita & Fenn, 1984a; Yamashita & Fenn, 1984b). ESI-MS is 
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Ionization technique Nature of analytes Sample introduction Mass Range Brief description 
I 
Electron Impact Volatile Gas chromatography <1000Da Hard method 
EI Thermally stable solid or liquid probe Mainly fragment ions 
Chemical Ionization Volatile Gas chromatography <1000 Da Soft method 
CI Thermally stable solid or liquid probe Molecular ion 
Fast atom Organometallic Liquid chromatography, <5000Da Soft method 
bombardment F AB compounds direct injection optimal range 200-2000 Require matrix 
Matrix assisted laser Biomolecules Sample is co- Can go beyond Very soft method 
desorption ionization (Proteins, DNA, crystallized with a 500,000 Da Singly charged ions 
(MALDI) glycoconjugates) matrix 
Electrospray ionization Organic & inorganic Sample in solution From very low masses Very soft method 
(ESI) compounds to extraordinarily high Mul!iply charged ions 
Table 1-1: Summary of the various features of current ionization methods used in mass spectrometry. 
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currently used for qualitative and quantitative studies of a wide variety of nonvolatile and 
thermally labile simple inorganic chemicals as well as complex biological structures 
(Pramanik eta/., 2002). 
In ESI-MS, the sample should be soluble in a preferably polar solvent which can 
be infused, under atmospheric pressure, into the ionization source via a thin needle. As 
the sample is being constantly sprayed, a high electrical potential is applied at the needle 
(3-4 K v) resulting in the formation of highly charged droplets (i.e. nebulisation). These 
droplets are then driven electrically and are vaporized with the aid of a warm neutral gas 
(usually nitrogen). Under these conditions, the droplets break down and, while shifting 
inside the source, their size is continuously being reduced. Eventually, the repulsive 
forces, also termed the coulombic forces, among the ions on the surface of the shrinking 
droplets become very high. These forces will ultimately exceed the surface tension of the 
solvent, resulting in ions which desorb into the gas-phase. This theory of ESI ion 
formation is termed the ion evaporation method (Iribarne & Thomson, 1976; Kebarle, 
2000) and is believed to favor ions with relatively low mlz values (Baldwin, 2005). An 
alternative theory, which is supposed to be dominant in the case of ions with very high 
mlz (Baldwin, 2005), is the charge residue model, which involves continuous evaporation 
of the solvent accompanied by droplet fragmentation so that a single ion (probably 
multiply charged) is formed at the end of this process (i.e. solvent is completely 
evaporated) (Dole et at., 1968; Griffiths et al., 2001; Kebarle, 2000). Figure 1-2 
illustrates the different proposed mechanisms of ion formation during the ESI process. 
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Figure 1-2: The formation of ions during electrospray ionization. The ~ample solution is passed through a charged capillary, resulting 
in the creation of charged droplets that evaporate with the aid of a stream of nitrogen. Coulomb explosion will break the highly 
charged droplets into smaller ones and eventually ions are desorbed from the surface according to the ion evaporation theory or solvent 
is completely evaporated as speculated based on the charge residue theory. This scheme represents ions as positively charged; the 
same mechanism applies in the case of negative ion mode. 
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ESI has obviously resolved the problems inherited in studying large biomaterials 
using traditional mass spectrometry and its performance can be further enhanced by 
linking it to liquid chromatography (a powerful analytical technique) in a process known 
as LCMS. In conventional ES pioneered by Fenn~s group, samples were injected at a 
flow rate of 2-20 J..tl/min (Whitehouse et al., 1985) which posed some problems when 
dealing with limited biological samples. Therefore, additional research efforts (Emmett 
& Caprioli, 1994; Gale & Smith, 1993) resulted in the development of nanospray 
technology which opemtes at a very low flow rate in the order of nanoliters per minute 
(nllmin). The advantage of nanospray technology is not limited to minimized flow rates, 
but also to the mechanism of ion formation, improving, for example, glycoconjugate 
analysis (Karas et al., 2000a). ESI continues to attract researchers from various 
disciplines who investigate both new applications as well as possible new improvements 
at the technical level. 
1.1.2.2 Matrix assisted laser desorption ionization (MALDI): 
MALDI is by far the leading mass spectrometric methodology currently being 
used for protein sequencing and proteomic research and is commonly utilized in tandem 
with ESI technology. Banoub's group, for example, have successfully characterized 
vitellogenin protein, a fish biomarker, by both ESI and MALDI (Banoub et al., 2004a; 
Banoub et al., 2003). Similar to ESI, however, MALDI is also powerful for studying 
DNA (Gut, 2004), lipids (Balazy, 2004) and glycoconjugates (Harvey, 2003). 
In MALDI, ions are desorbed from the solid phase. A sample is first dissolved in 
a suitable solvent and mixed with an excessive amount of an appropriate matrix. 
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Subsequently, it is spotted on a MALDI plate and air-dried (or under a stream of nitrogen 
gas). Under these circumstances, the sample is co-crystallized with the matrix. The 
components in the mixture are brought into the gas-phase via a laser beam (usually a 
nitrogen laser at a wavelength of 337 nm) that hits the sample-matrix crystal, leading to 
absorption of the laser energy by the matrix and subsequent desorption and ionization of 
the analytes in the sample. Figure 1-3 represents the process by which ions are formed 
during MALDI-MS. 
MALDI was initially operated under vacuum; however, atmospheric pressure 
(AP) MALDI was developed in 2000 (Laiko eta/., 2000). This development has reduced 
cost, enhanced ease of operation and improved the commercial production of mass 
spectrometers with interchangeable MALDI and ESI sources. The mechanisms by which 
ions are formed in MADLI are still not fully understood and the choice of a specific 
matrix is mainly experimental. Figure 1-4 shows the chemical structure of three of the 
most widely used MALDI ·matrices. In addition to its dependency on the nature of the 
analytes, the choice of the matrix can also be influenced by the ionization mode, whether 
positive or negative. Basic matrices are favored in the case of the latter, while acidic ones 
are more efficient in the case of the former (i.e. proton donor) (Baldwin, 2005; Henderson 
& Mcindoe, 2005). 
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Figure 1-3: MALDI ionization Process. The matrix-analyte crystal is bombarded 
with a UV laser beam that excites the matrix which, in turn, transfers the energy to 
the analytes. This results in the ionization and desorption of the analytes, mainly as 
singly charged species. 
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Figure 1-4: The chemical structures of three commonly used matrices in MALDI-MS 
analysis. 
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1.1.2.3. Comparison between MALDI and ESI: 
Both ESI and MALDI are very sensitive analytical techniques utilizing analyte 
concentrations which are as low as picomolar. One of the main differences, however, 
between MALDI and ESI is the state in which the sample is introduced to the ion source. 
ESI uses solvated sample which is infused into the instrument, while MALDI uses the 
solid state. Therefore, when interfaced with LC, it is possible to efficiently utilize ESI for 
quantitative measurements (Cohen et al., 2006). Despite the fact that ESI is capable of 
reproducing data better than MALDI, it should be noted that relative abundance of 
various ions in an ESI spectrum is not a real representation of the sample concentration. 
Hence, a standard solution (when the objective is quantification) should be prepared with 
suitable calibration, preferably with the use of an isotopic analogue of the analyte (Cohen 
et al., 2006). There were some attempts to expand the usage of MALDI from merely 
qualitative towards quantitative measurements (Biroccio et al., 2005; Grant et al., 2003) 
and it has been recently interfaced with LC (Fung et al., 2004). However, the 
heterogeneity of a MALDI crystal sample poses a major difficulty for such an application. 
In fact, the quality of MALDI spectra can be significantly influenced by the position of 
the laser beam and the operator should identify a "sweet spot" within the sample crystal 
that can produce the most informative spectrum. 
Attempts to interface MALDI to LC are, to some degree, related to the robustness 
of MALDI to the modest presence of salts and/or detergents (Breaux et al., 2000; 
Kallweit et al., 1996). In contrast, when using ESI, contaminants adsorbed to the tubes 
through which a sample is infused into the ESI needle can compete with the analytes and 
may influence the results. Such a problem is not encountered in MADLI as analytes can 
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escape impurities during ionization in the same fashion they escape the bulk of the 
matrix. Finally, ESI tends to produce multiply charged species for biomolecules that are 
over 1000 Da. This is the reason why ESI can, theoretically, have unlimited mass range, 
as very large biomaterials can appear at lower m!z values. MALDI, however, tends to 
produce singly charged species and this phenomenon is of great importance for 
identifying the molecular ion of proteins, carbohydrates and lipids. Karas and co-workers 
hypothesized that in MALDI-MS, neutralization of multiple charged species occurs due 
to the production of neutralizing electrons during the photoionization process and hence, 
singly charged ions are "the lucky survivors" (Karas et al., 2000b). 
MALDI and ESI applications continue to grow within the scientific community 
and are the basis for newer ionization sources that can be used for specific purposes. 
Surface enhanced laser desorption ionization (SELDI), for example, was a development 
of MALDI (Hutchens & Yip, 1993) and it combines the power of MALDI with the 
selectivity of a protein chip technique. It is currently being optimized for cancer 
diagnosis (Semmes et al., 2005) and biomarker discovery (El Aneed & Banoub, 2006). 
SELDI applications are not limited to human health; a recent investigation showed the 
usefulness of SELDI-MS profiling as a diagnostic tool in Atlantic salmon (Provan et al., 
2006). More recently, a desorption electrospray ionization (DESI) source was developed 
and mass spectra can now be recorded on a sample in its native environment (Cooks et 
al., 2006; Takats et al., 2004). 
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1.1.3. Mass analyzers: 
A mass analyzer is the part of the instrument in which ions, before reaching the 
detector, are separated based on their m/z values. In a mass spectrometer, the isolation of 
ions is usually electrically-driven, although traditional analyzers, namely magnetic 
sectors, employ a magnetic field that influences ion separation. Similar to the ionization 
process in terms of the available methodologies, there are numerous systems that can 
isolate ions based on their m/z values. Currently, four main analyzers are widely used by 
mass spectroscopists, namely quadrupole (Q), quadrupole ion trap (QIT), time of flight 
(ToF) and Fourier transform ion cyclotrone resonance (FT-ICR). These analyzers vary in 
terms of size, price, resolution, mass range, and the ability to perform tandem mass 
spectrometry experiments (MS/MS). While QIT is capable of multiple mass 
spectrometric experiments (MSn), FT-ICR is by far, the most powerful in terms of 
accurate mass measurements (Pasa-Tolic et al., 2004). Both are, however, limited with 
regards to mass range. 
The following sections will focus on quadrupole and time of flight analyzers and 
illustrate the development of hybrid instruments that link a quadrupole to a ToF analyzer 
with MS/MS capability (i.e. Q-ToF instrument). 
1.1.3.1. Quadrupole analyzer: 
The principle of a quadrupole mass analyzer was first described in the 1950s by 
Nobel Prize winning, physicist Paul Wolfgang and this ion filter was well-suited for GC-
MS instrumentation (Grayson, 2002). This analyzer is composed of four parallel 
electrical rods (with a circular cross section), as shown in Figure 1-5. A direct current 
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(DC) potential (U) is applied to two of these rods, while the other two are linked to an 
alternating radio-frequency (rf) potential (the potential is termed V, while the frequency is 
termed w ). Ions, formed in the ionization chamber, are pulsed towards a quadrupole by 
an electrical field in the range of 5K v. A positively charged ion, for example, will move 
in the direction of the negatively charged rod. However, once the polarity is changed, the 
ion will switch its movement path before striking the rod. In such a situation, ions will 
undergo complex oscillation (trajectory) and with the appropriate values of V, U and w, 
only ions within a narrow range of mlz will survive the path towards the detector. The 
remaining ions will possess the "wrong" trajectory and will eventually collide with one of 
the rods. The ramping of V, U and co values can result in the transmission of various ions 
(with different mlz) toward the detector (Downard, 2004; Henderson & Mcindoe, 2005). 
This simplified illustration of a quadrupole is based on a complicated second-order 
differential equation, known as the Mathieu equation (March & Hughes, 1989). 
A 
v 
Figure 1-5: Representation of a quadrupole mass analyzer. Four parallel electrical rods 
with varying direct current and alternating radio-frequency potentials. Only one m/z value 
will possess the "right" trajectory and survive the path to reach the detector (solid line). 
The rest will collide with rods and will be ejected (dotted line). 
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The major advantages of quadrupole analyzers are the low cost, relatively small 
size, robustness and ease of maintenance. A quadrupole possesses, however, limited 
capability in terms of mass range (usually < 4000 Da), resolving power, and the ability to 
perform MS/MS analysis. The final disadvantage can be overcome by attaching a 
quadrupole to other analyzers such as additional quadrupoles (triple quadrupole 
instrument) or a quadrupole linked to a ToF (QqToF). An rf-only quadrupole (especially 
in a hybrid mass spectrometer) will function as an ion focusing device that guides ions to 
other components of the apparatus. Such functionality can be significantly improved with 
hexapoles and octapoles which cannot, however, perform as ion filters. 
1.1.3.2. Time of flight (ToF) analyzer: 
This ion separation methodology is one of the simplest and although it was first 
described in the middle of the 20th century (Stephens, 1946), it was not until the 1990s 
(Brown & Lennon, 1995), when it was rediscovered. Unlike other mass filters, this 
analyzer does not apply electrical or magnetic fields. ToF simply relies on the free flight 
of the ionized molecules in a tube of 1-2 m in length, before reaching the detector. As 
seen in Figure 1-6, if two ions (At, and A2) are formed at the same time with the same 
charge but the mass of AI< Az, AI will reach the detector before Az. The main advantage 
of a ToF analyzer is that all formed ions will eventually reach the detector (unlike 
quadrupole or sector instruments). The equation that correlates mlz with total time of 
flight (tr) is expressed in the following formula (Merchant & Weinberger, 2000): 
mlz= tl 2 E s/ (2s+x) 
17 
Where E is the voltage applied, s is the length of the ion acceleration region and x is the 
length of the free flight region. Theoretically E, s, And x are fixed, therefore, the above 
equation can be reduced to 
m/z=K ti 
Where, K is the calibrating factor. This equation illustrates the direct relationship 
between the m/z value and the time of flight. 
While ToF has the advantage of being able to detect a very high mass range, the 
tube linearity of a conventional ToF analyzer (Figure 1-6 A) can influence its resolving 
power, as ions entering the ToF carry different kinetic energies (KE) and this 
subsequently will affect resolution and molecular ion measurements. This drawback was 
overcome by the development of the reflectron (electrostatic ion mirror) (Mamyrin & 
Shmikk, 1979) which is an ion optic device that changes the path of the ions within the 
ToF, as shown in Figure 1-6B. Ions with higher KE will penetrate deeper into the ion 
mirror and hence ions will be gradually repelled, improving the resolution of the ToF 
spectrum. Another factor is the flight time; since ions (in reflectron-To F) are traveling a 
longer path, better resolution as well as accurate mass measurements can be obtained due 
to the increase in the flight time (Clauser et al., 1999). Most ToF analyzers currently 
have a resolution value > 10,000 (Edmondson & Russell, 1996), however, a resolution of 
20,000 has been reported with commercial instruments having a second mirror (Ens & 
Standing, 2005). Resolution is defined based on the full width at half maximum 
(FWHM), or ~m, and can be obtained by dividing mass (m)/ ~m. 
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(A) and a reflectron-type ToF (B). 
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Most reflectron-type mass analyzers have two detectors: the first is beyond the ion 
mirror, and the second is at the end of the ion path. Due to the fact that a reflectron can 
result in ion loss, the operator can decide whether to compromise resolution, or 
sensitivity. Due to the nature of ToF, it is widely linked to the MALDI ion source (i.e. 
MALDI-ToF). Nevertheless, ToF can also be efficiently attached to an ESI source in 
hybrid instruments or orthogonal ToF, capable of performing tandem mass spectrometric 
experiments. 
1.1.3.3. Tandem mass spectrometry (MS/MS): 
Both single-stage ESI-MS and MALDI-MS are very valuable for molecular ion 
determination and can provide, under certain circumstances, useful structural information. 
These "circumstances" refer to the induction of fragmentation within the source, such as 
"post source decay'' (Purcell & Gorman, 2001) and "in source fragmentation" (Joly et al., 
2005) in the case of MALDI and ESI, respectively. Tandem mass spectrometry relies on 
the isolation of a specific m/z (i.e. precursor ion) that can be then subjected to dissociation 
and subsequent production of fragment or product ions (previously known as daughter 
ions). The users' task is to solve the "puzzle" created with an MS/MS spectrum, 
revealing valuable information with respect to the molecular structure of the analyte. 
To achieve this goal, multiple mass analyzers can be connected in a series, so that 
ion isolation is performed by the first analyzer followed by ion fragmentation in the 
collision cell, while the final analyzer separates fragment ions based on their m/z values. 
Figure 1-7 illustrates the differences between one-stage mass spectrometry and MS/MS 
instrumentation. In fact, various combinations of mass analyzers can be assembled 
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including sectors, quadrupoles, and ToF (Chemushevich et al., 2001; Shukla & Futrell, 
2000; Vestal & Campbell, 2005). Such MS/MS instruments are considered tandem-in-
space since the analysis is performed by different mass analyzers "in different spaces". 
Tandem-in-time, however, refers to trapping instruments where all ions are ejected except 
for one m/z that will be subsequently fragmented "in the same space". These instruments 
include ITQ and FT-MS; both of which have one analyzer and can perform multiple MS 
experiments (MSn), which are powerful tools for structural studies. It was shown, for 
example, that ion intensity is the only limitation to the extent of an MSn analysis in an 
ITQ mass spectrometer (Louris et al., 1990). 
One of the commonly used tandem-in-space mass spectrometers is the triple 
quadrupole instrument, introduced in late 1970s (Y osi & Enke, 1978). This 
instrumentation is currently abbreviated QqQ, where the lower q refers to the collision 
cell (an rf-only quadrupole). The selected ion for MS/MS analysis is filtered by the first 
quadrupole and undergoes collision with a stream of inert gas (e.g. helium, nitrogen, 
argon, xenon) within the collision cell. Such a collision will result in the transfer of some 
kinetic energy to internal one, causing ions to fragment. This process is referred to as 
collisionally-activated dissociation (CAD) or collision-induced dissociation (CID) 
(Jennings, 1968; McLafferty et al., 1973). CID can in turn be divided into high and low-
energy; the latter is associated with QqQ and Q-ToF (introduced below). High CID is 
observed with sector instruments that operate at high accelerating potential (in the order 
of Kilo electrvolts-keV) and it has been reported that charge driven fragmentation is 
dominant in case of high-energy CID (Gross, 1992). The accelerating potential is, 
however, less than 100 eV in the case oflow-energy CID and it was shown that neutral 
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losses are the main mechanism by which fatty acids, for example, are fragmented 
(Kerwin et al., 1996). CID is not the only process for precursor ion fragmentation, as 
alternative methods were developed including, for example, surface induced dissociation 
(Dongre et al., 1996) and electron-capture-induced dissociation (Kelleher et al., 1999). 
In a QqQ mass spectrometer, three quadruples are connected; however, an 
MS/MS which carries different analyzers is termed a hybrid mass spectrometer. One of 
the most widely used ones, capable of low-energy CID analysis, is Q-ToF mass 
spectrometer. 
1.1.3.4. Hybrid quadrupole orthogonal time-of-flight mass spectrometry (Q-ToF): 
the Q-ToF instrument was first described in 1996 (Morris eta/., 1996) as a means 
of combining the scanning capabilities of a quadrupole and the resolving power of a ToF 
analyzer. It can provide high-quality, informative, simple, one-stage MS and tandem 
MS/MS spectra. 
A diagrammatic representation of the Q-Star instrument, manufactured by Applied 
Biosystems, is shown in Figure 1-8. As seen in this figure, this mass spectrometer is 
composed of three quadrupoles linked to a ToF analyzer which is geometrically aligned 
in the orthogonal configuration with respect to the quadrupoles; and, hence, the name 
Q-ToF orthogonal mass spectrometry. The first and the third quadrupoles always operate 
in the rf-only mode. The first is utilized as an ion focusing device and to provide 
collisional cooling of the ions so that the quality of the ion beam is improved 
(Krutchinsky et al., 1998). This quadrupole is usually referred to as qo, while the third 
quadrupole is the collision cell where low-energy CID fragmentation occurs. The second 
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quadrupole is the ion filter portion of the instrument, used during MS/MS analysis. It 
should be noted that all quadrupoles operate in the rf-only mode during simple single-
stage MS analysis. The utilization of the second quadrupole as the analyzer, instead of 
the ToF, is only used for tuning the instrument since the ToF is more efficient for this 
purpose. Due to the crucial role of both the second and third quadrupoles during MS/MS 
analysis, these instruments are usually referred to as QqToF mass spectrometers, where 
the first Q refers to the mass-resolving quadrupole and the second q indicates the collision 
cell (rf-only quadrupole or hexapole). 
One of the major advantages of QqToF instrumentation is its ability to be 
interfaced with either ESI or MALDI with little manipulation of the configuration. The 
association with MALDI is. of great importance as conventional MALDI-ToF cannot 
perform MS/MS experiments. Due to the inherent limitation of a quadrupole in terms of 
mass range, there are, however, difficulties in orthogonal injection of large singly charged 
ions to the ToF. 
Other advantages of QqToF instruments include ease of operation, high 
resolution, high mass accuracy and up to 100-fold increase in sensitivity when compared 
to triple quadrupole (Ens & Standing, 2005). Nevertheless, QqQ instruments are still 
favored for quantitative studies as well as for precursor ion scans in which the "parent" 
ion of a specific fragment can be identified. In such an analysis (with QqQ), the final 
quadrupole is fixed while the first one is scanning. Such functionality can not be as 
efficiently obtained with QqToF instruments as with QqQ mass spectrometers. 
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Figure 1-8: Schematic representation of Applied Biosystems Q-ToF instrument (QSTAR hybrid QqToF). This Scheme 
was generously provided by Applied Biosystens. 
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1.2. Bacterial membranes and lipopolysaccharides 
1.2.1. Background: 
In 1884, Hans C. J. Gram, a Danish bacteriologist, developed a simple 
staining methodology that was capable of distinguishing bacterial microorganisms into 
two major groups (Gram, 1884). This method was named after its inventor so that 
bacteria are either gram-positive (violet color) or gram-negative (red color). This 
discrepancy in the staining properties among various bacteria is directly associated with 
the structure and the composition of the surface membrane. The bacterial cell wall 
protects the interior from the outside environment and provides safe means for 
transporting substances from the inner part to the outside surroundings and vice versa. 
1.2.2. Gram positive bacteria: 
The cell wall of gram positive bacteria is mainly composed of the inner 
phospholipid bilayer, peptidoglycans, polysaccharides and proteins (Seltmann & Holst, 
2002). The reason that these bacteria are colored violet (or dark blue) after gram staining 
is associated with the multilayered peptidoglycan ability to retain the crystal violet stain 
following decolourization with the solvent; this layer is significantly thicker within these 
bacteria than in gram negative ones (Dijkstra & Keck, 1996). Peptidoglycan, also known 
as murein, is a natural polymer that is composed of sugars and amino acids. It is a crucial 
part of the bacterial envelope and plays important role in the mechanical integrity of the 
membrane (Dijkstra & Keck, 1996). The interference in its formation by the 
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antimicrobial agent, penicillin, for example, can inhibit cell growth (Tipper & 
Strominger, 1965; Wise & Park, 1965). 
Another component of the bacterial membrane are polysaccharides which can 
either be linked to peptidoglycans or be present within the membrane as separate entities. 
Those associated with peptidoglycans can be differentiated into two main groups, namely 
teichuronic acids (Ward, 1981) and teichoic acids (Archibald et al., 1968). Other 
polysaccharides include lipoteichoic acids (Wicken & Knox, 1975) and lipoglycans 
(Seltmann & Holst, 2002). There is structural diversity among those carbohydrates which 
have multiple functions such as binding to proteins, attaching to metals, and providing 
phosphate moieties (Schaffer & Messner, 2005). 
Mass spectrometry has been successfully employed for quantitative and 
qualitative research related to these biological glycoconjugates. ESI-MS/MS, for 
example, was coupled to high-performance anion-exchange liquid chromatography to 
study neutral and acidic sugars isolated from various bacteria (including bacilli), grown in 
phosphate-restricted environments (Wunschel et al., 1997). The investigators 
successfully utilized this system for both structural confirmation and for selective 
quantification of these carbohydrates. Similarly, MALDI-ToP was recently used, in a 
study which evaluated the influence of acyl chains on lipoteichoic acid function, to 
confirm the deacylation process of pneumococcallipoteichoic acid (Kim et al., 2005). 
Despite its successful usage for studying polysugars isolated from gram positive bacteria, 
mass spectrometry has been much more appreciated, as shown below, for studying the 
molecular structure of lipopolysaccarides associated with gram negative bacterial 
membranes. 
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1.2.3. Gram negative bacteria: 
The major structural differences between gram negative and gram positive 
bacterial membranes is the presence of inner and outer portions in the former as well as a 
coat of lipopolysaccharides (the outermost part of gram negative bacterial membrane). 
Both inner and outer membranes are composed of phospholipids (mainly glycerol-
phospholipids) and proteins. The peptidoglycan layer is located within the gelatinous 
material, called periplasm, which separates the two layers. This peptidoglycan layer 
cannot retain gram staining; in fact, the gram procedure will dissolve the outer membrane 
and partially destroy the peptidoglycans (Beveridge & Davies, 1983) so that it cannot 
keep the original dye color. The outer leaflet of the outer membrane is mainly composed 
of the amphiphilic LPS moieties that contain a lipid portion (lipid A) embedded into the 
membrane environment. Figure 1-9 represents the configuration of gram positive and 
negative envelope structures. 
1.2.4. Lipopolysaccharide (LPS): 
LPS, also known as endotoxin, is a major component of gram negative bacterial 
membranes. Endotoxin as a concept was first described at the end of the 1800s by the 
German investigator, Richard Pfeiffer, ''the father of endotoxin" (Rietschel & Cavaillon, 
2003). LPS moieties can be isolated from the bacterial cell wall by the aqueous phenol 
method (Westphal eta/., 1952) and these isolates can then be subjected to biological and 
structural studies. Various portions of LPS have been used, in small amounts, for 
therapeutic purposes, such as, vaccines (Pupo eta/., 1999) and anticancer medications 
(Reisser eta/., 2002). LPS can be divided into three main parts: the lipid A, the core 
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region and the hydrophilic 0-antigen. The general backbone of an LPS moiety is 
presented in Figure 1-10. 
1.2. 4. 1. Lipid A: 
Lipid A is the portion of the molecule by which LPS is anchored to the cell 
membrane. It is the most toxic part of LPS whose biological activity is strongly 
associated with this lipid. It gives the amphiphilic LPS moiety its hydrophobic 
characteristics and it is the least heterogeneous part of the LPS molecule. Lipid A is 
basically composed of a hi-phosphorylated ~-(176)-linked glucosamine backbone. Fatty 
acids are attached to this backbone at positions C-2, C-3, C-2', and C-3' via both ester and 
amide linkages. These fatty acids are commonly present in the hydroxylated form 
(usually at position C-3 or C-2 of the fatty acids) and hence the hydroxyl group can be 
esterified with additional fatty acid residues. 
The number and the length of lipid A's fatty acids vary among different species. 
While ESI-MS-MS analysis of Enterobacter agglomeranas lipid A, for example, revealed 
the presence of 6 fatty acids including three C14 (3-0H), one C14, one C16, and two C1z 
(Chan & Reinhold, 1994). The lipid A isolated from Burkholdria cepacia, a plant 
pathogen, bears 5 fatty acids, two C16 (3-0H), two C14 (3-0H) and one C14 (Silipo et al., 
2005). MALDI-MS analysis has, however, shown that the latter extract was a mixture of 
penta- and tetra-acylated lipid As; the tetra-acy1ated one lacks the C14 fatty acid residue 
(Silipo et al., 2005). Despite the fact that lipid A fatty acids usually contain 10-16 carbon 
atoms, it has been shown that other unusual chains such as C18 and Czo exist within some 
isolates; for example, they are associated with the lipid A isolated from Chlamydia 
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Figure 1-9: Simplified schematic representation of gram positive and gram negative bacterial membranes. The scheme 
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inner and outer membranes. The peptidoglycan layer is significantly thicker in gram positive bacteria so that it can retain the 
initial gram dye. 
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trachomatis, a common infectious agent (Heine et al., 2003). The length of these fatty 
acids has a major influence on the toxicity of lipid A, with the most toxic ones, bearing 
C12, C12(0H), C14, and C14(0H) (Caroff & Karibian, 2003). Unsaturated fatty acids are 
rarely observed and, if present, they usually exist as a mixture with the saturated 
counterparts (Schwudke et al., 2003; Zdorovenko et al., 2001). LPS natural extracts, 
including lipid A, are complex mixtures of structurally-related glycoforms. This is 
mainly due to the presence of various. biosynthetic pathways and degradation during the 
isolation process. Mass spectrometry is capable of analyzing these mixtures, illustrating 
the exact molecular structure of each constituent (Mikhail et al., 2005) which can vary 
depending on growth conditions such as the temperature (Corsaro et al., 2004a). In 
addition, these complex biological glyco-mixtures are excellent candidates for qualitative 
and quantitative analysis by capillary electrophoresis interfaced with mass spectrometry 
(CE-MS) (Li et al., 2005). 
In addition to the substitution with fatty acids, phosphate, and sometimes 
pyrophosphate groups, usually exist at positions C-1 of the reducing glucosamine residue 
and C-4' of the non-reducing end (Rund et al., 2000; Ummarino et al., 2003). These 
phosphate groups can be in tum substituted with phosphoryl-ethanolamine (Kelly et al., 
1996), ethanolamine, or occasionally neutralized with other substituent, such as 
arabinosamine (Silipo et al., 2005). Structural studies of lipid A, in which mass 
spectrometry is an instrumental tool, are highly important with respect to its biological 
activity. For example, lipid A is generally considered a pro-inflammatory agent; some 
synthetic analogues have, however, been evaluated successfully as antagonistic factors 
against Esherchia Coli lipid A (Demchenko et al., 2003; Peri et al., 2006). This 
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discrepancy in the effects among such related structures is related to the exact structure of 
these active biological substances. 
1. 2. 4. 2. The core region: 
The second portion of LPS, namely the core region, is less conserved among 
species in comparison to lipid A. This part can be further divided into two subdivisions, 
the inner and outer cores (see Figure 1-1 0). The use of mutant bacterial strains bearing 
only the inner core can efficiently facilitate mass spectrometric analysis and structural 
determination (Olsthoom et al., 1999; Radziejewska-Lebrecht et al., 1994). These mutant 
bacteria are usually referred to as "rough mutant" because of the glossy colony 
morphology in comparison to the wild-type that are, in tum, termed "smooth" due to their 
unwrinkled visible colony texture. Notably, these rough-type bacteria can only grow in 
vitro and are more sensitive to antibiotics (Vaara, 1993). 
The inner-core region is usually composed of 8-12 branched sugars including a 
unique 8-carbon residue at the reducing end of the chain, namely a-3-deoxy-D-manno-
oct-2-ulosonic acid ("Kdo"), which has proven to be critical for the LPS biological 
activity (Haeffuer-Cavaillon et al., 1989). Kdo is the "linkage" between lipid A (usually 
through position C-6 of the non-reducing end) and the poly-sugar and this linkage is 
susceptible to mild-acid hydrolysis. Kdo can be substituted with additional one or two 
Kdo moieties. All of the sugar units within the inner core of Chlamydophila psittaci, 
which can infect both humans and animals, contained only Kdo units (Rund et a/., 2000). 
This inner core was composed of either three Kdo's (a-Kdo-(278)-a-Kdo-(274)-a-Kdo-
(276)-Lipid A) or four Kdo's with a branched moiety (a-Kdo-(274)-[a-Kdo-(278)]-a-
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Kdo-(2~4)-a-Kdo-(2~6)-Lipid A) (Rund et al., 2000). Traditionally, the presence of 
Kdo moieties was determined by the thiobarbiturate-based colorimetric assay, used as a 
characteristic test for taxonomic classification (Jann et a/., 1973). This test, however, 
fails to detect LPS with a single Kdo as in the Vibrio family (Caroff eta/., 1987). Mass 
spectrometric analysis, however, has overcome this deficiency, illustrating its presence 
within many species which were previously believed to lack Kdo (Banoub eta/., 1983; 
Brade, 1985). While Kdo can be considered a characteristic sugar in LPS, a few bacterial 
species (e.g. Yersinia pestis) contain Kdo analogues, such as D-glycero-D-talo-oct-2-
ulosonic acid ("KO") (Vinogradov et al., 2002). Similar to other sugars within LPS 
moiety, Kdo can be substituted with reactive groups such as phosphate or 
phosphoethanolamine (Li eta/., 2004). Another unique sugar within the LPS inner core 
region is L-glycero-D-manno-heptose (Hep) which is a 7-carbon sugar; some bacteria, 
however, lack Hep residues (Mollet a/., 1997). 
The outer core varies greatly and consists of hexoses, primarily glucose (Glc), 
galactose (Gal), N-acetyl-galactosamine and N-acetyl-glucosamine (GlcNAc). All of the 
core sugars are in the pyranose form and, in general, have the a-anomeric configuration. 
It should be noted that heptoses can also be present in the outer core and hexoses were 
identified in the inner core region, as in the case of Yersinia enterocolitica, in which is 
composed of a heptasaccharide, including 2 units ofD-Glc (Radziejewska-Lebrecht et al., 
1994). In all of the above investigations, mass spectrometry was an essential tool for 
studying the structure of these complex biological mixtures. Moreover, MS-MS has 
proven to be capable of evaluating these glycoconjugates without the need for tedious, 
time-consuming, separating techniques (Kondakova eta!., 2005). 
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1. 2. 4. 3. The 0-antigen (the 0-chain): 
Despite its heterogeneity in comparison to lipid A, the core is in tum less 
heterogeneous than the 0-antigen portion. The 0-chain is composed of repeating 
oligosaccharide units of varying six-carbon sugars and its composition is different among 
various genera and bacterial serotypes. This variation can be related to the composition 
of the sugar units within the building block, the position of the 0-glycosidic linkages, and 
the nature of the non-carbohydrate constituents. This 0-chain is exposed directly to the 
host during infection and it has a protective role from the surrounding environment. It 
has been demonstrated, for example, that wild-type bacteria can resist antibiotics, 
however, their rough mutant counterparts (lacking the 0-chain poly-sugar) are sensitive 
to antibiotic effects (Banemann et al., 1998). 0-antigen is also responsible for adhesion 
to the tissues during infection (Paradis et a/., 1994). This 0-chain can be branched, 
substituted with non-carbohydrate substituents such as phosphate and amino acids (Caroff 
& Karibian, 2003). In some pathogens, the 0-antigen is absent; however, the inner core 
is well-recognized and mono and oligosaccharide branches are extended from the core; 
such glyco-chains of the bacterial membrane are refereed to as lipooligosaccharides 
(LOS) rather than lipopolysaccharides (LPS) (Raetz & Whitfield, 2002). 
1.2.5. LPS-derived vaccines: 
1.2.5.1. LPS-protein conjugates: 
LPS derivatives have been mostly appreciated for their potential use as vaccine 
candidates. Bacterial LPS is the major contributor to the host immune reaction and 
hence, it has been successfully utilized for vaccination. The significance of LPS can be 
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illustrated with the use of LPS antibodies which can protect against infection (Bowden et 
al., 1995; Fulop et al., 2001). LPS when injected alone is not immunogenic as it can 
escape recognition by the immune system due to its relatively small size. LPS conjugated 
to a protein carrier, however, can provoke the desired immunological reaction and can 
induce prolonged immunity. The first attempts to test protein conjugates as immunogens 
dates back to the late 1920s by Landsteiner's group (Ada & Isaacs, 2003). Shortly after, 
A very and Goebel illustrated that bacterial carbohydrate-protein conjugates can induce 
strong antibody response (A very & Goebel, 1929). The sugar portion of a carbohydrate-
protein conjugate is usually referred to as a hapten which originates from the Greek verb 
"haptein", meaning to fasten (Soanes & Stevenson, 2005). 
The linkage between the LPS backbone and the protein carrier can be either a 
direct linkage or with the aid of a suitable spacer. Many protein carriers have been 
evaluated for the production of LPS-derived vaccines such as bacterial toxoids [e.g. 
tetanus toxoid (Gu eta/., 2003)], outer bacterial membrane proteins (Wu eta/., 2005) and 
bovine serum albumen (BSA) (Chernyak eta/., 2002). Regardless of the nature of the 
protein carrier, it should be stable, safe and capable of enhancing LPS immunogenicity. 
The first commercially available glycoconjugate vaccine was licensed in the late 1980s 
against Haemophilus influenza type b (Hib) and this work was originally pioneered by 
Schneerson and co-workers (Schneerson eta/., 1980). The infection has been virtually 
eliminated in countries where widespread vaccination among the general public has been 
executed (Robbins eta/., 1996). 
While many studies have focused on using natural LPS for the development of 
LPS vaccine conjugates, synthetic carbohydrate chains that mimic LPS epitopes (the part 
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of an antigen recognized by the immune system) seems to be evolving as a promising 
approach for the production of LPS-protein conjugates. Pavol Kovac's group, for 
example, has been spearheading the production of BSA-hapten conjugates that bear 
synthetic mono-, tetra- and hexa-sugars which mimic the terminal part of the 0-specific 
polysaccharide of the Vibrio cholerae, serotype Ogawa (Ma eta!., 2003; Zhang eta!., 
1998). Their novel conjugate (bearing the hexa-sugar) has shown protective immunity 
within mice (Chemyak et a!., 2002). BSA-LPS derived from the Vibrio cholerae, 
serotype Inaba (despite structural similarities to Ogawa) failed, however, to achieve this 
protective immunity (Meeks eta!., 2004). This has been attributed to the possibility that 
either the terminal sugars of Inaba are not protective epitopes or the delivery system was 
not optimized. The only difference between those two species lies within the terminal 
sugar which is characterized by a hydroxyl group at the 2 position in Inaba but a 2-0-
methyl group in Ogawa. The investigators have successfully utilized SELDI-MS to 
evaluate the degree ofBSA-sugar conjugation and have presented very promising results 
with respect to controlling the reaction and the degree of substitution (Ma eta!., 2003; 
Saksena eta!., 2003). These results, based on MS analysis, can have significant industrial 
impact during commercial production as it relates to quality control and quality 
assurance. 
1.2.5. 2. Liposome-derived vaccines: 
In addition to LPS-protein conjugates, liposomes have been used to present LPS 
as antigens within living organisms. Liposomes were first introduced in 1965 (Bangham 
et a!., 1965a; Bangham et a!., 1965b) as artificial cell membranes and were in 1974 
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evaluated as potential drug carriers (Gregoriadis et a/., 1974). Liposomes are self-
assembled in an aqueous medium that contains a suitable lipid mixture. They are 
currently one of the most widely used drug delivery systems capable of encapsulating the 
newest biologically-derived drugs, namely proteins, DNA and carbohydrates. 
Since liposomes have both hydrophobic and hydrophilic compartments, they can 
efficiently encapsulate amphiphilic LPS derivatives. Natural or modified lipid A-
liposome complexes are well-established as potent non-toxic adjuvants (Alving et a/., 
1992). Monophosphoryl lipid A, · for example, has been used successfully for 
immunotherapy in a clinical setting as a vaccine adjuvant to treat colorectal cancer 
patients (Neidhart eta/., 2004). Similarly, a cocktail of complete-core LPSs of four gram 
negative bacteria were encapsulated within multilamellar liposomes, producing an 
immunogenic and nontoxic formulation (Bennett-Guerrero et a/., 2000; Erridge et a/., 
2002). It should be mentioned that different LPS portions can have different effects in 
terms of toxicity and immunogenicity. LPS mutant-liposome complexes of Neisseria 
meningitidis were, for example, more potent and less toxic vaccines than the wild-type 
LPS or lipid A liposomal formulations (Arigita eta/., 2005). 
Regardless of the composition of a liposomal drug delivery system, these lipid 
spheres have an inherent deficiency in terms of stability and short half life within the 
circulation. These drawbacks have been the target for considerable research activity. 
Testing various lipid mixtures, reducing the size, and manipulating the zeta potential 
value are few examples of variables which have been evaluated to encounter the 
stability/short-half life problem (Wu & Zern, 1996). The usage of pegylated liposomes 
(i.e. liposomes bearing polyethylene glycol (PEG)) have been very useful in increasing 
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stability and to enhance liposomal efficiency as drug carriers (Simoes et al., 2004). In 
addition, these PEG chains can serve as arms to attach ligands for specific organ targeting 
(El Aneed, 2003). PEG influences liposomal formulation mainly through steric hindrance 
(sterically-stabilized liposomes). PEG-liposomes have been tested for different purposes 
including the encapsulation of LPS derived carbohydrate moieties, such as lipid A (Park 
& Huang, 1993). 
1.2.5.3. Neoglycolipids-stabilized liposomes: 
Synthetic carbohydrate residues linked to a lipid component via a suitable spacer 
can readily be incorporated into the surface bilayer of liposomal formulations. Such 
structures are termed neoglycolipids and have proven to efficiently enhance liposomal 
stability and to increase their circulatory half-life. In addition, the sugar portion of these 
novel glycoconjugates can effectively target liposomes to specific cells or organs (Duffels 
et al., 2000). It is believed that the glycosylated species will create a repulsive steric 
barrier that prevents molecular aggregation and adhesion. It has shown for example that 
the addition of 5 % oligomaltose distearoylphatidylethanolamine conjugate to a liposomal 
formulation can eliminate lipid aggregation in comparison to conventionalliposomes (Xu 
et al., 2002). Over a 10-h period, the turbidity was increased eightfold in conventional 
liposomes in contrast to the merely 5% in the neoglycolipid-stabilized liposomes. It was 
also shown that liposomal efficiency as drug carriers was significantly enhanced with the 
use ofneoglycolipid-coated liposomes (Perouzel et al., 2003). 
These novel liposomal structures can encapsulate various compounds including 
antigens. Neoglycolipid-stabilized liposomes were loaded, for example, with HIV 
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glycoprotein antigen enhancing the targeting ability of these formulas towards antigen 
producing cells (Fukasawa eta/., 1998). To validate the molecular structure of these 
synthetic compounds, mass spectrometry has been efficiently used (Pohlentz & Drees, 
2000; Pohlentz eta/., 1994). 
1.3. Mass spectrometric analysis of carbohydrates 
Carbohydrate chains are polymers of sugar units that are linked by glycoside 
bonds which resemble, in principle, peptide bonds in proteins. Mass spectrometry of 
proteins and peptides is a well-established science where significant information with 
regard to the sequence, structure and post-translational modifications are routinely 
obtained. During MS and MS/MS analysis, breakages at the peptide bonds are the most 
informative ones. Similarly, breakage at the glycoside bonds can be very useful in terms 
of structural determination of carbohydrates. Inner-sugar fragments can also serve as 
diagnostic fragment ions used to precisely illustrate the structure of the studied 
carbohydrate chains. Figure 1-11 is a theoretical representation of possible 
fragmentations of a simple di-sugar, namely lactose (P-D-Gal_.e-(1 ~4)-D-Glc_.e) where the 
reducing end is Glc (glucose) and the non-reducing unit is Gal (galactose). In this figure 
and in the following chapters, the systematic nomenclature for carbohydrate 
fragmentation by F AB MS/MS proposed by Domon and Costello (Domon & Costello, 
1988a; Domon & Costello, 1988b) is used. As can be seen from Figure 1-11, fragments 
that result from the elimination of the reducing end and the formation of ions containing 
the non-reducing end are referred to as A, B, and C with A being related to inner sugar 
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fragments. The fragment ions, however, that bear the reducing end are termed Z, Y and 
X with the latter being associated with inner~sugar fragments. Due to the many possible 
inner sugar breakages, specific numbers that represent the bond being broken are used to 
distinguish a specific fragment (see Figure 1-11 for details). In addition, this letter-coded 
representation is also numbered based on the sugar where fragmentation occurs, with the 
non-reducing end being 1 in case of A, B, and C ions, while the reducing end is numbered 
1 in the case of Z, Y. The X-type ions are numbered 0 if occurred within the reducing 
end group. Note that in a simple di-sugar B, C, Z, and Y fragments will not be assigned 
any number due to the absence of additional sugars (i.e. all can be numbered 1). 
However, both A and X ions are coded in this figure is based on the position of the 
breakage as well as on the sugar unit being fragmented. 
2,4A 
1 B c 
z 
o,2A 
OH 2 
5 
1 
OH 
o,2x 
0 
Figure 1-11: Theoretical possible fragmentation of a lactose sugar. Breakages at the 
glycoside linkage are termed B and C when retaining the non-reducing end sugar, 
while Z and Y refer to fragments that contain the reducing end. Inner sugar 
fragments are termed X and A ions, where the A ion retains the non-reducing end 
and X contains the reducing end. These inner sugar fragments are labelled based on 
the broken bond (numbered 0-5, as shown on the reducing end). 
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1.4. Research objective 
The objective of this work is to generate mass spectrometric fingerprints and establish 
fragmentation patterns of natural and synthetic glycoconjugates. These fingerprints can 
be used to evaluate and predict the mass spectrometric patterns of similar structures and 
can be efficiently used for quantitative purposes. The state-of-the-art ESI-MS, MALDI-
MS and MS/MS are used to achieve this goal and to elucidate the molecular structures of 
these compounds. 
1.4.1. Natural lipopolysaccharide: 
This study will evaluate the mass spectrometric fingerprints of both known and 
unknown structures of rough and smooth LPS isolated from the fish pathogen Aeromonas 
salmonicida. This gram negative bacterium is the etiological agent of a fatal disease, 
termed furunculosis, in salmonid fish which can result in significant loss in fish stocks. It 
is one of the oldest described fish pathogens and was first reported in 1894 (Austin & 
Austin, 1999). There are three main subspecies of A. salmonicida (Belland & Trust, 
1988) and the one investigated in this document is A. salmonicida subspecies 
salmonicida. Similar to any LPS, A. salmonicida LPS can serve as a potential vaccine 
that can have a positive impact on aquaculture. An additional benefit of the use of LPS 
vaccines in farmed fish is related to the possible reduction in the use of antibiotics in a 
food product; furthermore, bacteria can develop resistance to these antibiotics over time, 
reducing their therapeutic efficiency. Over a 10-year time period in Norway, for 
example, the use of fish vaccines was increased almost 1 0 times while the use of 
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antibiotics was reduced from 48,500 Kg to merely 1,010 Kg (Hastein et al., 2005). Both 
LPS-BSA conjugates and LPS-liposome complexes of A. salmonicida were successfully 
formulated (Banoub et al., 1989; Nakhla, 1995). 
The core and the lipid A antigens from A. salmonicida are both investigated in this 
work. While the exact molecular structure of lipid A is established for the first time, the 
structure of the core region was recognized over 20 years ago by Banoub and co-workers 
(Banoub et al., 1983; Shaw eta/., 1992). However, there is no information with respect 
to the ESI-MS-MS and MALDI-MS-MS fragmentation pattern of this core. MS analysis 
in this study established for the first time the mass spectrometric fingerprints of these 
biological extracts and suggested the molecular structure of the lipid A. The proposed 
structure of the LPS core region was also confirmed by ToF-MS and MS-MS 
experiments. In addition, the analysis revealed the presence of a phosphate group at the 
reducing end (i.e. the Kdo residue) which had not previously been recognized. 
1.4.2. Novel synthetic cholesteryl neoglycolipids: 
Boullanger's research group at the Universite Claude Bernard, France, has been 
pioneering the chemical synthesis of novelliposomal cholesteryl neoglycolipids that link 
sugar residues to a cholesterol moiety via a poly-ethoxy variable spacer (Boullanger et 
a/., 1995b; Kemoun et a/., 1999; Lafont et a/., 1996; Laurent et al., 2006). These 
glycojugates can be arranged on the liposomal surfaces increasing stability and enhancing 
their targeting capabilities (Faivre eta/., 2003; Gelhausen et al., 1998). 
This investigation authenticated the proposed structure of a ·series of novel 
cholesteryl neoglycolipids by mass spectrometry and established the ESI-MS-MS 
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fingerprints. The most striking finding was, however, the presence of a unique ion-
molecule reaction that yields the production of an unexpected C-glycoside species. This 
novel mass spectrometric phenomenon along with the establishment of a universal 
fragmentation pattern was evaluated in 18 new compounds that bear various sugars and 
spacers linked to the lipophilic cholesterol portion. 
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CHAPTER 2: Materials and Methods 
2.1. Lipopolysaccharides: 
2.1.1. Bacterial culture: 
Both the rough mutant and the smooth wild-type strains of A. salmonicida ssp 
salmonicida were obtained from Dr. T.P.T. Evelyn (Department of Fisheries and Oceans, 
Nanaimo, British Columbia, Canada). It was isolated originally from Sockeye salmon 
and is numbered as Strain SJ-15, wild type, and SJ-83, rough mutant, of the collection of 
the Northwest Atlantic Fisheries Centre, St. John's, NL. The cultures were grown to 
medium-to-late stationary phase in Trypticase Soy Broth without added glucose 
(Baltimore Biological Laboratories Inc.) for almost 20 hat 25°C and aeration at 20-1/min 
in a New Brunswick MF-128S fermentor. They were then killed by the addition of0.3% 
formalin with continuous agitation for 16 hrs at room temperature. Cells were 
subsequently collected by centrifugation at 20,000 rpm in a Sorvall SS-34 rotor (48,200 x 
g), washed with NaCl (0.15 M) and finally lyophilized and stored at -50° C until required. 
2.1.2. Purification of the lipopolysaccharides: 
LPS was extracted by the hot-phenol method (Westphal et al., 1952) and freeze-
dried. Basically, stored cells (1 0 g) were suspended in deionized water (175 ml) and 
heated to 70° C. An equal volume of heated phenol (90 %) was added and the mixture 
was stirred for 20 min at 70° C. The mixture was then cooled on ice and centrifuged 
using Sorvall SS-34 rotor (3500 rpm, 1475 x g). The aqueous layer was isolated by 
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aspiration and the procedure was repeated twice. The aqueous layers were combined and 
dialysed against water to remove any traces of phenol. Furthermore, the volume of the 
combined water mixture was reduced by evaporation (under vacuum) and finally 
centrifuged at 39,000 rpm (105,000 x g) for 3 hours. The LPS pellet was resuspended in 
water and centrifugation was repeated twice; LPS was finally lyophilized. 
LPS isolates were further purified using polymyxin-coated Affi-prep beads (Bio-
Rad Laboratories, Richmond, CA, USA). Fifteen milligrams of LPS was suspended in 15 
ml of phosphate-buffered saline (PBS, PH=7.4). LPS solution was then mixed with 
washed polymyxin beads (the beads were originally washed first with 0.1 M NaOH and 
then distilled H20). The mixture was incubated overnight with agitation using an orbital 
Shaker (1500 rpm). The mixture WaS then Centrifuged (2500 X g) for 10 min and the 
supernatant was collected. The beads were then washed twice with 15 ml and 5 ml 0.1 M 
NaOH. The supernatants were combined and LPS was dialysed against water and finally 
lyophilized. 
2.1.3. Hydrolysis of the lipopolysaccharides: 
LPS (1 00 mg) was hydrolyzed with 1% acetic acid for 90 min at 100°C. 
Centrifugation at 3000 x g for 30 min resulted in the precipitation of lipid A, while the 
polysaccharide was present in aqueous media. Lipid A was removed and washed with 
water, and the core oligosaccharide was recovered from the supernatant by 
chromatography on Sephadex G-50 (Pharmacia Ltd.). Fractions were visualized using a 
differential refractive index monitor (Waters Associates). 
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2.1.4. Methylation of the core oligosaccharide: 
Methylation was performed on the core region and was carried out according to 
the method ofHakomori (Hakomori, 1964). Briefly, 1-2 mg of the sample was dissolved 
in Dimethyl sulfoxide (DMSO) with the aid of stirring at room temperature (ultrasonicate 
if necessary). An aliquot of 0.4 ml of methylsulfinyl carbanion was added 
(methylsulfinyl carbanion was prepared by mixing NaH/oil (50 mg) with 1 ml DMSO 
with stirring and subsequent flushing with N2 for 20 secondes. Subsequent agitation at 
50-60° C for one hour; H2 was allowed to escape the reaction vessel). The reaction 
mixture was stirred for 1 hr at room temperature. One ml of CH3I is added to the mixture 
and agitate for 4 hrs. The methylated core oligosaccharide was purified on columns of 
Sephadex LH-20, eluted with chloroform, evaporated, weighed and dissolved in methanol 
for MALDI-MS, ESI-MS and CID-MS/MS analyses. 
Please note that all the pre-mass spectrometric analysis work, namely isolation, 
purification and methylation of LPS, was performed by the technical staff in Fisheries and 
Oceans Canada (DFO), St. John's, NL, Canada. 
2.1.5. Electrospray Quadrupole Orthogonal Time-of-Flight Mass Spectrometry: 
Mass spectrometry was performed using an Applied Biosystems API QST AR XL 
MS/MS quadrupole orthogonal time-of-flight (QqTOF)-MS/MS hybrid instrument 
capable of analyzing a mass range of m!z 5-40,000 with a resolution of 10,000 in both the 
positive and the negative ion modes. ESI was performed with a Turbo Ionspray source 
operated at 5.5 kV at a temperature of 80°C. Traces of lipid A were dissolved in 
dichloromethane/methanol (1:1) so that the final concentration was 0.5 mg/ml. The 
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solution was then electrosprayed underivatized in the negative ion mode. Aqueous 0.5% 
taurocholic acid solution (Applied Biosystems, Foster City, CA) was added to the sample 
for ToF calibration (exact mass [M-Hr = 514.2838). Nitrogen was used as the collision 
gas for MS/MS analysis with collision energies (CE) varying between -35 to -100 eV. 
In the cases of the core oligosaccharides, samples from the underivatized 
homogeneous mixture were dissolved in water for ESI in the negative ion mode while for 
the positive ion mode, the sample was dissolved in water/methanol/formic acid 
(90/9.9/0.1). Permethylated oligosaccharide mixtures were analyzed in the ESI-positive 
ion mode. Mixtures were prepared as 0.5 mg/ml solutions in methanol and aliquots (25 
!!L) were infused into the mass spectrometer with an integrated Harvard syringe pump at 
a rate of 10 !!Limin using the Turbo Ionspray source, operated at 5.5 kV at a temperature 
of 80-1 00°C. For the positive ion mode, the ToF analyser was calibrated with renin 
(Applied Biosystems, Foster City, CA), exact mass [M+Ht = 1758.9326; 
[M+2H]2+=879.9699. For CID MS/MS, the CE was set so that the selected precursor ion 
remained abundant (10 to 100 eV), and CID gas pressure was varied between 4 and 12. 
2.1.6. Electrospray Quadrupole-Hexapole-Quadrupole Mass Spectrometry: 
The ESI mass spectra (negative and positive ion modes) were recorded with a 
Micromass Quattro quadrupole-hexapole-quadrupole mass spectrometer equipped with a 
megaflow ESI source capable of analyzing ions up to mlz 4000. A personal computer 
(Compaq PII 266 MHz processor running Windows NT 4, service pack 3) equipped with 
Micromass MASSL YNX 3.2.0 Mass Spectrometry Data System software was used for 
data acquisition and processing. The temperature of the ESI source was maintained at 
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75°C. The operating voltage of the ESI capillary was 3.00 kV and the high voltage lens 
was set to 0.40 throughout the whole operation. ESI-MS were recorded with a cone 
voltage of 25V. MS/MS experiments were conducted using the same instrument. 
Product ion scans of selected masses were induced by collision with argon in the (r.£ 
only) hexapole. The resulting product ions were analyzed by the second quadrupole. 
Collision energieS- varying from 20 to 35 eV and a collision gas pressure in the collision 
cell varying from 3.5 x 104 to 6.5 x 104 mbar (1 bar= 105 Pa) were used in all MS/MS 
experiments. The collision gas (nitrogen) pressure was increased to induce the 
dissociation of the sodium adduct ions. Precursor ion scans were performed when needed 
of mass-selected ions which were induced by collision with argon in the (r.f.-only). 
1.1. 7. Matrix assisted laser/desorption ionization (MALDI) mass spectrometry: 
Samples for MALDI-MS analyses were prepared by mixing equal volumes of2,5-
dihydroxybenzoic acid (MALDI-Quality™ Matrix Solutions, Agilent Technologies) and 
a solution of 1 mg mr1 of the core oligosaccharide mixture. 0.5 ~L of this solution was 
loaded onto the sample plate. Alternatively, matrix solution was first spotted on the 
MALDI plate followed by spotting the analyte. Mass spectra from MS and MS/MS 
experiments were acquired on the same QST AR XL instrument described previously, 
equipped with a N2 laser oMALDI® source. The laser parameters were set to 25 Hz 
pulsed frequency at 25% power energy. For MS/MS experiments, collision energy was 
ramped from 40 to 1 OOe V to optimize the fragmentation of each individual precursor ion. 
Argon was used instead of nitrogen as CID gas; to ensure better fragmentation in the 
collision cell. 
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2.1.8. Gas chromatography-electron impact- mass spectrometry (GC-EI-MS): 
GC-EI-MS analysis was performed on a Varian Saturn 2000 GC MS/MS 
instrument equipped with Zebron capillary column (30m x 0.25 mm). Helium was used 
as the carrier gas. Lipid A was treated with 2M HCl in methanol (methanolysis) for 3 hrs 
at 100° C. Methyl esters were extracted by hexane and analyzed on GC-EI-MS in 
comparison with standard methyl esters (Supelco, Bellefonte, P A, USA). GC analysis of 
methyl esters was performed with following temperature program: 100° C for 5 min, 100° 
7 280° C at 5° C/ min, 280° C for 5 min. The methyl ester fatti acid analysis showed 
the presence of two major components namely 3-hydroxymyristic acid (C14:0(3-0H)) 
and lauric acid (C12:0) in a molar ratio of2:1 and minor traces of myristic acid (Cl4:0), 
3-hydroxytridecanoic acid (C13:0(3-0H)), palmitoleic acid (C16:1), palmitic acid 
(C16:0), and 3-hydroxypentadecanoic acid (C15:0(3-0H)). 
2.2. Synthetic cholesteryl neoglycolipids: 
2.2.1. The synthesis of the neoglycolipid derivatives: 
In these amphiphilic neoglycolipid cholesteryl derivatives, the cholesterol and the 
carbohydrate moieties were attached either by means of a polyethoxy variable spacer or 
with no spacer, as in the case of simple 0-glycosides. The general molecular structure of 
these compounds is presented in Figure 1-2. The synthesis of neoglycolipids 1-
3(Boullanger et al., 1995a; Lafont et al., 1996), 4(Lafont et al., 1997), 6(Boullanger et al., 
1995a; Lafont et al., 1996), 2 (with deuteriated chains) and S(Bardonnet et al., 2005; 
Laurent et al., 2006) were performed as reported earlier. The chosen carbohydrate 
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portion was: D-glucosamine (GlcNH2) (1), N-acetyl-D-glucosamine (GlcNAc) (2), N-
trideuterioacetyl-D-glucosamine (GlcNHCOCD3) (3), N-acetyllactosamine (LacNAc) (4), 
L-fucose (Fuc) (5), N-allyloxycarbonyl-D-glucosamine (GlcNAloc) (6), and the 
corresponding per-0-acetylated derivatives of GlcNAloc and LacNAc carbohydrate 
·residues (protected sugar species). The total number of neoglycolipids investigated in 
this study was 18. 
~0. H~0~o-[spacer]-Cholesterol 
NH2 
(1) [spacer] = none and (CH2CHzOh 
OH H~~Q-[spacer]-Cholesterol 
NHAc 
OH H~~O-[spacer]-Cholesterol 
NHCOCD3 
(2) [spacer]= (CH2CHzO)n with n=0-3, and 
CD2CH20CH2CH20CH2CH20, 
(3) [spacer] ={CH2CH20)3 
CH2CH20CH2CH20CD2CH20, 
CH2CH20CD2CH20CH2CH20 
~~Q OH HO~~~O-[spacer]-Cholesterol 
OH NHAc 
(4) [spacer] ={CH2CH20h 
tt~o oAc AcO~~~O-[spacer]-Cholesterol 
OH H~~O-[spacer]-Cholesterol 
NHCOOCH2CH::;CH2 
(6) [spacer] n=0,4 
OAc A~~~O-[spacer]-Cholesterol 
NHCOOCH 2CH=CH2 
OAc NHAc 
(4) [spacer] ={CH2CH20h, acetylated form 
0-[spacer]-Cholesterol WaH 
HO OH 
(5) [spacer] =(CH2CH20)4 
(6) [spacer] = 0,4, acetylated form 
Figure 2-1: The molecular structures of cholysterly neoglycolipids evaluated in this study 
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2.2.2. Electrospray Quadrupole Orthogonal Time-of-Flight Mass Spectrometry: 
Mass spectra of the neoglycolipid derivatives were acquired in the positive ion 
mode. All experiments were performed with an Applied Biosystems, API QST AR XL 
MS/MS quadrupole orthogonal time-of-flight (QqToF-MS/MS) hybrid tandem mass 
spectrometer. Traces of the neoglycolipid derivatives were dissolved in methanol or 
methanolldichloromethane (1: 1 ). Sample solution was then infused into the mass 
spectrometer with an integrated Harvard syringe pump at a rate of 5 f.!L/min using the 
- -
Turbo Ionspray Source. Formic acid was added to increase the formation of the [M+Ht 
protonated molecules. 
2.2.3. The influence of Declustering Potential (DP) and Focusing Potential (FP) on ion 
formation: 
DP and FP are electrical voltages within the ESI ionization source that have the 
greatest effects on in source fragmentation. In order to study the influence ofDP and FP 
on the ton count, the neoglycolipids were dissolved m methanol or 
methanolldichloromethane (1:1) such that the final concentration was 100 nmollml. 
Randomly selected values ofDP and FP were obtained using Microsoft Excel. Ion count 
of different ions was measured three times for each condition. All other instrument 
parameters were kept constant (Ion Source Gas 1 = 25, Ion Source Gas 2= 0, Curtain Gas= 
20, Temperature= 0, and DP2= 1 0). 
DP and FP values were randomized within the instruments' allowed ranges (DP [-
1 0,350] and FP [0,480]). The number of ion counts was performed for each combination 
of DP and FP values. Then, the correlation between ion counts and DP or FP values were 
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evaluated using the Spearman Rank Correlation coefficient (rspearman).(Conover, 1999) 
After these initial tests (see Chapter 6), it was clear that only DP has influence on the ion 
count. Considering this result, the shape of the relationship between ion count and DP 
obtained from the formation of the C-Glycoside with the ones obtained from the 
formation of other ions, namely [M+Ht and [(Sugar-Spacer)+Ht were compared. These 
pair-wise comparisons were made using the 2-samples Kolmogorov-Smimov Test 
(Conover, 1999). Ion counts from each experimental run were normalized to its 
maximum to ensure comparability among experiments (i.e. comparing the shape of these 
distributions, not their absolute magnitudes). 
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CHAPTER 3: Mass Spectrometric Analysis of A. salmonicida Lipid A 
3.1. Backgroud: 
Lipopolysaccharides (LPS) have been the center of considerable research activity. 
They have been recognized as the most significant biological components of the outer 
membranes of gram-negative bacterial cells and are the major contributor to the antigenic 
activity of these bacteria. It has been well established that LPS derivatives are potential 
candidates for bacterial vaccine development (Erridge et al., 2002; Fattom et al., 1999; 
Kawai et al., 2002). 
Lipid A, which is the most toxic part of the LPS, has been evaluated as a possible 
adjuvant in the therapy of immune diseases (Baldridge et al., 2000; Persing et al., 2002; 
Prince et al., 2001), as well as a potential anticancer medication (Larmonier et al., 2004; 
Reisser et al., 2002; Won et al., 2003). Therefore, the exact molecular structure of lipid 
A is required for the production of possible therapeutic formulations, for synthetic 
purposes and for the design of structure-activity relationships. 
The basic general structure of lipid A is shown in Figure 3-1 and is universally 
composed of the biphosphorylated P-D-(1 ~6) linked D-glucosamine (D-OleN) 
disaccharide which is acylated at both the N- and 0- positions. Various analytical 
techniques such as X-ray diffraction, Fourier transform infrared spectroscopy 
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Figure 3-1: Lipid A basic structure; it is composed of the biphosphorylated P-D-(1-+6) 
linked D-glucosamine (D-GicN) disaccharide which is acylated at both the N- and 0-
positions. 
(Brandenburg eta!., 2002; Brandenburg eta!., 1998; Fukuoka eta!., 2001) and nuclear 
magnetic resonance (NMR) spectroscopy (Brecker, 2003; Hashimoto et al., 2003) have 
been used to reveal the chemical structure of various lipid A moieties. Early MS methods 
such as laser desorption (LD) and fast atom bombardment (FAB), were used for the 
chemical identification of various lipid A extracts (Johnson et al., 1990; Qureshi et al, 
1988; Seydel et al, 1984). More recently, soft ionization methods, namely MALDI-MS 
and ESI-MS (as well as MS/MS) in both positive and negative ion modes were used to 
characterize lipid A (Boue & Cole, 2000; Chan & Reinhold, 1994; Corsaro et al, 2002). 
MALDI-MS is usually associated with many adduct ions which can complicate the mass 
spectrum and it lacks the formation of multiply charged species. On the other hand, ESI 
tends to produce multiply charged ions allowing very high molecular weight compounds 
to appear at lower mass-to-charge (mlz) ratios with significant reduction of the 
interference associated with adduct ions. ESI-MS/MS has been successfully utilized to 
obtain the detailed chemical structure of lipid A derived from different bacterial species 
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such as Enterobacter agglomerans (Boue & Cole, 2000), Pseudoalteromonas 
haloplanktis (Corsaro et al., 2002) and Shigellajlexneri (Chan & Reinhold, 1994). The 
negative ion mode has been shown to be of a particular advantage to lipid A analysis, 
since it requires no derivatization or manipulation of the molecule due to the natural 
existence of the easily ionized phosphate and hydroxyl groups. 
In reality~ lipid A extracts are usually formed as a microheterogeneous mixture 
composed of a major lipid A component, in addition to other minor products. This 
heterogeneity is most likely a result of complete and incomplete lipid A biosynthesis and 
differs mainly in the composition of fatty acid length and saturation and substitution of 
the phosphate by ethanolamine or various glycosyl groups (Chan & Reinhold, 1994; 
Krasikova et al., 2001; Zarrouk et al., 1997). 
In the present study, ESI-QqToF tandem mass spectrometry is used to 
differentiate and elucidate the molecular structure of the main constituent of native Lipid 
As isolated from the bacterial species A. salmonicida. In addition, this analysis has 
illustrated the fragmentation pattern and the mass spectrometric fingerprints of this 
biological compound; these data can be used in the future to evaluate related lipid A's and 
to perform quantitative studies on its formulations. 
The QqToF-MS/MS instrument equipped with LINAC (linear acceleration pulsar 
high-pressure) collision cell was used, since the collision induced dissociation (CID) 
tandem mass spectrometry analysis performed on a conventional quadrupole-hexapole-
quadrupole tandem instrument, failed to fragment the selected precursor ions using 
different collision energies and gas pressure conditions in the collision cell (spectra 
shown in Appendix 1). 
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3.2. ESI- QqToF analysis: 
The negative ion QqToF-MS scan of the lipid A was acquired with a declustering 
potential (DP) value of -60 (Figure 3-2). The obtained mass spectrum indicated a major 
doubly charged ion and its corresponding singly charged minor species, which were 
observed at mlz 883.5826 and 1768.1972, respectively. These ions were assigned as the 
[Ms - 2Ht and [Ms- Hr, the biphosphorylated lipid A moiety bearing a phosphate group 
on each sugar. The monophosphorylated lipid A was also observed as a major ion at mlz 
1688.2144, and was assigned as the [MM -Hr ion. The loss of HP03 can occur either at 
the reducing or the non-reducing sugar group. Based on fatty acid analysis, the presence 
of two major components, namely myristic acid (C14:0(3-0H)) and lauric acid (C12:0) 
was observed. Therefore, it is feasible to propose that the major compound of this 
heterogeneous lipid A mixture, is the D-glucosamine-disaccharide in which the 0- and N-
"free positions" are substituted by myristyloxylauric (C14:0(3-0(12:0))) groups at the 
non-reducing end sugar, whereas the reducing sugar moiety "free positions" were 
substituted with a 3-0H myristic acid chain (C14:0(3-0H)). 
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Figure 3-2: Negative QqToF MS scan of the native lipid A extract from A. salmonicida acquired at DP = - 60. 
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The proposed structure of the biphosphorylated lipid A and its distinctive ions 
observed in the QqToF-MS are illustrated in Table 3-1 and Figure 3-3. It should be 
noted, that at this stage of this study, the position of the esterified fatty acids was 
tentatively assigned and that there were many possible structures for the lipid A. The 
theoretical structure shown in Figure 3-3 corresponds to a biphosphorylated lipid A with a 
theoretical [Ma _ 2Hf and [Ma - Hr of m/z 883.5826 and 1768.1972, respectively. The 
structure shown in Figure 3-3 was, however, confirmed with a detailed analysis of the 
QqToF-MS and the MS/MS analysis of selected molecular anions, as described in the 
following sections. 
mlz Abundance 
Diagnostic Ion Empirical Formula 
Calculated Observed (%) 
[Ms-Hr' C92HmN202sPz 1768.1802 1768.1972 9.18% 
[Ma-2Ht C92HmN202sP2 883.5862 883.5826 100% 
[Ms- (C12:0)ketene- 2H t CsoH1soN2024P2 792.5026 792.5061 31.92% 
[Ms- (C12:0)ketene- H20 - 2H ]2- CsoH14sN2023P2 783.4974 783.5020 20.00% 
[MM-H(' C92HmN2022P 1688.2139 1688.2144 49.26% 
[MM- (C12:0)ketene- H ]" CsoH1soN202,P 1506.0468 1506.0656 13.52% 
[MM- (C14:0 (3-0H))ketene- H ]" C1sHw;N202oP 1462.0206 1462.0433 9.73% 
[MM- (C12:0)ketene- (C14:0 (3-0H))ketene - H ]" C&J!12~20,9P 1279.8535 1279.8653 23.81% 
[C-H]" CssH109N01~ 1074.7585 1074.7546 12.13% 
[C- (C14:0(3-0(12:0)))ketene -H]" C32H<;,NOuP 666.3982 666.3987 41.42% 
[Y-H]" C34ll<;sN0,2P 710.4244 710.4271 31.58% 
Table 3-1: Assignments of the diagnostic ions observed in QqToF mass spectrum of 
native lipid A extract acquired at DP= -60. 
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Figure 3-3: Schematic representation of the fully substituted biphosphorylated lipid 
A and the diagnostic ions [C- Hr and [Y- Hr observed in the QqToF MS scan. 
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Glycosidic cleavages induced by MS and MS/MS provide useful structural 
information and sugar sequencing of complex carbohydrates (Banoub et a/., 1990; 
Bateman eta/., 1996; Domon & Costello, 1988a; Domon & Costello, 1988b). In the 
conventional ESI-MS, two distinctive ions at mlz 1074.7546 and 710.4271 were observed 
and were assigned as the [C - Hr and [Y - Hr ions, respectively, and are shown in 
Figure 3-3. The ion observed at m/z 666.3987 was produced from the [C - Hr at m/z 
1074.7546 and was assigned as the [C- (C14:0(3-0(12:0))) ketene- Hr. 
In addition to the distinctive [Y] - and [C] - derived ions, four other structurally 
related ions were also observed. The first. was a doubly-charged ion at m/z 792.5061, 
which was assigned as [Ms - (C12:0)ketene - 2Hf. It was deduced to stem from the 
characteristic ion [Ms- 2Ht at m/z 883.5826 by the loss of one lauryl group (C12:0) as a 
neutral ketene (R-CH=C=O). Two others, however, originated from the mono-
phosphorylated ion [MM- Hr and were observed as singly-charged ion species at m/z 
1506.0656 and 1279.8653. These ions were assigned as [MM - (C12:0)ketene- Hr and 
[MM - (C12:0)ketene - (C14:0(3-0H))ketene - Hr, respectively. Similarly, mono-
phosphorylated lipid A eliminated a molecule of (C14:0(3-0H))-ketene to afford the ion 
observed at m/z 1462.0433, assigned as [MM- (C14:0(3-0H))ketene- Hr. 
Careful examination of the QqToF mass spectrum also revealed the presence of 
two higher and two lower signals with a difference of 14 Daltons for the major singly-
charged ions and 7 Daltons for the major doubly-charged species. These ions were 
attributed to the microheterogenic nature of lipid A extract due to lipid A compounds 
being linked to various longer and/or shorter fatty acids. This assumption was in 
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Figure 3-4: The presence of 7 Dalton signals lower and higher of the Biphosphorylated 
Lipid A [Ms - 2H]2- observed at mlz 883.5826 (A) and 14 Daltons of the 
Monophosphorylated Lipid A [MM- Hr observed at mlz 1688.2144 (B). 
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agreement with the composition of methyl ester fatty acid data obtained by GC-EI-MS 
analysis, in which traces ofmyristic acid (C14:0), 3-0H tridecanoic acid (C13:0(3-0H)), 
palmitoleic acid (C16:1), palmitic acid (C16:0), and 3-0H pentadecanoic acid (C15:0(3-
0H)) were also identified. Figure 3-4 shows these "satellite" signals for the [Ma- 2Hf 
and [MM- Hr. Similarly, the ions lacking the fatty acid chains reported in Table 3-1 can, 
in reality, be either a by-product of the uncompleted biosynthesis process, a hydrolysis 
product or a fragment of the lipid A-fully substituted molecule. Lipid A extract was 
subjected to additional acid hydrolysis for 30 and 60 min and then evaluated with the 
mass spectrometer. This showed a substantial increase in the diagnostic ions resulting 
from the C and Y breakages, confirming the assumption that hydrolysis influences the 
spectrum outcome. 
The assignment of the ions observed in the simple one-stage high resolution MS 
analysis is based on the exact molecular weight only, and additional evidence is usually 
required to validate these assignments. ·Therefore, without further confirmation, it would 
be possible to suggest various constitutional isomers structures of lipid A, as shown in 
Figure 3-5. For example, all the ions proposed in Table 3-1 and Figure 3-3 could also be 
correct, if the fatty acids were reversibly distributed between the two sugars. Tandem 
mass spectrometry, however, permitted the identification of the diagnostic product ions 
and to confirm the proposed molecular structure. It should be noted that both wild type 
and rough mutant lipid A extracts produced identical outcomes (see Appendix I). 
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Scheme 3-5: Four theoretical structures of the lipid A that can be proposed instead of the one illustrated in Figure 3-3. These 
structures share the same theoretical [Ms_2Hf and [Ms- HT at m/z 883.5826 and 1768.1972, respectively. 
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3.3. MS/MS analysis of the biphosphorylated and monophosphorylated lipid A 
The product ion scans of the selected precursor singly monophosphorylated 
[MM-Hr and doubly charged biphosphorylated [Ms- 2H]2 ions at mlz 1688.2144 and 
883.5826 were recorded with the QqToF-MS/MS instrument and are shown in 
Figure 3-6A and 3-6B, respectively. Collision energy (CE) and CID gas conditions were 
adjusted such that the precursor ion remained abundant. More energy and CID gas were 
required to break the singly charged monophosphorylated ion (CE= -75, CID= 8) in 
contrast to the doubly charged biphosphorylated ion (CE= -35, CID= 3). 
The fragmentation pathway of the monophosphorylated lipid A at m/z 1688.28 
was rationalized and is presented in Figure 3-7 and Table 3-2. The presence of a 
· myristyloxylauric (C14:0(3-0(12:0))) group at position 0-3' was evident from the 
consecutive losses of C12:0 acid followed by C14:1 either as neutral ketene or as a free 
fatty acid. 
In the MS studies of lipid A, it is understood that the negative charge is localized 
on the highly ionized phosphate group. It has been established that the loss of fatty acid 
during collision induced dissociation (CID) of glycerolphospho-ethanolamine occurs 
either as a neutral free fatty acid retaining the charge on the phosphate group (charge 
remote process) or as a neutral ketene derivative relocalizing the charge on the oxygen 
(charge driven process) (Hsu & Turk, 2000). Similarly, the fatty acid at position 0-3' of 
lipid A can also fragment via charge-remote or charge-driven mechanisms. These two 
competing processes are illustrated in Figure 3-8 for the ions [MM- (C12:0)acid - Hr, 
[MM- (C12:0)acid -(C14:1)acid- Hr, [MM - (C12:0)acid- (C14:1)ketene- Hr observed 
at m/z 1488.09, 1261.87, and 1279.86, respectively. Similar losses can be rationalized for 
65 
iU'Ic 
61/c 
5J'Ic 
'KJ'Ic 
[MM- (C14:0 (3-0H))acid- (Cl2:0)acid- H ]" 
'OOffi 
A 
[MM- (C14:00-0H))acid- (C12:0)acid- (C14:1)acid- H r 
1017.67 
[0•4 A1 - (C14:0 (3-0(C12:0)))ketene- H20- H]" 
Em$ 
[MM- (Cl2:0)acid- H r 
'IE.OO 
rnr~~~~~~~~~~~~~-+~~~~~~~~~~~~~~~~~~ 
m ~ E ~ ~ ~ E ~ ~ 1~ 1m ~ m ~ ~ m m m ~ ~ 
mz.lJIU 
B 
[Ms- (C12:0)acid- 2H ]'-
783.47 
[Ms- (C12:0)acid- (C14:1)ke ene- 2H ]'-
~ ® ~ ~ ~ ~ ® ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 
rr/z,!l'llJ 
Figure 3-6: Negative ion CID-MS/MS ofthe singly-charged Monophosphorylated 
Lipid A [MM - H r at mlz 1688.2 (A) and of the doubly-charged Hi phosphorylated 
Lipid A [Ms- 2Ht at mlz 883.5 (B). 
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Table 3-2: Assignments of the diagnostic product ions in CID- MS/MS analysis of the 
singly charged monophosphorylated Lipid A ion [MM -2Hr at m/z 1688.27. 
m/z Abundance 
Diagnostic Ion 
Calculated Observed (%) 
[MM-Hr 1688.21 1688.28 33.65% 
[MM- (C14:0 (3-0H))acid- H r 1444.01 1444.07 27.88% 
[MM- (C14:0 (3-0H))acid- (C12:0}ketene- H r 1261.84 1261.87 12.50% 
[MM- (C12:0)acid- (C14:1)acid- H r 1261.84 1261.87 12.50% 
[MM- (C14:0 (3-0H))acid- (C12:0}acid- H r 1243.83 1243.88 100% 
[MM- (C14:0 (3-0H)}acid- (C12:0}acid- (Cl4:1)ketene- H r 1035.64 1035.67 38.46% 
[MM- (C14:0 (3-0H))acid- (C12:0)acid- (C14:1)acid- H r 1017.63 1017.67 48.07% 
[MM- (C12:0)acid- H r 1488.03 1488.09 68.26% 
[MM- (C12:0)acid- (C14:1)ketene- H r 1279.85 1279.86 7.69% 
[0•4 A1- (C14:0 (3-0(C12:0)))ketene- Hr 708.40 708.41 7.69% 
[0•4 A1- (C14:0 (3-0(C12:0)))ketene- H20- (C12:0)acid- Hr 490.22 490.21 7.69% 
e·4 AI- (C12:0)ketene- (C14:0 (3-0H))CONH2- Hr 976.61 976.62 8.65% 
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the major product ions assigned as [MM- (C14:0 (3-0H))acid- (C12:0)acid- Hr, [MM-
(C14:0 (3-0H))acid- (C12:0)acid- (C14:1)ketene- HL and [MM- (C14:0 (3-0H))acid-
(C12:0)acid - (C14:1)acid - Hr at mlz 1243.88, 1035.67 and 1017.67, respectively. In 
addition to these two aforementioned mechanisms, another fragmentation route cannot be 
excluded. This latter mechanism can occur simultaneously, allowing the product ion 
[MM- (C12:0)acid - (C14:1)ketene - Hr at m/z 1279.86, for example, to lose a water 
molecule, and produce the ion [MM - (Cl2:0)acid - (C14:l)ketene - H20 - Hr at mlz 
1261.85 instead of the one described earlier and designated as [MM - (Cl2:0)acid -
(Cl4:1)acid- Hr (see Figure 3-8). Similarly, it should also be noted that the ion at m/z 
1261.87 can be obtained by two routes and support two different isomers structures which 
are illustrated in Figures 3-7 and 3-8. 
The multiple origin of this series of isomer product ions is generated either by 
concerted or consecutive multiple neutral losses. The losses could be composed of either 
fatty acid and ketene molecules, or ketene and water molecules. In this context, note that 
"concerted" or "consecutive" losses of many such product ions in the MS/MS experiment 
simply means that they are both lost at the same time and within the same reaction region 
in the hybrid tandem mass spectrometer. 
Furthermore, two diagnostic inner sugar fragment ions were distinguished at mlz 
708.41, and 976.62. The first of these was assigned as the [0'4A2 - (C14:0(3-
0(C12:0)))ketene - Hr ion and was a result of a cleavage of the product ion [MM -
(C14:0(3-0H))acid- (C12:0)acid- (C14:1)ketene- Hr at m/z 1035.67. The product ion 
observed at m/z 976.61, however, originated from the [MM-(C12:0)acid-(C14:1)acid- H]" 
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ion at mlz 1261.85 and was proposed as the e'4A2- (C12:0)acid- (C14:0(3-0H))CONH2-
Hr ion (structures shown in Figure 3-7). The presence of these fragment ions suggest 
that the phosphate group is retained at position 4', which is in agreement with the losses 
of ketene or free fatty acid at position 0-3' through charge remote and charge driven 
processes. These two distinctive product ions predetermined the presence of C14:0 (3-
0H) on the reducing end group of the D-GlcN disaccharide and authenticate the structure 
presented in Figure 3-3. 
The MS/MS scan of the doubly-charged biphosphorylated lipid A [Ma - 2Hf 
observed at mlz 883.80 (Figure 3-'6B) did not provide evidence for the presence of any 
distinctive product ions which would indicate the locations of the fatty acids. However, 
the presence of Cl2:0, C14:0(3-0(12:0)) and Cl4:o (3-0H) fatty acid groups were once 
again confirmed through the distinctive losses of these fatty acid chains. Table 3-3 
sunimarizes the ions observed in this CID MS/MS. 
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Table 3-3: Assignments of the diagnostic product ions in CID- MS/MS analysis of the 
doubly-charged biphosphorylated lipid A ion [Ms -2Ht at mlz 883.56. 
m!z Abundance 
Diagnostic Ion 
Calculated Observed (%) 
[Ms- 2H]- 883.58 883.56 6.76% 
[M8 - (C12:0)acid- 2Hf 783.49 783.47 100% 
(M8 - (C12:0)acid- CH2 - 2Hf 776.48 776.47 8.25% 
(M8 - (C12:0)acid- (C14:1)ketene- 2Hf 679.40 679.38 35.97% 
(M8 - (C12:0)acid- (C14:1)acid- 2Hf 670.40 670.38 9.90% 
[M8 - (C12:0)acid- (C14:1)ketene- (C14:0 (3-0H))acid- Hf 557.30 557.28 4.45% 
(MM-H]" 1688.21 1688.23 0.99% 
[MM- (C12:0)acid- H]" 1488.03 1487.99 4.95% 
[MM- (C12:0)acid- (C14:0)acid- H]" 1243.83 1243.81 2.97% 
[M8 - (C12:0)acid- H]" 1568.00 1567.97 3.46% 
[M8 - (C12:0)acid- (C14:0 (3-0H))acid- H]" 1323.79 1323.75 1.48% 
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3.4. MS/MS analysis of the [C - Hr and [Y - Hr ions: 
As mentioned earlier, three distinctive ions, namely [C - Hr, [Y - Hr and [C -
(C14:0(3-0(12:0))ketene- Hr associated with the glycosidic cleavages ofthe P-D-(1~6) 
of the D-OleN disaccharide were observed in the QqToF MS at m/z 1074.7546, 710.4271 
and 666.3987, respectively (see Figures 3-2 and 3-3). To confirm the proposed structure 
of these ions, MS/MS were acquired and are shown in Figures 3-9A, 3-9B, and 3-9C. 
The product ion scan of the selected ion [C - Hr at m/z 1074.74 (Figure 3-9A) 
showed the loss of a (C12:0) acid chain to yield the product ion assigned as [C-
(C12:0)acid - Hr observed at m/z 874.56 which can further fragment by losing a 
((C14:1)ketene) molecule to afford the product ion observed at mlz 666.37. This latter 
loss probably takes place at the labile 0- linked fatty acid rather than the more stable N-
linked one. It is well-accepted that during MS/MS analysis of the lipid A moiety, the 
elimination of the fatty acid derivatives occurs mainly from the 0- linked fatty acid esters 
(Boue & Cole, 2000; Chan & Reinhold, 1994). Therefore, it was projected that the major 
ion observed at mlz 648.37 would be associated with the loss of the ((C14:1)acid) at 
position 0-3', rather than a loss of H20 from the product ion observed at m/z 666.37, and 
it is very possible that these two processes occur simultaneously, as mentioned earlier. 
The latter product ion could further fragment by losing another C12:0 acid chain or 
H3P04 to produce the distinctive product ions [C - (C12:0)acid - (C14:1)acid -
(C12:0)acid - Hr and [C - (C12:0)acid - (C14:1)acid -H3P04 - Hr appearing at m/z 
448.19, and 550.40, respectively (see Figure 3-9A for proposed structures). These 
product ions confirmed the proposed structure of lipid A bearing two myristyloxylauric 
(C14:0(3-0(12:0))) and one phosphate group at its non-reducing end sugar. 
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Figure 3-9: Negative ion CID-MS/MS of the diagnostic ions: [C -Hr at mlz 1074.7 (A), 
[Y-Hr at mlz 710.4 (B), and [C- (C12:0(3-0(14:0)))ketene- Hr at mlz 666.3 (C). 
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On the other hand, as shown in Fig 3-9B, MS/MS analysis of the [Y - Hr ion at 
m/z 710.41 clearly illustrated, that the loss of the neutral acid C14:0(3-0H) at m/z 466.21 
occurs initially, followed by C14:0(3-0H)ketene, to produce the distinctive ion observed 
at rnlz 240.02, which was proposed to be 3-deoxy-1-phosphate glucosamine (structure 
shown in Fig 3-9B). Similar to the [C- Hr fragmentation pathway, a distinctive loss of 
H3P04 also occurs to produce the ion observed at mlz 368.23. This latter product ion 
spectrum supports the proposed original structure, which designated the presence of two 
C14:0 (3-0H) acid chains and one H3P04 on the reducing end group oflipid A. 
The fragmentation pathway of the [C- (Cl2:0(3-0(14:0)))ketene- Hr ion at m/z 
666.38 was also rationalized and is presented in the self-explanatory Figure 3-10. Despite 
the many possible fragmentation routes that can lead to the formation of the same ions 
observed in this spectrum, the fragmentation pattern presented in Figure 3-10 was 
confirmed by using precursor ion scan analysis. The precursor ion scan of the ion 
observed at m/z 193 is included in Figure 3-10, and it clearly illustrates that this ion was 
indeed produced from the ion observed at m/z 153 (losing CH2) eliminating the 
theoretical possibility that this ion was obtained from the ion observed at 181 losing 
CH2=C=O. The rationale presented in Figure 3-10 further confirms the proposed 
structure, and illustrates, once more, that this product ion retains the fatty acids at position 
0-2' due to the appearance of the diagnostic second generation product ions observed at 
m/z 224.33 and 325.31. These latter ions were identified as (myristene-3) acid amide 
((C14:1)CONH2) and a product of2,4 inner-sugar elimination, respectively. 
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The MS/MS of all the remaining ions observed in the conventional ESI-MS 
(Table 3-1) were also acquired and their fragmentation pathways were rationalized 
confirming the proposed structure of lipid A. Figure 3-11 shows the MS/MS of the 
precursor ions, [Ms-Hr m/z 1768.18, [Ms- (C12:0)ketene- 2Ht at m/z 792.50, [MM-
(C12:0)ketene - Hr mlz 1506.04, and [MM - (C14:0(3-0H))Ketene - Hr m/z 1462.05. 
The detailed fragmentation routes and the corresponding structures of the fragment ions 
are illustrated in figures 3-12, 3-13, 3-14 and 3-15, respectively. The elimination of fatty 
acids occurs either via charge-remote or charge-driven mechanisms, as discussed earlier. 
In addition, the presence of inner-sugar fragments can confirm the structure of the 
precursor ion as well as the proposed structure of other fragment ions. The loss of H3P04 
in Figure 3-12 was speculated, for example, to occur on the reducing-end. This 
assumption is based on the formation of the 0•4 A2 and the C fragment ions which confirm 
the presence of the phosphate group at position C-4f of the non-reducing end sugar. 
Similarly in Figures 3-13 and 3-14, the presence of diagnostic inner-sugar fragments 
confirmed the localization of the H3P04 group at the non-reducing end. It should be 
noted that more than one possible fragmentation route can exist in some structures, 
especially in the case of fatty acid losses. The transition [MM-(C12:0)ketene-Hr (m/z 
1506.05) -7 [MM-(C14:0(3-0H))acid-(C14:0(3-0(C12:0)))-Hr (mlz 1053.64) in 
Figure 3-13, for example, has been illustrated by a loss of (C14:0(30H) ketene) at 
position C-3 of the reducing end while (C14:0(30H) acid) was eliminated on position C-
3' of the non-reducing end. The alternative assumption of (C14:0(30H) ketene) 
elimination on position C-3' and (C14:0(30H) acid) loss on position C-3 is also valid as 
no diagnostic ions were present to confirm either of these closely related structures. 
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Figure 3-11: Negative ion CID-MS/MS of the ions: [MM- (C12:0)ketene- Hr at mlz 
1768.18 (A); [MB- (C12:0)ketene- 2Hf" at m/z 792.50 (B); [MM- (C12:0)ketene- Hr 
at m/z 1506.04 (C); [MM- (C14:0(3-0H))Ketene- Hr at mlz 1462.05 (D). 
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Figure 3-12: Schematic representation of the rationalized fragmentation routes of the [M8 -Hr ion observed at mlz 1768.18. 
Although these fragments are illustrated in a step-wise fashion, it is possible that these breakages can occur either 
consecutively or simultaneously. 
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Figure 3-13: Fragmentation pattern of the doubly-charged precursor ion [M8 -(C12:0) 
Ketene -2Hf observed at m/z 792.50. Both singly and doubly-charged fragment ions 
were formed confirming the proposed structure of this precursor. 
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3.5. Summary: 
The chemical structure of lipid A, isolated by mild acid hydrolysis from 
Aeromonas salmonicida lipopolysaccharide, was investigated using electrospray 
ionization QqTOF hybrid tandem mass spectrometry and showed a great degree of 
microheterogeneity (El-Aneed & Banoub, 2005). The chemical structure of the main 
constituent of this heterogeneous mixture was identified as a D-(1 ~6) linked D-
glucosamine disaccharide substituted by two phosphate groups, one being bound to the 
non-reducing end at position 0-4' and the other to position 0-1 of the reducing end of the 
D-glucosamine disaccharide. The location of the fatty acids linked to the disaccharide 
backbone was established by identifying diagnostic ions in the conventional QqToF-MS 
scan. Low-energy collision tandem mass spectrometry analysis of the selected precursor 
diagnostic ions confirmed, unambiguously, their proposed molecular structures. It was 
established that myristyloxylauric (C14:0(3-0(12:0))) acid residues were both N-2' and 
0-3' linked to the non-reducing end of the D-GlcN residue, whereas two 3-hydroxy 
myristic (Cl4:0(3-0H)) acid chains acylated the remaining positions of the reducing end 
(El-Aneed & Banoub, 2005). The MS and MS/MS data obtained allowed us to determine 
the complex molecular structure of lipid A. In addition, the fragmentation patterns were 
clearly illustrated and established for this biologically-active structure. 
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CHAPTER 4: Mass Spectrometric Analysis of the Core Oligosaccharide 
of Wild-Type Areomonas salmonicida 
4.1. Background: 
In the previous chapter the molecular structure and the fragmentation pattern of 
the hydrophobic lipid A was demonstrated. The other LPS portion, a hydrophilic 
polysaccharide, may be further subdivided into the 0-specific chain and the core 
oligosaccharide. The core oligosaccharide is relatively conserved in its structure and 
composition compared to the 0-chain and can be divided into inner and outer subdomains 
(see Figure 1-10). The inner core oligosaccharides include unique residues characteristic 
of LPS, namely Kdo (a-J-deoxy-D-manno-oct-2-ulosonic acid) and Hep (L-glycero-D-
manno-heptose ). 
Both 0-antigenic carbohydrate chains and core oligosaccharides have been used 
for biomedical applications such as vaccine and antibody design. It has been shown in 
the last decade that antibodies directed against the core region of bacterial 
lipopolysaccharides are of significant clinical interest for their potential of neutralizing or 
enhancing the manifold biological effects of endotoxins (Di Padova et al., 1993) and their 
potential use as fish vaccines in aquaculture ventures (Banoub et al., 1989). 
The molecular structure of the inner-core region usually contains a a-Kdop-
(2---+8)-a-Kdop-(2---+4)-a-Kdop-(2---+ trisaccharide as in the structure of the LPS of 
Klebsiella pneumoniae ssp. Pneumoniae (Susskind et al., 1995). The LPS of Chlamydia 
trachomatis was shown to contain the disaccharides a-Kdop-(2---+4)-a-Kdop-(2---+ and a-
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Kdop-(2__..8)-a-Kdop-(2__.. which were identified by GC-MS (Holst et al., 1992). A 
feature of some inner core regions of lipopolysaccharides such as the core oligosaccharide 
of Yersinia ruckerii, Serotype II, is the presence of at least one residue of Kdo (Bateman 
et al., 1996). 
The inability to detect Kdo in LPS from the genera Vibrio and Aeromonas was 
first pointed out in 1971 (Jackson & Redmond, 1971) and subsequently by Jann et al. and 
by Hisatsune et al. for V. cholerae (Hisatsune et al., 1982; Jann et al., 1973). 
Accordingly, it was commonly believed by all researchers that Kdo was absent from the 
LPS of all members of the Vibrionaceae family of gram-negative bacteria, and its 
absence, as established by the thiobarbiturate-based colorimetric assay (the Weissbach 
reaction), was used as a characteristic for taxonomic classification (Jann et al., 1973). 
Nevertheless, the first demonstration of the presence of one residue of Kdo or Kdo-like 
substance in LPS of the Vibrionaceae, family was reported in early 1980s (Banoub et al., 
1983), in direct contrast to the generally accepted view of the absence of this compound. 
Phosphorylated Kdo units have been isolated from and detected in a number of 
lipopolysaccharide preparations. Kdo derivatives phosphorylated in position 0-5 were 
released from the lipopolysaccharide of V. cholerae Ogawa and Inaba after strong acid 
hydrolysis. The phosphorylated Kdo was identified by gas-liquid chromatography and 
mass spectrometry, after reduction and permethylation, as Kdo-5-phosphate (Brade, 
1985). Phosphorylated Kdo units have been isolated from various LPS preparations 
obtained from different types of gram-negative bacteria. It has been shown by Szabo's 
research group that Kdo derivatives, phosphorylated in position 4, behave differently 
from the other positional isomers. It was found that at 1 00°C, they eliminate their 
86 
phosphate group with extreme facility in acidic, neutral or alkaline media (Chaby & 
Szabo, 1975). The olefinic acid presumably formed as the first product produces a 
derivative of furoic acid by ring closure involving (C-2)-(0-5)-(C-5), (Figure 4-1 ). Carof 
and coworkers have shown that in the LPS-2 of Bordetella pertussis endotoxin, the Kdo 
unit was substituted at 0-5 by the inner core oligosaccharide portion and also carried a 
. phosphate substituent on the 0-4 position. They established that, following mild 
hydrolysis of the glycosidic bond of the Kdo unit, the phosphate group was easily 
released and eliminated. They noticed that no furoic acid derivative was produced and 
the product formed was still attached to the core oligosaccharide portion and could not be 
identified (Carof et al., 1987). Auzaneau et al have shown that mild acid hydrolysis of a 
Kdo unit which was methylated at 0-5 and phosphorylated at position 0-4 produced a 
mixture of type-specific 4,8- and 4,7-anhydro-Kdo units. They proposed that this was 
most probably the case for a lot of other "Kdo-less" endotoxins or thiobarbiturate 
negative endotoxins, in which the Kdo terminal reducing end group could not be 
determined by conventional analysis (Auzanneau et al., 1991). 
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Figure 4-1: Facile elimination of 0-4 phosphorylated Kdo to produce a furoic acid 
derivative by ring closure involving (C-2)-(0-5)-(C-5). 
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To date, there is no evidence for the occurrence of a phosphorylated Kdo unit 
within the LPS of A. salmonicida. This phosphate group, if present, will be sensitive to 
acid hydrolysis, Following treatment of the LPS with 1% acetic acid at 1 00°C for 90 min 
to glycosidically cleave the lipid A from the rough core oligosaccharide, the 0-4 
phosphate group is instantaneously eliminated as phosphoric acid to form the core 
oligosaccharide containing the C-3-C-4 olefinic D-arabino-3-en-2-ulonic acid open chain 
reducing end (Figure 4-2). This latter oligosaccharide, containing the straight chain 
olefinic acid at the reducing end of this molecule, undergoes an intramolecular addition 
reaction between the alcoholic function at C-7 or C-8 to the olefinic double bond, to 
produce the isomer pairs of 4,8- and 4,7-anhydro derivatives of the enolizable a.-keto-
acids 3A and 4A (Figure 4-3). 
In the following sections, the fragmentation pathways of the smooth wild-type 
core region of A. salomonicida have been established for the first time. In addition, this 
analysis confirmed precisely the molecular structure of the core oligosaccharide, 
illustrated a decade ago (Shaw et al., 1992). This biological extract is now shown to be a 
homogeneous mixture of the native core oligosaccharide 2B (Figure 4-2) and the 
degraded oligosaccharide containing the isomeric pairs of 4,8- and 4,7- anhydro-a-keto 
acid derivatives 3A, 4A (Figure 4-3), and the open olefinic chain 2A (Figure 4-2). This 
was accomplished using a combination of ESI and MALDI mass spectrometry with a 
QqToF-MS hybrid instrument and low energy collision induced dissociation (CID)-
QqToF-MS/MS analyses. The ESI-QqToF-MS/MS analyses and sequencing of the core 
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Figure 4-2: Products formed after treatment of the LPS of A. salmonicida (Structure 
lA) with 1% acetic acid at 100°C for 90 minutes. Two products are formed, the core 
bearing the intact 0-4- phosphorylated Kdo (2B) and the the C-3-C-4 olefinic D-
arabino-3-en-2-ulonic acid open chain (2A). 
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Figure 4-3: Formation of the dephophorylated core oligosaccharide containing the 
diasteromeric mixture of the 5-0-glycosylated 4,8-anhydro- and 4,7-anhydro derivatives 
of the enolizable a.-keto-acid. 
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oligosaccharide containing the intact 0-4 phosphorylated Kdo residue, and, the remainaer 
of the homogenous mixture of the dephosphorylated core oligosaccharide, allowed the 
exact identification of a series of diagnostic protonated molecular ions. The 
stereospecific fragmentation routes obtained during the tandem mass spectrometric 
analyses are also illustrated. 
Furthermore, concrete MS/MS evidence of the presence of the intact 0-4 
phosphorylated and 0-5 glycosylated reducing end terminal Kdo residue 2B and the 4,8-
~ ~ 
and 4,7-anhydro derivatives 3A and 4A of the enolizable a-keto acids, in this cleaved 
core oligosaccharide homogeneous mixture is presented. Similarly, the low energy CID-
MS/MS experiments performed on the permethylated samples precisely confirmed the 
structure of the degraded core oligosaccharides, containing the isomers 4,8- and 4,7-
anhydro a-keto acid dephosphorylated Kdo terminal reducing end residue. Also, notable 
was the complete permethylation of the 0-5 glycosylated D-arabino-3-en-2-ulonic acid, 
open terminal chain, 2A, providing direct evidence for the presence of this open chain 
unit. 
4.2. MS analysis of the homogenous mixture of the core oligosaccharide: 
4.2.1. Negative-ion mode QqToF-MS analysis: 
The homogeneous mixture of the core oligosaccharides obtained after cleavage 
from the lipid A was analyzed by electrospray mass spectrometry in the negative ion 
mode. The ESI-QqToF-MS, measured with a declustering potential (DP)= -IOOV (Figure 
4-4), showed the presence of an unforeseen ion at mlz 982.2939. This ion was assigned 
as the deprotonated molecule [MPo4-2H]2- of the intact 0-4 phosphorylated and 0-5 
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substituted a-D-manno-octulosonic acid Kdo in the pyranose form 2B. This native core 
oligosaccharide containing the intact 0-4 phosphorylated Kdo molecule, was assigned the 
empirical formula of C69Htl7N206oP, corresponding to an observed and calculated 
monoisotopic mass of 1966.60 Da, and 1966.61 Da, respectively. 
The deprotonated molecules [M-2Hf at m/z 933.3015 and [M-Hr at mlz 
1867.6866 were also observed. This species is consistent with a core oligosaccharide 
composed of nine glycone units, having an empirical formula of C69Htt6N20s6, observed 
Mr 1868.69 Da , calculated Mr 1868.63 Da. It should be noted that the same structure of 
the core oligosaccharide containing the 4,8-anhydro-a-keto acid derivatives 3A (or 3A') 
has the same molecular mass. The same could be corroborated for compounds 2A and 
4A, meaning that when recording a conventional mass spectrum of a series of 
underivatized diastereoisomers with a one stage instrument (one analyzer), it is not 
possible to know the exact structure of the population of all the ions produced, as these 
have the same masses. 
The rationale behind the formation of the intact [MPo4-2Hf 0-4 phosph~rylated 
Kdo deprotonated molecule, is that the treatment of the LPS with 1% acetic acid at 100° 
C for 90 minutes, is not long enough to promote the complete elimination of the C-3-C4 
phosphoric acid to form the open chain 2A olefinic compound D-arabino-4-0-phosphate-
3-en-2-octulonic acid. Some 0-4 phosphorylated Kdo units remain attached intact to the 
core oligosaccharide region. MS in the negative ion mode was, however, sensitive 
enough to detect this minor ion and due to the presence of the phosphate group, this ion 
was dominant in the spectrum under the experimental conditions. 
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Figure 4.4: Negative ion mode ESI-MS spectrum of the homogeneous core oligosaccharide mixture using a declustering potential 
(DP) of -1 OOV 
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4.2.2. Negative-ion mode MS-MS analysis: 
Structural information on the glycone sequence of oligosaccharides was obtained 
using tandem mass spectrometry. The unique dissociation patterns of the precursor ions 
provided diagnostic product ions, which facilitate the glycone sequences, and may be 
helpful in the discrimination of the various isomeric structures of the product ions. 
The low energy ESI-CID-QqToF-MS/MS (CE=40eV) of the precursor 
deprotonated molecules [M-2Hf at m/z 933.3015 is shown in Figures 4-5 and 4-6. The 
proposed fragmentation routes obtained were rationalized by using the scheme for 
systematic nomenclature of carbohydrate fragmentation using F AB MS/MS proposed by 
Domon and Costello to describe the putative fragmentation process (Domon & Costello, 
1988a; Domon & Costello, 1988b ). 
The product ion scan of the deprotonated molecule [M-2Hf at m/z 933.3015 
appears to contain several diagnostic dissociation patterns. As can be seen in Figures 4-5 
and 4-6, several different major series of diagnostic product ions, namely: the [A r, [Br 
and [Cr series, in which charge retention occurs on the non-reducing part of this core 
oligosaccharide; and the [XL [Yr and [Zr series in which charge retention occurs at the 
reducing end, were observed. Notably, the presence of the major abundant product ions 
at m/z 888.39 as the [0'3Xt;]2- product ion; mlz 798.84 assigned to the [0•3X5-H20f product 
ion; m/z 756.83 assigned as the [M-2H-(GlcN1 ~7Hep)J2- product ion; m/z 711.81 
assigned as the [0'3X6-(GlcN1 ~7Hep)f; mlz 616.29 assigned as the e,4~-Hr product 
ion, and mlz 412.20 assigned as the e,s A6-BsT product ion was observed. Some of the 
diagnostic product ions belonging to the [ZT series are illustrated in Figures 4-5 and 4-6. 
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Figure 4-5: (A) ESI-MS/MS spectrum of the precursor ion [M-2Hf at mlz 933.30. 
(B) The proposed fragmentation routes and the product ions of [M-2Hf. 
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Figure 4-6: Schematic representation of the fragmentation pattern of the core 
oligosaccharide of A. salmonicida recorded in the negative ion mode. ESI-MS/MS 
common fragmentation routes of both the [M-HT and [M-2H]2- at rn/z 1867.68 and 
933.30, respectively are shown in red. Fragmentation patterns exclusive to the [M-H]" 
and [M-2H]2- are shown in blue and green, respectively. 
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The product ion scan of the precursor deprotonated molecule [M-Hr at mlz 
1867.63 shown in Figure 4-7 A, afforded less dissociation than the deprotonated 
precursor ion [M-2Hr2. The formation ofthe product ions are illustrated in Figure 4-7B 
and Figure 4-6, all of which are straightforward dissociations of the precursor ions. Some 
of the diagnostic product ions obtained from the [X]", [Yr and [Zr series and two 
diagnostic product ions at m/z 820.37 and 802.36, assigned as [Z2-H-CH2COC02Hr and 
[Z2-H-CH2COC02H-H20L are illustrated in Figure 4-8, and confirms, without doubt, the 
ubiquitous presence ofthe 4,7-anhydro-a.-keto acid (terminal reducing end). 
It should be noted that, for simplicity, derivative 4A from the obtained 
homogeneous mixture of oligosaccharide has been chosen to illustrate all of the ESI-CID-
QqToF-MS/MS fragmentations described in this rationale. The same fragmentation 
routes are expected to be identical for the olefinic open chain derivative lA and the 
anomeric mixtures 3A, 3A' and 4A'. 
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Figure 4-7: (A) ESI-MS/MS spectrum of the precursor ion [M-2H]" at m/z 1867.84. (B) 
The proposed fragmentation routes and the product ions of [M-2H]". 
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of both the [M-2H]2- and [M-Hr precursor ions are illustrated. 
100 
4.2.3. MS/MS evidence for the presence of phosphorylated Kdo unit within the core 
oligosaccharide: 
The previous section has confirmed the sequence of the LPS core region isolated 
from A. salmonicida and provided indirect evidence for the presence of an 0-4 
phosphorylated Kdo reducing end unit. The presence of this phosphate group can be 
established by evaluating the fragmentation pattern of the ion [MPo4-2Hf- observed at 
mlz 982.29 in the single-stage MS-ToF experiment (see Figure 4-4). 
The product ion scan of the precursor deprotonated molecule [MPo4-2H]2- selected 
from the intact phosphorylated Kdo at mlz 982.2939 is shown in Figure 4-9. The most 
striking aspect of this product ion scan is that when it was recorded with a collision 
energy of 40 eV and aCID gas pressure= 4, the formation of only the doubly and singly 
charged species ofthe dephosphorylated form of this oligosaccharide containing the 4,7-
anhydro-a-keto acid was observed. Thus the [Mp04-2Ht ion at mlz 982.2939 dissociated 
by the elimination of phosphoric acid to afford the [M-2Ht and [M-Hr product ions at 
m/z 933.33 and 1867.71, respectively. This instantaneous elimination from C-3-C-4 
affords the deprotonated molecules obtained from the olefinic D-arabino-3-en-2-ulonic 
acid open chain reducing end. 
This finding is in agreement with the phosphorous content analysis (FisKe & 
Subbarow, 1925), performed kindly by Dr. P. Davis, Department of Biochemistry, 
Memorial University ofNewfoundland, of the cleaved lipid A and the complete LPS that 
indicated a phosphate content of 2 mol/mol for lipid A and 3 mol/mol for LPS. 
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Figure 4-9: ESI-MS/MS spectrum and the proposed product ions of the precursor ion [Mp04-2Hf at m/z 982.29 
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This is due to the fact that acid hydrolysis would cleave a significant portion of the 
phosphate group; the presence and the location of which being on the Kdo was only 
established by MS and MS/MS analysis. The negative ion mode analysis was of great 
importance as it facilitates the production of the doubly charged species [Mp04-2H]2• 
4.2.4. Positive-ion modeMS and MS/MS analysis: 
The homogeneous mixture of degraded core oligosaccharide was dissolved in a 
mixture of water/methanol/formic acid and electrosprayed in the positive ion mode. The 
ESI-QqToF-MS, measured with declustering potential (DP)=80V, is shown in Figure 4-
10. The protonated molecules [M+2Hf+ at mlz 935.3332 and [M+Ht at m/z 1869.6236 
were observed. It should be stated that increasing the DP values (up to 150), in both the 
negative- and positive-ion MS analysis modes, enhanced the formation of the singly 
charged species in comparison to other ions. 
The product ion scan and the fragmentation pattern of the di-protonated molecule 
[M+2H]2+ at m/z 935.33 is shown in Figures 4-11 and 4-12. The fragmentation to afford 
the series of diagnostic product ions is self explanatory, and these were shown to be 
straightforward dissociations mainly occurring from the terminal reducing end of the 
molecule. A diagnostic product ion [Y6+2H]2+ was observed at m/z 854.37 from the non-
reducing end of the core oligosaccharide (Figure 4-12). 
The product ion scan of the protonated molecule [M+Ht at m/z 1869.62, shown in 
Figure 4-13, indicated a series of diagnostic product ions (Figure 4-12 and Figure 4-13). 
Once more the genesis of the product ions is self explanatory and does not need to be 
further discussed. 
103 
1000/o 
00% 
00% 
70% 
00% 
&l% 
4<Jl/o 
3Y/d 
20% 
10% 
0% 
500 a:xl 700 00) 
[M+2Hl2+ 
935.3:m 
.3233 
9)J 100) 
1216.1412 
[M+Ht 
1869.6236 
1100 1200 13Xl 1400 1~ 100) 1700 100) 100J 2COO 
m'z, arru 
Figure 4-10: Positive ion mode ESI-MS specta of the homogeneous core oligosaccharide mixture using a declustering potential 
(DP) of80V. 
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Figure 4-11: Positive ion mode ESI-MS spectra of the homogeneous core 
oligosaccharide mixture using a declustering potential (DP) of 80V. The proposed 
fragmentation routes and product ions are also shown. 
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Figure 4-12: Fragmentation pattern of the core oligosaccharide of the wild-type A. 
salmonicida recorded in the positive ion mode. ESI-MS/MS common fragmentation 
routes ofboth the [M+Ht and [M+2H]2+ at m/z 1869.62 and 935.33, respectively are 
shown in red. Fragmentation routes exclusive of [M+2H]2+ are shown in green. 
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proposed fragmentation routes of the product ions. 
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It is interesting to note the absence of the [Mro4+2H]2+ and the [Mp04+Ht species 
in the positive mode ESI-MS. This was not surprising considering that under the 
experimental conditions the negative charges were most likely localized on the phosphate 
group. This is clearly illustrates that the core bearing intact 0-4 phosphorylated Kdo is a 
minor constituent within this complex mixture. 
4.3. MS analysis of the permethylated core oligosaccharide: 
4.3.1. QqToF-MS: 
The permethylated core oligosaccharide mixture, dissolved in methanol, was 
electrosprayed in the positive ion mode. The ESI-QqToF-MS is shown in Figure 4-14A 
and indicates the presence of a multitude of protonated [Mn+Ht in addition to the di-
protonated molecules [Mn+2H]2+ and the sodiated cluster [Mn+H+Na]2+. The observed 
molecular masses of the obtained series were compared to the calculated molecular 
masses of the expected products, and these are presented in Table 4-1. 
The formation of the [MNHMe+Ht ion at m/z 2374.2003, which is consistent with 
an empirical formula Cw5H1s9N20s6 resulting from the incorporation of36 methyl groups 
was observed. This is due to the presence of the free amino group on the D-glucosamine 
residue, which tends to form NHMe in addition to NMe2 (Banoub et al., 1984). The 
[M+Ht ion at mlz 2388.2289, which is consistent with an empirical formula of 
C106H191N20s6, results from the incorporation of 37 methyl groups. The remaining 
[Mn+Ht ions of this series is indicated in Table 4-1. The incorporation of 38 methyl 
groups to form the [M1+2H]2+ ion involves the formation of the enol form of the 4,7-
anhydro-a-keto acid derivative 4A'. The incorporation of 39 methyl groups to form the 
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[M2+2H]2+ was, however, attributed to an extra C-methylation of the H-3 olefinic proton 
in the enol form of the 4,7-anhydro derivative 4A'. The QqToF-MS of this permethylated 
homogeneous mixture reflects the complexity of the composition, and the number of 
diastereomers of these oligosaccharide series. This was not quite as evident from the 
conventional ESI-QqToF-MS of the underivatized homogeneous oligosaccharides 
mixture. 
The incorporation of 40 methyl groups to form the [M3+2Hf+ was attributed, 
once more, to an extra C-methylation on C-5 of the 4,7-anhydro-derivative 4A'. The 
incorporation of 41 methyl groups to form the [M4+2H]2+ can be attributed to enolization 
of the carbonyl group at C-2 followed by oxidation at C-4, methylation, and addition of a 
molecule of methanol on C-3-C-2, most probably occurring in the methylation reaction 
and subsequent work up. The incorporation of 42 methyl groups results in a final 
substitution reaction with the hydrogen located at C-5 (See Table 4-1 ). 
To investigate whether it was possible to enhance the formation of the mono-
charged series of protonated molecules, another ionization method was utilized, namely, 
MALDI-MS. The spectrum of the permethylated heterogeneous mixture of the core 
oligosaccharide was recorded using 2,5-dihydroxybenzoic acid (DHB) as a matrix. The 
spectrum showed only the expected series of the singly charged protonated molecules 
shown in Figure 4-14B and Table 4-1. 
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Figure 4-14: Positive ion mode ESI-MS (A) and MALDI-MS (B) spectra of the permethylated 
homogeneous core oligosaccharide mixture dissolved in methanol with the addition of trace 
amounts of formic acid. MALDI-MS produced a major shift towards the formation of 
diprotonated ions and sodiated clusters. 
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Table 4-1: Protonated molecular ions derived from the ESI-MS of the permethylated 
homogenous mixture of the core oligosaccharides of A. salmonicida. 
Protonated Incorporation of Molecular Calculated Observed Difference 
Molecules Me grou~s Formula ·m/z m/z {~~m} 
[MNHMe+H] + 36 C10s H1a9N20sa 2374.2003 2374.2129 -5.3071 
[M+H]+ 37 C1os H191N20sa 2388.2160 2388.2289 -5.4015 
[M1+H] + 38 C101 H193N20ss 2402.2316 2402.2429 -4.7040 
[M2+H] + 39 C1oa H19sN20ss 2416.2473 2416.2315 6.5391 
[M3+H] + 40 C1o9 H191N20ss 2430.2629 2430.2330 12.3032 
[M4+H] + 41 C11o H2o3N20sa 2480.2997 2480.2581 16.7722 
[Ms+H] + 42 C111 H2osN20sa 2494.3075 2494.2429 25.8990 
- 2+ [MNHMe+2H) 36 C10s H19oN20sa 1187.6041 1187.6019 1.8525 
[M+2H] 2+ 37 C1oa H192N20sa 1194.6119 1194.6071 4.0180 
[M1+2H] 2+ 38 C1o1 H194N20ss 1201.6197 1201.6137 4.9933 
[M2+2H] 2+ 39 C10a H19sN20ss 1208.6276 1208.6037 19.7745 
[M3+2H] 2+ 40 C1o9 H19aN20ss 1215.6354 1215.6116 19.5782 
[M4+2H] 2+ 41 C11o H2o4N20sa 1240.6438 1240.6341 7.8185 
[Ms+2H] 2+ 42 C111 H2oaN20sa 1247.6537 1247.6269 21.4803 
[M+H+Na] 2+ 37 C1os H191N2 1205.6029 1205.6041 -0.9954 NaOss 
[M1+H+Na] 2+ 38 C1o1 H193N2 1212.6107 1212.6083 1.9792 NaOsa 
[M3+H+Na] 2+ 39 C1o9 H197N2 1226.6263 1226.6114 12.1471 NaOsa 
[M5+H+Na] 2+ 42 C111 H2osN2 1258.6238 1258.6122 9.2164 NaOsa 
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4.3.2. MS/MS analysis of the permethylated core oligosaccharide: 
[M4+2H]2+ and [M5+2H]2+ ions at mlz 1194.61, 1201.61, 1208.60, 1215.63, 1240.6341 
and 1247.63, respectively, were recorded with aCE varying from 40 -60 eV and CID gas 
pressure=4, and it was noted that all tandem mass spectra showed some degree of 
similarity. The tentative pathways of the dissociation of these selected precursor ions are 
presented in Figure 4-15. 
As an illustration, the ESI-CID-QqToF-MS/MS of the di-protonated molecule 
[M+2Hf+ at m/z 1194.61 is shown in Figure 4-16. In this tandem mass spectrum, the 
fragmentation routes are governed from both the non-reducing and reducing terminal 
ends ofthe molecule(Figures 4-15 and 4-16). 
It should be noted that for all the CID-MS/MS of this series of precursor ions: 
2+ 2+ [ ]2+ 2+ [MNHMe+2H] , [M+2H] , M1+2H , [M2+2H] , 
[M5+2H]2+ have in common the same mlz values for the diagnostic product ions derived 
from the [Bt and [Ct series, as shown in Figures 4-15 and 4-16 (detailed analysis is 
shown in Appendix II). In addition, the presence of the diagnostic product ion [0 '2X1~-Z1 -
2H+ Ht at mlz 1718,90 in some of the CID-MS/MS of the precursor series 
[MNHMe+2H]2+, [M+2H]2+, [MI+2H]2+, [M2+2H]2+ and [M3+2H]2+ is noteworthy. The 
presence of this product ion indicates that the incremental increase of 14 Da, as 
speculated, is localized on the (degraded Kdo) 4,6-anhydro-keto acid [ZI] portion of the 
permethylated core oligosaccharide. 
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Figure 4-15: Schematic representation of the fragmentation patterns of the 
permethylated homogeneous mixture of core oligosaccharides recorded in the positive 
ion mode. ESI-MS/MS are illustrated for the [M+2Hf+, [Mt+2H]2+, 
[M2+2Hf+,[M3+2H]2+, [M.+2H]2+ and [Ms+2Hf+ structures indicating the multiple 
methylated species of the 4,7-anhydro-a-keto acid derivatives 4A and 4A'. 
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Figure 4-16: ESI-MS/MS spectra of the permethylated precursor ions [M+2Hf+ at mlz 
1194.61 and the proposed fragmentation routes and product ions ofthis precursor. 
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In the special case of the CID-MS/MS of the precursor [M3+2Hf+ ion, the 
intensity of the product ion at m/z 1718.90 was increased considerably. This was 
explained by the different genesis of two isobaric product ions, which resulted from two 
different consecutive mechanisms. One fragmentation mechanism produced the [0 •2X1 ~­
ZI-2H+ Ht,whereas the other product ion [Y4-CHOMe+Ht was formed by a [Y4r 
cleavage, followed by a loss of a hydroxyl methyl group and protonation. This latter 
product ion loses the [Bsa] terminal heptose group, to afford the [Y4-CHOMe- Bsa+Ht 
product ion at m/z 1456.75 (shownin Appendix II; Figure II-3). 
However, for the [Yt series, namely the [Y4+Bsa-CHOMe+Ht, [Y4-
CHOMe+H]\ [Ys+Ht, [Y2a+Ht and [Y6+Ht, the obtained diagnostic product ions 
resulted from an incremental addition of 14 Daltons, produced by the introduction of a 
extra methyl group, as shown in Table 4-2. 
The product ion scans of the precursor di-protonated molecules [M4+2H]2+ and 
[Ms+2Hf+ at m/z 1240.63 and 1247.63, respectively, are somewhat different from those 
obtained above. The ESI-MS/MS spectrum of the [M5+2H]2+ ion and the tentative 
dissociation pathways obtained during this ESI-CID-QqToF-MS/MS are presented in 
Figure 4-17. In this tandem mass spectrum, more product ions containing the fully 
permethylated open Kdo chain were formed (Figure 4-17 and Table 4-2). In Table 4-1, it 
was indicated that the precursor ion [M5+2Hf+ resulted from the incorporation of 42 
methyl groups which, as stated earlier, seems to arise from an overmethylation during the 
Hakamori methylation (1964) of the cleaved heterogeneous core oligosaccharide 
containing the olefinic open chain. This occurred by the enolization of the carbonyl 
group at C-2, followed by oxidation of C-4, methylation, addition of a molecule of 
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methanol on C-2-C-3 and, finally, substitution reaction on the hydrogen of C-5 with a 
methyl group, most probably occurring in the methylation reaction and subsequent work 
up. 
The ESI-CID-QqToF-MS/MS of the singly charged protonated molecule of this 
permethylated series was also affected. The product ion scans of the protonated molecules 
[MNHMe+Ht, ~M+Ht, [Mt+H]\ [M2+H]+, [M3+Ht, [M4+Ht and [Ms+Ht respectively 
at mlz 2374.21, 2388.23, 2402.24, 2416.23, 2430.23, 2480.26 and 2494.24 were also 
measured with aCE= 80 eV and CID gas pressure= 8. Unfortunately these series of 
product ion scans did not produce diagnostic high mass product ions, but rather low mass 
product ions such as [GlcN1-7Hept at mlz 464.15, [B2-MeOHt at m/z 432.14, [Hept 
at m/z 199.05 and [B1-MeOHt at m/z 187.06. These MS/MS indicate that the peripheral 
region and the side branch glycones of the precursor protonated molecule are easily 
fragmented. 
To investigate whether it was possible to enhance the fragmentation of these 
mono-charged series of protonated molecules, MALDI tandem mass spectrometric 
analyses were performed. These tandem mass spectra were identical to those obtained by 
ESI-CID-QqToF-MS/MS of the same precursor ion series, producing [GlcN1-7Hept at 
mlz 464.1585 and [B2-MeOHt at m/z 432.1360. These results confirm the ease of 
fragmentation of the peripheral region glycones and suggest that the singly charged 
protonated molecules are resilient to the experimental gas phase dissociation conditions 
of both ESI- and MALDI-CID-MS/MS analysis. ESI-MS/MS and MALDI-MS/MS are 
shown in Appendix III. 
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Table 4-2: Diagnostic product ions of the [Y]+ series resulting from incremental addition 
of 14 Da, indicating the multiple methylated species of the 4,7-anhydro-u-keto acid 
derivatives 4A and 4A'. 
Diagnostic Product Ions 
Protonated 
Molecules (Y4 -Bsa-
CHOMe+Hf (Y4-CHOMe +Hf [Ys+Hf [Y2a+Hf [Ys+Hf 
[MNHMe+2H] 2+ 1400.71 1662.85 1910.97 2112.06 2156.13 
[M+2H] 2+ 1414.72 1676.86 1924.97 2126.07 2170.07 
[M1+2H] 2+ 1482.74 1690.88 1938.99 2140.11 2184.10 
[M2+2H] 2+ 1442.72 1704.86 1952.99 2154.08 2198.10 
[M3+2H] 2+ 1456.74 1718.87 1967.00 2168.09 2112.10 
[M4+2H] 2+ 1506.73 1768.89 2016.99 2118.10 2262.12 
[Ms+2H] 2+ 1520.86 1782.89 2013.01 2232.10 
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Figure 4-17: ESI-MS/MS spectra ofthe permethylated precursor ions [M5+2Ht at mlz 
1247.63 and the proposed fragmentation routes and product ions of this precursor. 
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4.4. Summary: 
The molecular structure of the wild-strain of the lipopolysaccharide core of 
Aeromonas salmonicida has been sequenced using tandem mass spectrometry, illustrating 
for the first time the mass spectrometric fingerprints of this biologically-active extract 
(Banoub et a!., 2004b ). In addition, the core oligosaccharide was determined to contain 
an 0-4 phosphorylated and 0-5 substituted Kdo reducing group, and its structure is 
proposed as the following: 
L-a-D-Hepp 
1 P04 
-!.. -!.. 
6 4 
R-L-a-D-Hepp-(1--+2)-L-a-D-Hepp-(1--+3)-L-a-D-Hepp-(1--+5)-a-Kdop-(2--+lipid A) 
4 
t 
1 
a-D-GlcpN-(1--+ 7)-L-P-D-Hepp 
R= a-D-Galp-(1--+4)-a-D-Galp NAc-(1--+6)-a-D-Glcp-(1--+4) 
After the core oligosaccharide of the LPS was released from the lipid A portion by 
conventional treatment with 1% acetic acid, the existence of a homogeneous mixture 
composed of the native core oligosaccharide containing the Kdo with its 0-4 phosphate 
group intact, and a degraded core oligosaccharide mixture, which eliminated the 0-4 
phosphate group with extreme facility were demonstrated. The precise molecular 
structure and glycone sequence of the homogeneous mixture of phosphorylated and 
dephosphorylated core oligosaccharides was determined by ESI mass spectrometry and 
tandem mass spectrometric analysis. CID-MS/MS of the homogeneous mixture of 
permethylated core oligosaccharides afforded a series of diagnostic product ions which 
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confirmed the established sequence of the glycones to be determined. MALDI tandem 
mass spectrometry reconfirmed the molecular structure of the dephosphorylated 
homogeneous permethylated mixture of the core oligosaccharides containing the 
structural isomers 4,8- and 4,7-anhydro-a.-keto acids. 
120 
CHAPTER 5: Mass Spectrometric Analysis of the Core Oligosaccharide 
of Mutant Areomonas salmonicida 
5.1. Background: 
The core oligosaccharide isolated from the mutant A. salmonicida is composed of 
four sugar residues (i.e. the inner core) and is shown in Figure 5-1. MS analysis of the 
inner core supports the observations associated with the presence of a phosphorylated 
Kdo unit at the reducing end of this poly-sugar. It illustrates the presence of the C-3-C-4 
olefinic D-arabino-3-en-2-ulonic acid open chain reducing end (Figure 5-l) and the 
isomers 4,8- and 4,7-anhydro-a-keto acids depvatives as shown in Figure 4-3. 
The MS fingerprint identification has a similar impact as in the case of the wild-
type core. That it is to say, for identification or quantification purposes, which can be 
essential for any biochemical study that includes this biologically-active inner core. One 
of the interesting findings in the MS analysis of the mutant inner-core is the absence of a 
[Mpo4-Hr species. This is not surprising as this extract was acid treated accidentally for 2 
hours while the wild-type core was hydrolyzed for merely 90 min. The identification of 
the open chain reducing end (Figure 5-1), however, provided strong evidence for the 
presence of the 0-4 phosphorylated Kdo unit. 
The ESI-QqTOF-MS/MS analyses of the permethylated inner core also allowed 
the exact identification of the series of diagnostic protonated molecular ions and, similar 
to the core isolated from the wild-type bacterium, pseudomolecular ions formed by 
addition of extra methyl groups were identified. The stereo-specific fragmentation routes 
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obtained during the tandem mass spectrometric analyses also permitted the precise 
sequencing of this dephosphorylated rough core oligosaccharide. 
HO 
COOH 
I 
C=O 
I CH 
II 
CH 
I 
-CH 
I CHOH 
I CHOH 
I CH20H 
Figure 5-l: The molecular structure of the core oligosaccharide of the mutant form A. 
salmonicida lipopolysaccharide, containing an 0-4 phosphorylated Kdo residue. 
122 
5.2. MS analysis of the homogenous mixture of the inner-core oligosaccharide: 
5.2.1. Negative-ion modeMS analysis: 
The native core oligosaccharide of the mutant form of A. salmonicida, after 
cleavage from the lipid A, was analyzed by electrospray mass spectrometry in the 
negative ion mode. The ESI-QqTOF-MS at DP;::::15 showed abundant [M-Hr molecules 
at m/z 794.8839 (see Figure 5-2). The presence of this deprotonated molecule confirms 
the newly revised structure which consists ofL-a-D-Hep(l---+2) L-a-D-Hep(l---+3) L-a-D-
Hep(l--+5)Kdo(4,7-anhydro-derivative 4A) (Figures 5-1 and 4-3). 
The same structure of the core oligosaccharide terminated at the reducing end by 
the 5-0-glycosylated, 4,8-anhydro-a-keto acid derivative 3A (or 3A') has the same 
molecular mass. The same can be corroborated for compounds 2 and 4A' (Figures 5-1 
and 4-3). The prevalence of the 4,7-anhydro-a-keto acid derivative of the degraded core 
oligosaccharide is expected, as the preference for a furanose structure has been illustrated 
(Susskind et al., 1998). 
5.2.2. Negative-ion mode ESI-QqToF-MS/MS analysis: 
Structural information, such as sequence patterns of branched oligosaccharides or 
differentiation of isomeric hexosyl units, has been obtained using tandem mass 
spectrometry. The unique dissociation patterns of the precursor ions provide diagnostic 
product ions which facilitate differentiation of isomeric species. 
The low energy CID-QqTOF-MS/MS (CE;::::15 eV) of the precursor deprotonated 
molecular ion [M-Hr at m/z 794.88 is shown in Figure 5-3. The proposed fragmentation 
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Figure 5-2: Negative ion mode, full scan, ESI-QqTOF-MS of core oligosaccharide of mutant A. salmonicida at DP=15. 
124 
[0·4x3r 
704.8986 
50 0 
450 
[ 1'3A2r 
250.9851 
4 0 0 [BJ]-
190.9907 
3 50 
3 0 0 
2 50 
[M-H]" 
794.8861 
2 0 0 208.9942 [B2]-
382.9668 
1 50 
1 0 0 [B3]-
50 
0 
1 0 0 
-11,72. 
I. I 
9 2 1 
[ I,sx 1-2 [ 1,4x co ] _ 5 1 4 .·9 3 8 o r2,5'V' 1 440.9801 2- 2 1 "· 
[,, 14 6 8 . 9 ~ 9 7 -5 3 0 . 9 ~- 9 2 ,6 6 0 . 9 4 1 8 - 7 0 7 .Ill 5 0 1 7 9 6 -~ 9 0 0 
1 50 8 0 0 2 0 0 2 50 3 0 0 350 400 4 50 50 0 55 0 600 6 50 7 0 0 7 50 
m /z, am u 
Figure 5-3: Product ion scan ofmlz 794.88. Peaks are labelled according to the proposed fragmentation routes. 
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routes obtained have been rationalized by using the scheme for systematic nomenclature 
for carbohydrate fragmentation using F AB MS/MS proposed by Domon and Costello to 
describe putative fragmentation processes (Domon & Costello, 1988a; Domon & 
Costello, 1988b) and is shown in Figure 5-4. 
The product ion scan of the ion at m!z 794.88 afforded three different major series 
of diagnostic product ions, namely, the [XL [Br and [Ar series. The charge retention 
occurs in the case of the [Br and [Ar ions on the non-reducing part of this core 
oligosaccharide. Thus, the major abundant product ions [B3L [B2r and [Btr at m/z 
574.93, 382.96 and 190.99, respectively, were observed. It was also noticed that the 
rt'3 A2r product ion at mlz 250.98 loses a molecule of ketene (42 Da) to afford the rt'3 A2-
CH2cor product ion at mlz 208.99 (Figure 5-4A and 5-4 B). 
Additional diagnostic ions, namely [Yr and [Xr ions, in which charge retention is 
localized on the reducing end were also formed. The major product ion [0,4X3r at m/z 
704.89 was formed; resulting from the elimination of monoglyceraldehyde C3H703 (90.0 
Da) from the non-reducing terminal L-glycero-D-manno-heptosyl residue of this core 
oligosaccharide (Figure 5-3 and Figure 5-4 A and 5-4 B). Cleavages of the C-1 and C-4 
bonds in the 0-2-substituted L-glycero-D-manno-heptosyl residue afforded the rt'4X2r 
product ion at m/z 512.92 which loses a molecule of C02 to afford the rt,4X2-C02r 
product ion at mlz 468.95. There are other product ions which are depicted in 
Figure 5-4B. 
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Figure 5-4: (A) Proposed major fragmentation patterns of the deprotonated molecule 
[M-Hr at mlz 794.88 (A). Types of product ions observed in this CID-MS/MS analysis 
(B) (next page); Dotted lines indicate a low relative abundance (<10%). 
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The very low abundance of the "Y -type" product ion series was noted. In this 
case, the charge retention also occurred on the portion containing the open olefinic chain 
and the anhydro derivatives present in 2, 3A, 3A' and 4A' on, typically, what is supposed 
to be the reducing end of this core oligosaccharide. Thus, the presence of the small 
abundant diagnostic product ions [Y3r and [Y2r containing the respective 4,7-anhydro-
derivative 4A of the terminal degraded reducing end of Kdo at m/z 602.89 and 411.97 
was observed. In addition, the [Ytr product ion at mlz 218.97 was also present in low 
abundance. In the CID-QqTOF-MS/MS of the [M-Hr ion at mlz 794.88, aside from the 
low abundances of the Y series product ion, no product ion resulting from internal 
fragmentations of the anomeric mixtures of the 4,8-anhydro- and 4,7-anhydro-derivatives 
of the reducing end terminal degraded Kdo residue was observed. This is not really 
surprising, considering the fact that the degraded 4,7-anhydro-Kdo-derivative is a 
C-linked glycoside attached to the C-3 of the aglyconic CH2-CO-C02H chain rather than 
an 0-linked glycoside. Consequently, the fragmentation will occur in a different manner 
during MS/MS analysis; an observation that was also noted in the previous chapter, 
concerning the wild-type core oligosaccharide. 
The MS fingerprints data obtained from the product ion scan of the [M-Hr 
corroborates the majority of the glycosyl sequences and establishes, without a doubt, the 
presence of the 4,7-anhydro-derivative of the degraded Kdo which was formed from the 
4-0-phosphorylated, 5-0-glycosylated reducing end Kdo residue which. 
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5.3. MS analysis of the permethylated core oligosaccharide: 
5.3.1. ESI-QqToF-MS: 
The permethylated, cleaved oligosaccharide was electrosprayed in the positive ion 
mode in a quadrupole-hexapole-quadrupole MS/MS instrument using methanol as the 
mobile phase. The ESI-MS is shown in Figure 5-5 A and indicates the presence of various 
sodiated molecules. The first sodiated molecular ion [M+Nat at m/z 1043.1754 resulting 
from the incorporation of 16 methyl groups and cationization with a sodium atom in the 
4,7-anhydro-derivative 4A, was identified. The presence of the [M1+Nat at mlz 
1057.1564 was consistent with the incorporation of 17 methyl groups and cationization 
with a sodium atom ofthe enol form of the 4,7-anhydro-derivative 4A•. 
In addition, another pseudo-molecular ion of this sodiated cluster was identified as 
the [M2+Nat at mlz 1071.16S8, which results from the incorporation of18 methyl groups 
and cationization with a sodium ion in the enol form of the 4,7-anhydro-a-keto acid 
derivative. The incorporation of an extra methyl group (from M1) was attributed to a C-
methylation of the H-3 olefinic proton in the enol form of the 4,7-anhydro-derivative. It 
has already been suggested by Dell and coworkers that C-methylations of Kdo residues 
are possible and were encountered during the FAB-MS of permethylated core 
oligosaccharide containing "normal," non-phosphorylated and 0-glycosylated reducing 
pyranose Kdo residue (Dell et al., 1990). Finally, another pseudo-molecular sodiated 
[M3+Nat ion was observed at m/z 1135.1561 which resembles the ion [M4+Ht of the 
wild-type bacterium (Figure 4-15). 
It should be noted that, for the sake of simplicity, the mlz values reported for all 
the permethylated, protonated molecules and sodiated molecule clusters reported in the 
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above and following sections, are those obtained with the ESI-QqTOF-MS hybrid 
instrument (Figure 5-5C). The m/z reported on Figures 5-5A and 5-5B are those obtained 
with the quadrupole-hexapole-quadrupole instrument. The permethylated, cleaved core 
oligosaccharide was once more electrosprayed in methanol containing traces of formic 
acid. The ESI-MS in Figure 5-5C showed the presence of the protonated molecule 
[M+Ht at m/z 1021.2127 of the permethylated 4,7-anhydro-derivative. The [Mt+Ht at 
mlz 1035.1846 was obtained from the incorporation of 17 methyl groups in the enol form 
of the 4,7-anhydro-a.-keto acid derivative. The [M2+Ht at mlz 1049.1980 was attributed 
to the incorporation of 18 methyl groups resulting in permethylation of the enol form of 
the 4,7-anhydro-a.-keto acid derivative followed by C-methylation. Once more, the 
[M3+Ht at mlz 1113.1575 Da was also noted. The permethylated cleaved core 
oligosaccharide was electrosprayed in methanol alone in the QqToF-MS hybrid 
instrument and the spectra did not change whether it was electrosprayed in methanol 
alone or methanol containing traces of formic acid (Figure 5-5C). 
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Figure 5-5: (A) Positive ion mode full scan MS of permethylated core 
oligosaccharide of mutant A. salmonicida by ESI-QhQ MS. (B) Positive ion 
mode full scan MS of permethylated core oligosaccharide of mutant A. 
salmonicida treated with traces of formic acid by ESI-QhQ MS. (C) Positive ion 
mode full scan MS of permethylated core oligosaccharide of mutant A. 
salmonicida by ESI-QqTOF MS. 
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5.3.2. Positive-ion mode MS/MS analysis: 
The low energy collision CID-QqTOF-MS/MS analyses were repeated with the 
hybrid instrument. The product ion scans of the protonated molecule [M+Ht at mlz 
1021.52, recorded at collision energy (CE)=10, is shown in Figure 5-6 . The proposed 
fragmentation routes obtained from these product ion scans are indicated in Figure 5-7 
and 5-8. 
The product ion scans of m/z 1021.52 gave no product ions resulting from charge 
retention of this so-called terminal reducing end; that is, no [Yt type product ions were 
observed. However, all the diagnostic product ions formed during MS/MS fragmentation 
were identified, with charge retention on the non-reducing part of this permethylated core 
oligosaccharide. All of the expected product ions belonging to the [Bt series were 
· observed in high abundance. Thus, the major diagnostic product ions [B3t, [B2t and 
[Bit at m/z 759.39, 511.28 and 263.16, respectively, were observed (Figure 5-7 and 5-8). 
In addition, product ions resulting from elimination of methanol molecules were also 
observed. The product ion [B3-MeOHt was observed at mlz 727.39 (Figure 5-8) as well 
as the product ions [B2-MeOHt, [B2-2MeOHt and [B3-3MeOHt at mlz 479.26, 447.23 
and 415.20, respectively. Finally, the product ions [B1-MeOHt, [BI-2MeOHt and [B1-
3MeOHt at m/z 231.13, 199.10 and 167.08, respectively, were also formed. In this 
context, it should be noted that the series of product ions [Ba-bMeOHt, in which a=l-3 
and b=l-3, could be formed by either consecutive fragmentation via the B-route followed 
by the loss of methanol, or by a concerted fragmentation mechanism occurring at the 
·same time. In these MS/MS experiments, it simply means that they are both lost at the 
same time and within the same reaction region in the tandem mass spectrometer. Thus, it 
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Figure 5-6: Product ion scan of mlz 1021.52 by ESI-QqTOF MS/MS using low energy CID at two different collision energies (A: 
lOeV and B: 15eV). 
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Figure 5-7: Proposed major fragmentation patterns of the permethylated protonated molecules [M+Ht at m/z 
1021.52, [M1+Ht at mlz 1035.5134 and [M2+Ht at mlz 1049.5251. 
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is difficult to deduce the order of fragmentation involving consecutive or concerted losses 
under MS/MS conditions. 
Another [At type diagnostic product ion resulting from the fragmentation of the 
terminal non-reducing end of this dephosphorylated core oligosaccharide was also 
observed. Thus, the [0'1 A2t product ion at m/z 497.26 was identified (Figures 5-7 and 
5-8). The methanol eliminated product ions [0'1Az-MeOHt and [0'1Az-2MeOHt at m/z 
465.26 and 433.21, respectively, were identified. Finally, the [0'1A3t product ion was 
also observed at 745.39. This product ion gave a series of elimination product ions [0'1A3-
bMeOHt, in which b=1-4 at m/z 713.37, 681.3371, 649.31 and 617.28, respectively 
(Figure 5-8). 
The product ion scan of the protonated molecule [M1+Ht at m/z 1035.52 was 
measured with different collision energies (10 and 15 eV). This protonated molecule 
corresponds to the incorporation of 17 methyl groups on the enol form of the 4,7-
anhydro-a-keto acid derivative 4A'. Please note that the obtained product ion scans in 
this CID-QqTOF-MS/MS are identical to those obtained for the product ion scan of 
[M+Ht at m/z 1021.52 (Figure 5-8). This could be explained by the fact that the MS/MS 
-
fragmentation of the [M1+Ht at m/z 1035.51 was governed by the loss of 276 Da, 
corresponding to the non-observed [Y I] portion containing the permethylated, enol form 
ofthe 4,7-anhydro-derivative ofthe degraded Kdo reducing end group (Figure 5-7). 
Similarly, the product ion scans of the protonated molecule [M2+Ht at mlz 
1049.53, corresponding to the incorporation of 18 methyl groups on the enol form of the 
4,7-anhydro-derivative 4A, were recorded at different collision energies of 10 and 15 
volts. Once more, the obtained CID-QqTOF-MS/MS afforded the same series of product 
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ions obtained for the protonated molecule [M+Ht at mlz 1021.52. Again, the MS/MS 
fragmentation of the [M2+Ht at mlz 1049.52 was governed by the loss of290 Da, which 
corresponds to the non-observed [Y I] portion containing the permethylated enolizable 
4,7-anhydro-derivative. The CID-MS/MS spectra of the [Mt+Ht and [M2+Ht are 
shown in Appendix IV. 
The product ion scan of the [M3+Ht at mlz 1113.1562 was recorded and is shown 
in Figure 5-9. This tandem mass spectrum was completely different from those obtained 
for [M+Ht, [Mt+Ht and [M2+Ht and seemed to arise from a complicated mechanism 
occurring during the Hakomori permethylation of the cleaved core oligosaccharide 
containing the open olefinic chain having the D-arabino-oct-3-en-2-ulonic acid terminal 
residue (as shown for the wild-type core LPS, Figure 4-15). The fragmentation routes of 
the product ion scan of[M3+Ht at mlz 1113.15, are proposed in Figures 5-10 and 5-11. 
As can be seen in this scan, the fragmentation routes are governed from both ends 
of the molecule. Indeed, the presence of the major product ions [Y3+Ht, [Y2+Ht and 
[Yt+Ht at mlz 851.12, 603.06 and 355.02, respectively, confirms the proposed structure. 
Additional diagnostic ions were observed such as the [Y1+H-MeOHt product ion at mlz 
323.02 which results from the elimination of one molecule of methanol from the [Yt+Ht 
product ion. These result from the permethylated alditol chain derived from the reducing 
end Kdo residue. A minor series of ions were formed from the non-reducing end of the 
core oligosaccharide. The low intensity [Btt, [B2t and [B3t product ions were observed 
at mlz 263.06, 511.12 and 759.39, respectively. Similar to the [M+Ht, [Mt+Ht, and 
[M2+Ht series, product ions resulting from elimination of methanol, as expected, were 
also noted for the [Bt series. Thus, the [Bt-MeOHt and [Bt-2MeOHt were observed at 
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Figure 5-9: Product ion scan ofmlz 1113.15 by ESI-QqTOF MS/MS using low energy CID. 
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mlz 231.05 and 199.03, respectively. The product ions [B2-MeOHt, [B2-2MeOHt and 
[B3-MeOHt at mlz 479.10, 447.08 and 415.07, respectively, were also formed. 
5.4. Summary: 
The molecular structure of the mutant form of the lipopolysaccharide of 
Aeromonas salmonicida was determined to contain an 0-4 phosphorylated and 0-5 
substituted Kdo reducing group, and is proposed as the following: 
P04 
~ 
4 
L-a-D-Hepp-(1--+2)-L-a- D-Hepp-(1--+3)- L-a-D-Hepp-(1--+5)-a-Kdop-(2--+Lipid A) 
It was established. that during the cleavage of this LPS with 1% acetic acid, to 
release the core oligosaccharide from the lipid A portion, a degraded core oligosaccharide 
was obtained which eliminated its phosphate group with extreme facility. The molecular 
structure and the fragmentation patterns of this dephosphorylated core was deduced by 
electrospray mass spectrometry and is proposed as the following: 
L-a-D-Hepp-(1--+2)-L-a- D-Hepp-(1--+ 3)- L-a-D-Hepp-(1--+5)-a-D-Kdop-( 4, 7-anhydro )-
a-keto acid 
Low energy collision ESI-QqTOF-MS/MS analysis of the dephosphorylated core 
oligosaccharide confirmed the presence of the 0-5 glycosylated 4,8- and 4,7-anhydro 
derivatives of the enolizable a-keto-acids. The CID tandem mass spectrometric analysis 
of the heterogeneous mixture of the permethylated core oligosaccharide established the 
methylation reaction on the isomeric 4,8- and 4,7-anhydro a-keto-acids and the complete 
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permethylation and addition reaction of the 0-5 glycosylated open chain reducing end 
terminal D-arabino-3-en-2-ulonic acid. The stereo-specific fragmentation routes obtained 
during the tandem mass spectrometric analysis permitted the sequencing of this 
dephosphorylated rough core oligosaccharide of the mutant LPS of A. salmonicida. 
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CHAPTER 6: Mass Spectrometric Fingerprints of Synthetic Cholesteryl 
Neoglycolipids: The Presence of a Unique C-Glycoside 
6.1. Background: 
Liposomes are widely used as drug delivery systems; Cationic liposomes, for 
example, are one .. of the most prevalent non-viral gene delivery systems used in gene 
therapy (El-Aneed, 2004). Their safety, simplicity of preparation and high encapsulation 
capacity of foreign genetic materials make them excellent candidates as alternatives to the 
immunogenic viral vectors which have been traditionally superior in terms of their gene 
transfer ability (Katsube et al., 2004; Lundstrom & Boulikas, 2003). 
One major limitation of the usage of liposomal formulations is their tendency to 
aggregate, as well as their rapid clearance in the circulatory system. Many modifications 
have been introduced to counter and prevent these drawbacks. Liposomes-drug 
complexes bearing polyethylene glycol (i.e. PEG-liposomes) were, for example, 
introduced (Klibanov et al., 1991; Klibanov et al., 1990) and have proven to significantly 
prolong the half life of liposomal formulations via steric stabilization. More recently, 
synthetic neoglycolipids were tested as an alternative to PEG-liposomes, providing better 
formulations in terms of stability and therapeutic outcomes (Perouzel et al., 2003; Xu et 
al., 2002). 
Structural conformation and purity of synthetic neoglycolipids can be investigated 
with the aid of mass spectrometry (Pohlentz et al., 1994; Routier et al., 1999). In addition 
to structural studies, quality control and quality assurance of liposomal formulations are 
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pharmaceutical necessities for the production of any therapeutically relevant liposomal-
based drug carrier. Mass spectrometric analysis and fingerprint identification (through 
CID-MS/MS analysis) of different liposomal components can, with a great degree of 
sensitivity, assist in monitoring various steps in the production process as well as during 
any pharmacokinetic study (Khan et al., 2003; Ng et al., 2004). 
In the following sections, it is reported, for the first time, the fragmentation pattern 
and the unique "in situ" formation of a steroidal C-glycoside species both within the ESI 
interface and in the collision cell during CID-MS/MS analysis of novel amphiphilic 
neoglycolipid cholesteryl derivatives. This C-glycosylation reaction results from an ion-
molecule reaction between the sugar oxonium ion and the neutral cholest-3,5-diene 
molecule. This finding is of great interest to the field of carbohydrate chemistry, as the 
occurrence of a C-glycosylation is, by far, more difficult than that of normal 0- or N-
glycosylation reactions. 
C-Glycoside chemistry has grown over the years and numerous published 
materials focus on the various methodologies of C-glycoside synthesis (Postema, 1995). 
In addition, many C-glycoside analogues have been used for their therapeutic values such 
as anti-cancer vaccines (Kuberan et al., 2003; Peri et al., 2001) and for protection against 
malaria as well as melanoma metastases (Schmieg et al., 2003). The formation of aryl 
C-glycoside within the mass spectrometry is a novel finding that needs to be explored and 
may allow interesting simple gas-phase C-glycoside reactions in contrast to tedious 
conventional bench-top chemistry. 
In this chapter, a new series of cholesteryl neoglycolipids bearing vanous 
carbohydrate moieties were synthesized and these are presented in Figure 2-1. The low-
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energy CID-MS/MS analyses of these series of novel synthetic neoglycolipids were 
performed and, subsequently, the fingerprint fragment ions were identified; which were 
common among different structures. 
6.2. QqToF-MS Analysis: 
Regardless of the structure of the tested neoglycolipid, abundant protonated 
[M+Ht species were observed during ESI-QqToF-MS analysis; and in most cases, the 
sodiated [M+Nat along with the corresponding [M+Kt adduct ions were also formed. 
The formation of the protonated singly-charged ion was enhanced by the addition of 
formic acid, whereas the series of fragment ions obtained in the ESI-MS were the same 
(i.e. with or without acid). QqToF-MS experiments also revealed the presence of a series 
of 1,2 sugar oxonium ions, namely [GlcNAct at m/z 204.08, [GlcNHzt at mlz 162.07, 
[GlcNHCOCD3t at mlz 207.10, [Fuct at 147.06, [GlcNAloct at mlz 246.07, [LacNAct 
at mlz 366.11, and the corresponding per-0-acetylated species of GlcNAloc and LacNAc 
at m/z 372.12 and 618.20 respectively. Figure 6-1 represents the QqToF-MS spectra of 
four neoglycolipids bearing GlcNHCOCD3, GlcNAloc, GlcNHz and GlcNAc (exact 
structures are shown within the figure) and illustrates the formation of the expected sugar 
[Oxoniumt ions. The complete ESI-MS spectra of all the remaining compounds are 
shown in Appendix V and VI. In addition, the cholesteryl cation that bears a positive 
charge, speculated to be localized on C-3 ', was formed, possibly via intact C-C covalent 
bond cleavage and was assigned as the [Cholestenet ion observed at mlz 369.35. 
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Figure 6-1: Four examples of positive QqToF-MS scans of different amphiphilic 
neoglycolipids (structure shown within the figure). 
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Figure 6-2 is a general schematic representation of the fragment ions observed 
during ESI-QqToF analysis of these series of neoglycolipids. In this schematic 
representation, and for the sake of simplicity, the sugar oxonium portion was illustrated as 
a glucosamine derivative. As can be seen from Figures 6-1 and 6-2, these neoglycolipds 
can fragment at either of the spacer's ends producing the two diagnostic fragment ions 
designated as [(Sugar-spacer-OH)+Ht and/or [(Cholesterol-spacer-OH)+Ht. Obviously, 
the length of the "Spacer-OH" corresponds with high accuracy to the tested 
neoglycolipids. Evidently, there were no "Spacer-OH" in the simple neoglycolipids with 
0-glycoside linkages and these were observed as protonated reducing sugars bearing the 
anomeric hydroxyl group. The occurrence of the [(Sugar-spacer-OH)+Ht species was 
more frequently formed during the analysis than the [(Cholesterol-spacer-OH)+Ht ion 
and was present in most of the studied neoglycolipids. The genesis of the [(Sugar-spacer-
OH)+Ht fragment ion was confirmed using four identical neoglycolipds that bear 
GlcNAc and a spacer of (CH2CH20)3 which includes deuterated CH2 at varying positions 
of the chain. As expected the non-deuterated species produced the [(Sugar-spacer-OH) 
+Ht fragment ion at mlz 354.17 while the mlz value for the corresponding deuterated 
species was 356.18 (see Figure 6-3). Similarly, the presence of GlcNHCOCD3 instead of 
GlcNAc resulted, as expected, in a shift in the mlz value of the [(Sugar-spacer-OH)+Ht 
ion from mlz 354.17 Th to mlz 357.19 Th (see Figure 6-3). 
Additional elimination products, originating from the sugar [Oxoniumt ions, 
were also observed. These can be summarized as ions formed by the expected loss of one 
or two water molecules designated as [Oxonium-H20t and [Oxonium-2H20t. The 
subsequent elimination of CO and CH2CO from these product ions was also noted, 
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Figure 6-2: General :schematic representation of the common fragmentation 
-
pattern of the cholesteryl neoglycolipids observed in ToF-MS analysis. The sugar 
portion is illustrated as glucosamine derivative where R = H, COCH3, COCD3, or 
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Figure 6-3: Confirmation of the genesis of the ions designated as 
[(Sugar-spacer-OH)+Ht using deuterated neoglycolipid species. 
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forming the ions assigned as [Oxonium-2H2o-cot and [Oxonium-2H20-CH2cot. 
Figure 6-1 and Figure 6-2 show the proposed mechanism of these losses. Such 
elimination products were absent in the case of the sugar [Oxoniumt ions of the pre-0-
acetylated neoglycolipids. Instead, elimination products that correspond to [Oxonium-
OAct, [Oxonium-20Act and [Oxonium-30Act were observed (see Appendix VI). 
The confirmation of the proposed structure of the various ions observed in the QqToF-
MS was accomplished by CID-MS/MS analysis, as described below. 
6.3. CID-MS/MS analysis: 
The discussion in this section will be divided based on the presence or absence of 
the acetylated hydroxyl groups within the sugar portion (i.e. protected vs non-protected 
species). 
6.3.1. CID-MS/MS analysis of the precursor protonated molecules of the non-
protected neoglycolipids: 
Table 6-1 summarizes the fragment ions observed in the CID-MS/MS analysis of 
the precursor protonated species [M+Ht of some of the amphiphilic neoglycolipids. In 
this table, a comparison was made between 9 neoglycolipids which bear different sugars; 
either a linker with different lengths of polyethoxy spacer or a simple 0-glycoside 
linkage. The coding of the compounds in this table was based on the assigned number in 
Figure 2-1 and the nature ofthe spacer. 
As can be seen from Table 6-1, a general fragmentation pattern which is in 
agreement with Figure 6-2 was observed. Fragment ions, representing [Cholestenet, 
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l(CHzCHzO)z tO-glycoside 2(CHzCHzO)J 20-glycoside 3(CHzCHzO)J 4(CHzCHzO)J 5(CHzCHz0)4 60-glycoside 6(CHzCHz0)4 
Frngment Ion 
[M+Ht 636.47 548.43 722.54 590.46 725.53 884.60 709.49 632.47 808.58 c31~No1 CllHssNOs C41HnN09 ClsliwN06 C41~9D3N09 C41HszN014 c41H7309 c31~zN01 C4sH34NOu 
[Cholestenet 369.36 369.35 369.38 369.36 369.36 369.34 369.35 369.33 Cn~s Cn~s Cn~s Cn~s Cn~s - c11~s Cn~s c11~s 
[(Sugar-spacer- 268.15 180.08 354.21 222.09 357.20 516.18 34l.l7 264.10 440.16 
OH)+Ht CwHnN01 C~14NOs C14HzsN09 CsH16N06 C14HzsD3N09 CzoH3sN014 c14H2909 CwH11N01 C1sH1sNOu 
[(Cholesterol-
- - -
563.45 
-
563.47 
spacer-OH)+Ht - - - Cls~JDs CJsH6JOs 
[ C-Glycoside t 530.42 530,43 572.46 572.44 575.45 734.49 614.46 614.33 C33Hs6N04 C33Hs6N04 ClsHssNOs CJsHssNOs ClsHssDJNOs C41H6sNOw - C37JiwN06 c31HwN06 
[Oxoniumt 162.09 162,07 204.11 204.08 207.11 366.ll l47.Ql 246.09 246.07 C6H12N04 C~12N04 CsH14NOs CsH14NOs CsHuDJNOs C14H24NOw C~u04 CwH1~06 CwH16N06 
[Oxonium-HzOt 144.08 144.06 186.10 186,07 189.10 228.09 228.08 C~wN03 C6HwN03 CsH1zN04 CsH12N04 CsH9D3N04 - - CwH14NOs CwH14NOs 
[Oxonium-2HzOt 168.10 168.06 171.09 210.07 210.05 - - CsHwNOl CsHwNOl CsH7D3N03 - - CwH12N04 CwH12N04 
[Oxonium-2Hz0- 138.07 138.05 141.09 180.06 180.04 
cor 
- - C1HsNOz C1HsNOz C1HsD3NOz - - C9HwN03 C9HwN03 
[Oxonium-2Hz0- 126.08 126.05 129.08 168.06 168.05 
CHzCOt - - C6HsNOz C6HsNOz C6Hs~NOz - - CsHwNOl CsHwNOl 
[(OH-Spacer-OH) 
-
195.11 
-
195.09 
+Ht - - - - - CsH190s CsH190s 
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Table 6-1: list of characteristic ions observed within MS/MS analysis of 9 protonated 
molecules [M+Ht of the neoglycolipids bearing non-protected sugar species. Each 
neoglycolipid was designated based on the sugar portion (Figure 2-1) and the nature 
ofthe spacer. 
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[Oxoniumt, [(Sugar-spacer-OH)+Ht and [(Cholesterol-spacer-OH)+Ht were identified. 
Figure 6-4 shows the CID-MS/MS spectra of three neoglycolipids bearing LacNAc and 
GlcNAc sugar moieties. The [(Sugar-spacer-OH)+Ht fragment ion was simply [(Sugar-
OH)+Ht when the sugar was attached to the cholesterol portion through 0-glycoside (see 
Figure 6-4A). As expected, elimination product ions derived from the sugar [Oxoniumt 
species were also observed and were similar to those obtained via conventional single 
stage QqToF-MS analysis (Figure 6-2). The general fragmentation pattern observed in 
the CID-MS/MS spectra (Table 6-1) suggested that the ions obtained in the one-stage 
QqToF-MS (Figure 6-1) are indeed fragments that originate from the protonated species 
of these neoglycolipids, rather than being separate species. This was supported by the 
fact that the "in source" fragmentation was significantly repressed when manipulating the 
mass spectrometry parameters, namely reducing the Declustering Potential (DP). It was 
also observed that the presence of the [(Cholesterol-spacer-OH)+Ht and [(OH-Spacer-
OH) +Ht fragment ions were only associated with the neoglycolipids bearing a 
polyethoxy spacer of (CH2CHz0)4 (Table6-l, Fig 6-4B). The CID-MS/MS spectra of all 
the neoglycolipids are presented in Appendix VII. 
In addition to the expected fragment ions, an unforeseen peak, whose mass was 
compatible with that of a C-glycoside species, presumably formed by nucleophilic attack 
of the neutral cholest-3,5-diene molecule on the sugar [oxoniumt ion formed during the 
CID-MS/MS process. The formation of the unique [C-Glycosidet ion was observed 
during the CID-MS/MS only when the neoglycolipids contained a 1,2-participating 
group, with the exception of L-fucose. In fact, this ion was also present in the 
conventional one-stage ESI-QqToF-MS; careful examination of the spectra shows that the 
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Figure 6-4: MS/ MS experiments of neoglycolipids bearing (A) GlcNAc linked to 
the cholesterol portion via 0-Glycoside; (B) GlcNAc linked to the cholesterol portion 
via (CH2CH20)3 spacer; and (C) LacNAc linked to the cholesterol portion via 
(CH,CH?0)1 soacer. 
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[ C-Glycoside t ion was also formed during ESI ionization and it was not simply an 
"impurity'' as was speculated initially when examining the QqToF-MS spectra (refer to 
Figure 6-1 ). It was hypothesized that this ion results from a unique ion-molecule reaction 
between the sugar portion as an oxonium ion and a neutral cholesterol species. Further 
discussion on the structure and formation of this ion using the various neoglycolipids 
evaluated in this study will be presented in the following sections. 
Finally, the presence of LacNAc (P-n-GalJZ-{1 ~4)-n-GlCJzNAc) resulted in the 
formation of additional sugar fragment ions beside the ones presented in Table 6-1 
(Figure 6-4C). These ions were formed from the diagnostic [LacNAct ion observed at 
m/z 366.11 (i.e. [Oxoniumt) and include the [GlcNAct ion at m/z 204.08, the [GlcNAc-
2H20t ion at m/z 186.04, and the [GlcNAc-2H20-COt ion at m/z 138.03 (all derived 
from the reducing end of the disaccharide). The presence of these additional fragments is 
expected and they serve as diagnostic product ions confirming the structure of this 
neoglycolipid. 
To verify the authenticity of the fragment ions assigned based on the conventional 
single-stage QqToF-MS analysis and on the CID-MS/MS experiments of the precursor 
protonated species [M+Ht, additional CIO-MS/MS were obtained by increasing the "in 
source" fragmentation (also called "in nozzle" fragmentation) which can be enhanced and 
optimized for each tested species through manipulation of the Declustering Potential (DP) 
and the Focusing Potential (FP) values within the ionization source (i.e. optimum 
potentials for each precursor ion, in terms of ion count and SIN ratio). 
Figure 6-5 represents the CID-MS/MS spectra of the neoglycolipid structure 6 
(Figure 2-1) bearing (CH2CH20)4 as a spacer (Figure 6-5A) as well as the CID-MS/MS of 
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the [(Cholesterol-spacer-OH)+Ht (Figure 6-5B) and the [(OH-Spacer-OH)+Ht fragment 
ions (Figure 6-5C). As can be seen in Figure 6-5A, the CID-MS/MS analysis of the 
[M+Ht ion followed the same pattern as discussed earlier and shown in Figure 6-2 and 
Table 6-1. However, the CID-MS/MS of the [(Cholesterol-spacer-OH)+Ht species at 
563.47 produced two major product ions corresponding to [Cholestenet at mlz 369.33 
and the [(HG-(CHzCHz0)3-GH)+ Ht at mlz 195.09. Similarly, the CID-MS/MS of the 
[(HO-(CHzCHz0)3-QH)+Ht ion at 195.09 produced product ions corresponding to the 
proposed structure of this ion (see Figure 6-4C). It showed distinctive, consecutive losses 
of water molecules followed by elimination of an acetylene species (CH=CH). These 
findings established the universal fragmentation pattern illustrated in Figure 6-2. 
6.3.1.1. The formation of [C-Glycosidet: 
As shown in Table 6-1 and Figure 6-4, [ C-Glycoside t species were observed first 
during the MS/MS experiment within the collision cell of the tandem mass spectrometer. 
However, this ion was also present in the one stage ESI-QqToF experiment (see Figure 
6-1 ). The formation of this unique ion cannot be explained based on the molecular 
structure of these novel synthetic neoglycolipids (Figure 2-1 ). To confirm the proposed 
structure of this ion, CID-MS/MS was performed on the isolated C-glycoside and showed 
that this ion can undergo two concerted cleavages which occur simultaneously from the 
precursor [C-glycos~det ion. The first involves the elimination ofthe axial H-2 hydrogen 
of the sugar moiety, with consecutive rupture and migration of the anomeric C-1-C-3' 
bond and the consequent formation of the neutral fragment 2-N-acetyl-2-deoxy-D-glucal. 
This is followed by formation of the C-3'-C-4' double bond and migration of the 
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endocyclic C-4' -C-5' double bond, to afford the protonated cholest-3,5-diene molecule 
assigned as [Cholestadiene+Ht at mlz 369.35. The second mechanism suggests the 
participation of the lone pair of electrons on the sugar ring oxygen to afford the stable 
sugar 1,2-oxonium ion [Oxoniumt, with identical rupture of the anomeric C-1-C-3' bond 
and migration ofthe double bonds, to produce the neutral choles-3,5-diene molecule. 
Figure 6-6 shows the CID-MS/MS of two [C-Glycosidet ions that contain 
LacNAc and GlcNAloc (extracted from the neoglycolipids 4 and 2, containing the 
(OCH2CHz)3 spacer or simple 0-glycoside, respectively) and illustrates clearly the 
presence of [Cholestadiene+Ht at mlz 369.35, [LacNAct at mlz 366.13 and [GlcNAct 
at mlz 204.08. Elimination products of the sugar [Oxoniumt were also present in this 
MS/MS analysis. This MS/MS analysis authenticated the proposed structure of the 
[C-Glycosidet ion. A list of all the [C-glycosidet species, their sources and the 
diagnostic product ions is shown in Table 6-2. 
Table 6-2: Tabulated CID-MS/MS results of the [C-Glycosidet ions 
mlz value of the Source Diagnostic product ions 
C-glycoside species [Cholestenet, [Oxoniumt 
530.42 Compounds 1 369.35, 162.07 
572.43 Compounds2 369.35, 204.08 
575.44 Compound3 369.35, 207.10 
734.48 Compound4 369.35, 366.13 
614.44 Compounds 6 369.35, 246.09 
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Figure 6-6: MS/MS of the ion identified as [C-Glycosidet, extracted from the 
neoglycolipids bearing (A) GlcNAc and linked to the cholesterol through 0-glycoside 
linkage and (B) the LacNAc linked to the cholesterol through the (CH2CH2)3 spacer. 
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To explain the rationale beyond the formation of the [C-glycosidet ion, it was 
proposed that a unique ion-molecule reaction occurs in the collision cell and within the 
ESI interface of the turbo ion spray source. It was postulated that the parent [M+Ht ion 
of the complete neo·glycolipid molecule undergoes covalent bond cleavages producing the 
sugar [Oxoniumt ion as well as the neutral cholestene. The latter can then attack 
through the electrophilic center of the nucleophilic cyclic sugar [Oxoniumr species 
producing the ion designated as the [C-Glycosidet. The presence of the amino group at 
position C-2 of the sugar residue enhances the formation of a more "reactive" 1,2 cyclic 
oxonium aziridinium species with a "strong" electrophilic position that is prone to 
nucleophilic attack from the neutral cholestene species to afford for the formation of the 
corresponding C-glycoside (see Figure 6-7A & 6-7B for details). In the event that the 
glycosyl moiety of the neoglycolipid did not bear a participating group at position C-2, 
the [ C-Glycoside t was absent as in the case of neoglycolipid bearing the Fuc sugar 
(Table 6-1). Despite the presence of the [Fucr oxonium ion at mlz 147.01 during ESI 
ionization, this ion failed to react with the neutral cholestene species since it lacks the 
participating group at position C-2 and as a result it can not form the corresponding ion 
[ C-Glycoside t (Figure 6-7C). As can be seen from Figure 6-7 and Figure 6-6, it was 
opted to illustrate that the [ C-Glycoside t ions were produced by the formation of a C-1-
C-3' covalent bond between the sugar and the cholesteryl portions. However, the 
presence of another [C-Glycosidet species that carries the C-1-C-5' covalent bond can 
not be excluded by the same mechanism, although it is improbable due to the potential 
steric hindrance of this latter C-glycoside. Needless to say, there is no way to tell for sure 
whether the formed C-
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Figure 6-7: Schematic representation of the mechanistic process that leads to the formation of the [ C-Glycoside t ion within 
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glycoside possesses the ~-D-configuration, the a-D-configuration, or an anomeric mixture 
of both. Nevertheless, the attributed ~-D-configuration is, without doubt, the preferred 
configuration as it is known that it more kinetically and thermodynamically stable 
(Banoub et al., 1992). 
In addition to the absence of the [ C-Glycoside t in the case of the Fuc derived 
neoglycolipids, this ion was also absent in the low energy CID-MS/MS analysis of the 
sodiated adducts [M+Nat of the neoglycolipid series evaluated in this study. For 
illustration purpose, Figure 6-8 represents the fragmentation pattern of the product ion 
scan of the [M+Na]+, isolated from the neoglycolipid designated as 3, containing the 
spacer (CHzCHzO)J. The fact that both [Oxoniumt and [Cholestenet ions were absent 
in the MS/MS of the [M+Nat, suggests that this adduct breaks in different fashion than 
the one observed with [M+Ht and does not form the reactive species that can result in 
the formation of the C-glycoside bond. All the fragment ions were actually sodiated 
species and included a fragment ion that is generated from inner sugar breakage, namely 
o.zx. Such inner sugar fragments are common and widely observed in glycoconjugate 
analysis (Banoub et al., 2004b; El-Aneed & Banoub, 2005), and it was observed in our 
study of the [M+Ht, namely the ion designated [Oxonium-2HzO-CHzCOt (see 
Figure 6-2). 
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Figure 6-8: The proposed fragmentation pattern of the [M+Nat of the 
neoglycolipid bearing GlcNAc with a (CH2CH20)3 spacer. 
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6.3.1.2. The influence of Declustering Potential (DP) and Focusing potential (FP) on 
the formation of C-Glycoside: 
Both DP and FP are electrical voltages that have the greatest effects on the extent 
of the fragmentation within the orifice-skimmer region of the ESI source of the QStar XL 
hybrid tandem mass spectrometer. C-Glycoside ion formation was significantly 
correlated with the DP (Spearman's correlation coefficient, p-value=0.009), (Figure 6-9A) 
but not with the FP (p-value=0.54) (Figure 6-9B). Therefore, the FP value was kept 
constant (FP=220) while studying the influence of the DP on ion formation. The pattern 
between the ion count (intensity) and the DP values was similar for the formation of the 
C-glycoside species and the sugar [oxonium t ions (2 samples Kolmogorov-Smirnov 
Test, p-value=0.34), but showed significance differences when the formation of the 
. C-glycoside was compared to that of other ions such as [M+Ht and. [(Sugar-spacer-
OH)+Ht (p-value= 8.082e-08 and< 2.2e-16, respectively). 
As shown in Figure 6-10, the [C-Glycosidet ion formation (with respect to DP 
values) followed the exact pattern of the sugar [oxoniumt species. This supports the 
theory that the formation of the [ C-Glycoside t species was a product of a reaction 
between the sugar [oxoniumt ion and the neutral fragment cholesta-3,5-diene. Please 
note that when comparing different species the ion count values were normalized to the 
maximum reading. 
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6.3.2. CID-MS/MS analysis of the precursor protonated molecules of the protected 
per-0-acetylated neoglycolipids: 
The per-0-acetylated neoglycolipids were used, as it was anticipated that the 
formation of the more reactive 1 ,2-cyclic oxonium ion would enhance the rate of the ion-
molecule reaction. This may result in more efficient formation of the C-glycoside in the 
ESI source and in the collision cell of the hybrid tandem mass spectrometer. Table 6-3 
summarizes the fragmentation pattern of the protonated molecules [M+Ht of the 
per-0-acetylated neoglycolipids. The presence of the diagnostic fingerprint ions namely 
[Cholestenet, [(Sugar-spacer-OH)+Ht,and [Oxoniumt were observed. Similar to the 
non-protected. neoglycolipids, the presence of [(Cholesterol-spacer-OH)+Ht was only 
associated with the neoglycolipid bearing (CH2CH0)4 spacer. As expected, the 
elimination products originating from the [Oxoniumt ions were a result of one, two or 
three losses of acetic acid groups (see Table 6-3). Additional elimination products of the 
[Oxoniumt are also formed and are presented in detail below. 
The most interesting finding was, however, that the [ C-Glycoside t ion was absent 
in the case of these per-0-acetylated sugar derivatives (See Table 6-3). This observation 
contradicts expectations, as the per-0-acetylated sugars are routinely used for 
C-glycosylation reactions in synthetic chemistry (Postema, 1995). In fact, the per-0-
acetylated neoglycolipids are not used for liposomal preparations and they were 
synthesized in order to enhance to formation of C-glycoside. However, the fact that this 
reaction occurs in the gas phase can introduce many new factors which are different from 
the conditions that rule solid and solution chemistry. One possible explanation is the 
overall reactivity of the per-0-acetylated-sugar oxonium ions. These oxonium ions, 
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4(CH2CH20)3 6(CH2CH20)4 60-glycoside 
Fragment Ion 
[M+Ht 1136.66 943.62 758.51 Cs9H94NOzo Cs1Hs4N0,4 C43H6sN010 
[ Cholestene t 369.34 - 369.37 c77~s c77~s 
[(Cholesterol-spacer-OH)+Ht 563.47 - C3sH630s 
[ (Sugar.:.spacer-OH)+Ht 768.29 566.25 390.16 
C32HsoNOzo Cz4H4oN0,4 C,6H24NOw 
[ C-Glycoside t 
[Oxoniumt 618.20 372.12 372.14 C26H36N0,6 C,6HzzN09 C,6HzzN09 
[Oxonium-OAct 558.18 - 312.10 C24H32N0,4 C,4H1sN07 
[Oxonium-20Ac t 498.15 252.08 252.09 
CzzHzsN012 C,zH14NOs C12H14NOs 
[Oxonium-30Ac t 438.09 192.06 192.07 CzoHz~010 CwHwN03 
Table 6-3: list of characteristic ions observed within MS/MS analysis protonated molecules of the neoglycolipids bearing 
protected sugar species. Each neoglycolipid was designated based on the sugar portion (Scheme 1) and the nature of the spacer. 
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being extremely reactive due to the presence of OAc groups, preferentially eliminate 
molecules of acetic acid and ketene, by concerted mechanisms, destabilizing the 1,2-
cyclic oxonium ion. Therefore, this oxonium ion has no time to form the cyclic reactive 
species which can react with the nucleophilic cholesta-3,5-diene molecule in the collision 
cell. Although this speculation can provide some explanation for the absence of the [ C-
Glycoside ]\ other possible mechanisms such as steric hindrance cannot be excluded. 
Other possibilities may also unfold in the future with advances in the field of gas-phase 
chemistry. 
CID-MS/MS, once more, confirmed the assigned structure of the product ions 
shown in Table 6-3. Figure 6-11 represents a comparison of the CID-MS/MS of the 
[Oxoniumt ions that corresponds to neoglycolipids bearing the 2-N-
allyloxycarbonylamino-2-deoxy group (GlcNAloc), or the per-0-acetylated GlcNAloc 
sugar species with the (CH2CH20)4 spacer. This figure shows the discrepancy in the 
fragmentation patterns as the per-0-acetylated [Oxoniumt ion produces unique ions that 
are directly related to the presence of acetyl groups. As can be seen from Figure 6-llA, 
the non-protected [GlcNAloct produced 6 fragment ions that are in accordance with 
Figure 6-2 and Table 6-1. The protected per-0-acetylated [GlcNAloct ion, however, 
produced 15 fragment ions (Figure 6-llB). This fact supports the speculation regarding 
the overall reactivity of the per-0-acetylated oxonium ion in comparison to the non-
protected oxonium. 
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Figure 6-11: CID-MS/MS of the [Oxoniumt ions extracted from neoglycolipid that bear 
GlcNAloc sugar species (A) and the per-0-acetylated GlcNAloc (B). 
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The fragmentation pattern of the protected per-0-acetylated [GlcNAloct ion is 
schematically presented in Figure 6-12. The protected [GlcNAloct at m/z 372.13 can 
lose a molecule of either acetic acid or ketene producing the minor fragment ions 
designated as [Oxonium-CH3COOHt at m/z 312.11 and [Oxonium-CHzCOt at mlz 
330.12. The former product ion can further eliminate a molecule of C3H4 from the 
-
allyloxycarbonyl side chain and produce the ion [Oxonium-CH3COOH-C3H4t at 272.08 
which bears the carboxylic acid group. The structure of this ion was confirmed by the 
distinctive loss of 44 Da (i.e. COz), producing the ion observed at m/z 228.09. The 
[Oxonium-CH3COOHt product ion can lose an additional molecule of acetic acid, 
resulting in the formation of the major ion [Oxonium-2CH3COOHt at mlz 252.09. This 
major ion can produce three additional product ions, the first of which is produced by 
eliminating of a molecule of C3H50 from the allyloxycarbonyl chain producing the 
species assigned as [Oxonium-2CH3COOH-C3H50t at m/z 194.03. The second involves 
a neutral loss of a ketene group to yield the [Oxonium-2CH3COOH-CH2CO+Ht ion at 
m/z 210.06 which bears a ketone group at position 4 of the sugar. This ketone group can 
then be eliminated as a molecule of CO through inner-ring contraction, forming the 
transitional minor ion species observed at 182.06, which then eliminates a molecule of 
H2, producing the resonantly-stabilized ion observed at m/z 180.06. Finally, the 
[Oxonium-2CH3COOHt can undergo a final breakage by eliminating an additional 
molecule of acetic acid, with relocation of the double bonds, producing the stabilized ion 
designated as [Oxonium-3CH3COOHt at m/z 192.05. Due to the presence of an amino 
group at position C-2, the [Oxonium-3CH3COOHt ion can also exist in 1,2-cyclic form 
that can lose the internal COz accompanied by structural rearrangement, to yield the 
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[Oxonium-2CH3COOH-C02t ion at m/z 148.07. The latter ion can finally undergo 
subsequent breakages losing CO followed by CH2 resulting in the formation of the 
product ions observed at mlz 120.08 and 106.06, respectively. 
It should be noted that the fragmentation pattern and the proposed origin of the 
various ions, shown is Figure 6-12, were authenticated by performing multiple MS/MS 
experiments (can be referred to as quasi MSn). For example, the [Oxoniumt ion was a 
daughter of the [M+Ht (see Table 6-2) and the MS/MS experiment of this ion can be 
- -
considered a quasi MS3. Therefore, the CID analysis of the [Oxonium-CH3COOHt 
fragment ion at mlz 312.11 can be argued to be MS4 and has proven that both [Oxonium-
originate from this ion (see Figure 6-12). Similarly the CID analysis of the [Oxonium-
CH3COOH-C3H4t ion at m/z 272.08 (MS5) showed that 228.08 was a product of this ion. 
Such quasi MSn experiments are very powerful for structural studies and Banoub's 
research group were the first to conduct and describe such a series of quasi MSn using 
ESI-CID-QqToF-MS/MS in which the novel fragmentation routes of morphine opiate 
receptor antagonists. were established (Joly et al., 2005). The multiple MSn spectra that 
established the fragmentation pattern presented in Figure 6-12 are shown in Table 6-4. 
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OH 
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8 
~~ 
CH2=CH-CH2-0-n-NH ~OH 
[Oxonium-CH2COt 
mlz 330.10 
0 CH2 + 
[Oxoniumt AcO~~\_ 
m/z372.11 AcO~ 
CH2=CH-CH2-0-C-NH 
II 
kO~ 
O=C-N 
[Oxonium-2CH3COOH-C3H50t 
mlz 194.03 
0 
~0~ 
CH2=CH-CH2~ 
8 
[Oxonium-3CH3COOHt 
mlz 192.06 
CH2 + 
AcO~~\_ 
AcO~ 
NH2 
[Oxonium-CH3COOH-C3H4-COl 
mlz228.08 
---C~3H_4'----~4 
HO-C-NH 
II 
0 
-CO 
[Oxonium-3CH3COOH-C02-CO-CH2t 
mlz 106.06 
[Oxonium-3CH3COOH-C02-COt 
m/z120.08 
[Oxonium-3CH3COOH-C02t 
rnlz 148.07 
Figure 6-12: The fragmentation pattern of the protected [GlcNAloct. 
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Table 6-4: Tabulated CID-MS/MS results that established Figure 6-12. 
Precursor Ion Product ions 
312 272,228,252 
272 228 
252 210,194,192,148,120,106 
210 182, 180 
192 148, 120, 106 
180 No diagnostic ions 
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6.4. Summary: 
The fragmentation patterns of 18 novel amphiphilic neoglycolipid cholesteryl 
derivatives were evaluated. These compounds can be used to increase liposomal stability 
and efficiency. These neoglycolipids bear different sugar moieties namely, D-
glucosamine, N-acetyl-D-glucosamine, N-trideuterioacetyl-D-glucosamine, N-acetyl-
lactosamine, L-fucose, N-allyloxycarbonyl-D-glucosamine, and some of their per-0-
acetylated derivatives. Regardless of the structure of the tested neoglycolipid, QqToF-
MS analysis using ESI source showed abundant protonated [M+Ht species. It has also 
been identified by both QqToF-MS and low-energy collision tandem mass spectrometry 
(CID-MS/MS) of the [M+Ht ion, the presence of specific common fingerprint fragment 
ions namely, [Cholestenet, sugar [oxoniumt, [(Sugar-spacer-OH)+Ht, [oxonium-H20t 
and [(Cholesterol-spacer-OH)+Ht. 
In addition, a unique ion, which could not be rationally explained by the expected 
fragmentation of these amphiphilic molecules, was observed. This ion was compatible 
with that of a C-glycoside species formed by a chemical reaction between the sugar 
portion and the cholesterol. MS/MS analysis ofthis unique [C-glycosidet, confirmed the 
authenticity of the proposed structure of this ion. The presence of an amino group at 
position C-2 and free hydroxyl groups of the sugar motif is crucial for the formation of a 
"reactive" sugar oxonium ion that can form the [ C-glycoside t species. 
In summary, the fragmentation patterns of the tested series of neoglycolipid 
cholesteryl derivatives was precisely established and their structure as well as the 
formation of a C-glycoside with the ESI source under atmospheric pressure and in the 
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collision cell during MS/MS analysis was authenticated (Banoub et at., 2005a; El Aneed 
et al., 2006). 
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CHAPTER 7: Conclusions and Summary 
Advancements in biological mass spectrometry have significantly grown over the 
past few decades; over 5000 abstracts, for example, were presented in the 54th ASMS 
(American Society for Mass Spectrometry) annual conference in 2006. MS has the 
advantages of limited sample consumption and relatively short analysis time. One of the 
most significant mass spectrometric research areas is concerned with the identification of 
mass spectrometric fingerprints of natural and synthetic compounds (Es-Safi et al., 2005; 
Li et al., 2006). ESI-MSn using FTMS ·instrumentation, for example, elucidated the 
fragmentation patterns and the molecular structures of synthetic indole derivatives (Cao et 
al., 2005), as well as natural core oligosaccharide extract isolated from the bacteria 
Proteus (Kondakova eta/., 2005). 
Natural and synthetic glycoconjugates are evaluated in this document and their 
· fragmentation patterns are presented for the first time. These compounds are divided into 
two major groups, the naturally-occurring LPS-derived oligosaccharides and the synthetic 
neoglyclolipids. While the latter is a liposome-stabilizing and targeting agent, the former 
is isolated from the outer membrane of the fish pathogen A. salmonicida, a candidate for 
vaccine development either as liposomal formulations (Nakhla et al., 1994) or as protein-
hapten conjugates (Banoub et al., 1989). The LPS portions include the lipid A, the inner 
core and the complete core oligosaccharide. The data presented are additional steps 
which will help in understanding the mechanisms that govern sugar MS analysis; this will 
eventually lead to the development of robust and efficient sequencing algorithms (Joshi et 
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al., 2004; Tang et al., 2005) that can, similar to MS protein and peptide sequencing 
programs, be incorporated into the software of future commercial MS instruments. 
7.1. Mass spectrometric analysis ofLPS oligosaccharide: 
7.1.1. Lipid A: 
ESI-MS is commonly used for the characterization of lipid A molecules (Boue & 
Cole, 2000; Chan & Reinhold, 1994; Corsaro et al., 2004b; Corsaro et al., 2002) which 
have been proven to be universally composed of two D-GlcN sugar moieties forming a ~­
D-(1 ~6)-D-GlcN disaccharide. This disaccharide is substituted by two phosphate 
groups, one being attached at position 0-4' of the non-reducing end sugar and the other at 
the anomeric OH of the disaccharide reducing end ( C-1 position). Fatty acid chains 
acylate the various free positions of the D-GlcN disaccharide-backbone, resulting in the 
formation of 0- and N- linked fatty acid esters (see Figure 3-1). It has been reported in 
the literature that the phosphate group can also be substituted by other functional groups 
such as phosphate or phosphorylethanolamine (Kulshin et al., 1992; Masoud et al., 1994). 
A glycosyl residue such as 4-amino-4-deoxy-L-arabinose, has been identified to be 
attached at position 0-4' of the phosphate group (Reitschel et al., 1984). More recently, 
the presence of lipid A containing a-D-mannose sugars instead of phosphate residues was 
reported (Schwudke et al., 2003). 
Lipid A extracts are not merely composed of a single entity and are in reality a 
mixture of many structurally- related components (Chan & Reinhold, 1994; Corsaro et 
al., 2004b; Hsu & Turk, 2000; Krasikova et al., 2001; Zarrouk et al., 1997). Due to this 
complex nature of lipid A, ESI coupled to tandem MS/MS is an excellent tool to illustrate 
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the precise molecular structure of this biologically active extract. Tandem mass 
spectrometry was used to analyze the lipid A which was the major compound in a mixture 
of various structurally related components, without the need for any tedious separating 
techniques. It was demonstrated that lipid A, isolated by acid hydrolysis from the A. 
salmonicida-LPS, had two phosphate groups at position 0-1 and 0-4'. In addition, both 
D-GlcN units of the ~-D-(1 ~6) disaccharide were 0- and N- substituted with various 
fatty acids which were identified to be C12:0 and C14 (3-0H). The distribution ofthe 
fatty acids on the molecule was established through the presence of the distinctive ions in 
the QqToF-MS, namely the [Yr and [Cr derived ions (see Figure 3-2 and 3-3), as well as 
from the product ions originating from inner sugar :fragments, observed in the MS/MS 
analysis. Furthermore, MS/MS analysis of the [Yr and [Cr ions clearly confirmed the 
presence of two C14:0 (3-0H) fatty acids on the reducing end group, and two C14:0(3-
0(12:0)) on the non-reducing end group of the disaccharide (Figure 3-9). This was also 
evident by the generation of product ions associated with distinctive losses of these fatty 
chains, either as neutral ketene or as a free fatty acid (Figure 3-8). 
In summary, the high-resolution hybrid QqToF-MS/MS instrument was used 
resourcefully to "separate" the major lipid A components and to locate the fatty acid and 
phosphate groups on their proper positions on the D-GlcN disaccharide. In addition, the 
mass spectrometric fingerprints of this biological compound were identified and 
established (Table 3-1 and Table 3-2). This allows the precise molecular structure of the 
major lipid A component to be elucidated from the other modified lipid A compounds of 
this complex mixture. 
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7.1.2. The core oligosaccharide: 
There has been considerable confusion during the last few decades concerning the 
presence (or absence) of Kdo in lipopolysaccharides isolated from bacteria of the 
Vibrionaceae family (Hisatsune et al., 1982; Kondo et al., 1992). Difficulty in measuring 
the Kdo in the case of the LPS of A. salmonicida indicates the presence of a phosphate 
group attached through 0-4 and glycosylated through 0-5. Thus, the determination of the 
Kdo by the Weissbach thiobarbiturate colorimetric reaction could not measure the 
formation of malonaldehyde released by periodate oxidation. 
The wild-type core oligosaccharide of A. salmonicida was isolated from the lipid 
A portion with 1 % acetic acid at 100° C for 90 minutes and a homogeneous mixture of 
oligosaccharides was obtained. This mixture was composed of the native core 
oligosaccharide containing the intact 4-0-phosphorylated reducing Kdo residue 2B 
(Figure 4-2), in addition to the core oligosaccharide containing the C-3-C-4 olefinic D-
arabino-3-en-2-ulonic acid open chain reducing end 2A (Figure 4-2), obtained from the 
elimination of the 0-4 phosphate group as phosphoric acid from the C-3-C-4 position. 
This degraded core oligosaccharide underwent an intramolecular addition reaction 
between the alcoholic function at 0-7 or 0-8 to the olefinic double bond, to produce a 
mixture of isomeric pairs of the 4,8- and 4,7-anhydro derivatives 3A and 4A of the 
enolizable a-keto acids (Figure 4-3). 
The ESI-QqToF-MS/MS has assisted in the complete structural characterization 
of the core oligosaccharide containing ah 0-4 phosphorylated and 0-5 glycosylated Kdo 
reducing end group. This work contributes an extra step in a unique approach for the 
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elucidation of more sophisticated natural bacterial oligosaccharides. The ESI-CID-
QqToF of the precursor ion [MPo4- 2Hf at mlz 982.29, obtained from 2B (Figure 4-9) 
illustrated the diagnostic elimination of phosphoric acid to afford the [M-2Hf and [M-
Hr respectively at mlz 933.33 and 1867.71. The mechanism of the elimination of the P04 
group from the 0-4 phosphate and 0-5 glycosylated Kdo terminal reducing end group 2B 
was explained by a three-stepwise mechanism to afford the 4,8- and 4,7-anhydro-a-keto 
acid derivatives 3A and 4A (Figures 4-2 4-3). 
The characteristic molecular ion fingerprint obtained from the CID-QqToF-
MS/MS of the five diprotonated perrnethylated molecules [M+2H]2+, [M1+2H]2+, 
[M2+2H]2+, [M3+2H]2+, and [M4+2H]2+ allowed the facile identification of the cleaved 
core oligosaccharide mixture containing the anomeric 4,8-anhydro-and 4,7-anhydro 
degraded Kdo derivatives (Figures 4-15, 4-16, 4-17 and Table 4-2). The ESI- and 
MALDI-QqToF-MS/MS of the singly protonated molecules [M+Ht, [M1+Ht, [M2+Ht, 
[M3+Ht , [~+Ht and [MsHt gave tandem mass spectra containing a series of product 
ions of limited diagnostic value (Appendix III). 
Similarly, the rough-type core oligosaccharide (representing the inner-core) was 
investigated and the mass spectrometric fingerprints were identified (Figure 5-4). The 
ESI-QqTOF-MS/MS has assisted in the complete structural characterization of a core 
oligosaccharide from a mutant form of A. salmonicida lipopolysaccharide containing an 
0-5 phosphorylated, 0-4 substituted Kdo reducing end group. 
Finally, it should be mentioned that this type of homogeneous core 
oligosaccharide containing an 0-4-phosphorylated and 0-5 substituted Kdo in the 
lipopolysaccharide, can be representative of all wild type A. salmonicida (Banoub et al., 
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1983), A. hydrophila (Auzanneau et al., 1991; Carof et al., 1987), and V. anguillarum 
(Kondo et al., 1992) lipopolysaccharides, which were previously studied. Accordingly, 
many of these published core oligosaccharide structures were presented without the 
presence of any Kdo residue at all, due to the limited technology available at that time. 
These molecular structures will have to be revised to incorporate the presence of the 0-4 
phosphorylated and 0-5 substituted Kdo reducing end. Obviously, MS can be of great 
assistance in the rapid screening of core oligosaccharides obtained from different strains 
in order to investigate the presence of the structures currently established for other strains 
(including A. salmonicida) and ·to report new structural findings. In fact, minimum 
changes on the structural level can alter bond breakages and fragment formation. 
7.2. Synthetic neoglycolipids: 
7 .2.1. Mass spectrometric fingerprints: 
Synthetic neoglycolipids that bear a mono- or disaccharide glycosyl moiety 
(hydrophilic) and a cholesterol moiety (hydrophobic), which are linked by a polyethoxy 
spacer, were evaluated using QqToF-MS/MS hybrid instrumentation (ESI and CID-
MS/MS analysis). The results demonstrated clearly that, both in the ESI source and 
within the collision cell of the mass spectrometer, the neoglycolipids follow a universal 
fragmentation pattern, producing a series of daughter ions which correspond precisely to 
the theoretical structure ofthese amphiphilic molecules (Figure 6-2 and Table 6-1). 
Breakage can occur at either of the spacers ends, producing most of the fragments 
observed in the ESJ;-qQ-ToF and MS/MS analysis. In addition, elimination products that 
are generated from the sugar portion were also observed and include product ions which 
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are related to inner sugar fragmentation, such as the [Oxoniurn-2H20-CH2Cot ion (see 
Figure 6-2). The genesis of these product ions was further confirmed by MS/MS analysis 
as shown in Figures 6-5. 
This newly-established universal fragmentation pattern {Table 6-1) can be utilized 
to easily predict the fragmentation of new· compounds that have the same general 
structural backbone. In addition, single or multiple ion monitor reactions can be 
performed for any quantitative studies of liposomes bearing these novel neoglycolipids as 
stabilizing components. 
7.2.2. C-glycosylation reaction: 
In addition to the establishment of the mass spectrometric fingerprints of these 
compounds, the most interesting finding was the presentation of concrete evidence for the 
formation of ati unprecedented C-glycosylation reaction during the ESI-MS and MS/MS 
analysis (Figures 6-6 and 6-7). Such a reaction does not occur easily and requires 
reasonable efforts on a bench-top in a chemistry lab. It occurred, however, in a timeframe 
of milliseconds within the mass spectrometer. Ion-molecule reactions within mass 
spectrometry are old phenomena which were first noticed as early as 1913 (Thomson, 
1913). They are mainly observed and monitored within ion trap (IT) mass analyzers 
(quadrupole IT and Fourier Transform MS) (Cerda et al., 2002; Ottens et al., 2005; 
Vidasky et al., 1994; Wojcik & Markowski, 2005). It was suggested, for example, that 
poly-( ethylene/propylene glycol) under collisionally activated dissociation using FT-ICR 
MS/MS resulted in misleading rearrangements (Cerda et al., 2002; Vidasky et al., 1994). 
Both triple- and penta-quadrupoles were also used to evaluate ion-molecule reactions 
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(Chen et al., 2005; Meurer et al., 2005). Banoub's and Eberlin's research groups were 
the first to show that such reactions can occur under atmospheric pressure in the ESI 
source (Banoub et al., 2005a; El Aneed et al., 2006; Meurer & Eberlin, 2006). 
In this investigation, a quadrupole time of flight mass spectrometer was used and 
illustrated the occurrence of a unique C-glycosylation reaction in the collision cell as well 
as under atmospheric pressure in the ESI source. The production of a C-glycoside occurs 
from a reaction between the positively charged N-sugar oxoniom ion and a neutral 
cholesterol species. When studying these compounds in the negative ion mode, this 
reaction fails to occur, supporting the mechanism presented in Figure 6-7. The presence 
of an amino group at position C-2 and the free OH groups on the C-3, C-4 and C-6 
positions are both critical for the formation of the C-Glycoside ion. This reaction is very 
distinctive,. since the formation of the C-glycoside is very difficult in comparison to 0- or 
N-glycosylation. 
McLafferty's group has suggested that poly(ethylene/propylene glycol) under 
collisionally activated dissociation using FT-ICR MS/MS or other energetic methods, 
leads to misleading rearrangements (Cerda et al., 2002; Vidasky et al., 1994). It has been 
also reported that MS/MS analysis of underivatized and per-0- methylated trisaccharides, 
with either high- or low-energy CID using F AB ionization, resulted in losses of the 
internal residue of 1 ~6 substituted monosaccharide (Briill et al., 1997). This 
phenomenon of 'internal residue loss', which was characterized as an "internal 
rearrangement" process catalyzed by a proton, was not observed in the CID-MS/MS 
analysis of sodium-cationized oligosaccharides containing N-acetyl-D-glucosamine (Brull 
et al., 1998). Claeys and collaborators evaluated the CID-MS/MS of 0-flavonoid 0-
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eutinosides and 0-neohesperidosides, illustrating internal glucose residue loss. They 
proposed mobilization of the proton from the aglycone to the disaccharide portion (Ma et 
al., 2000). It should be noted that in the previous cases, these rearrangements reinstate 
the final formation of either 0-ether or 0-glycosidic linkages. 
By comparison to the rearrangements in the aforementioned studies, the work, 
presented in this rationale, includes a quite different series of amphiphilic molecules 
containing an amino sugar and cholesteryl moieties separated by a polyethylene spacer. 
Also the formation of the final compounds is not an 0-glycoside but a C-Glycoside, the 
formation of which, represents a formidable synthetic task to be achieved in a MS 
instrument. 
It was therefore proposed that the mechanism of formation of the [ C-glycoside t 
product ion which occurs in the collision cell of the tandem mass spectrometer, arises 
from the nucleophilic attack of the neutral fragment cholest-3,5-diene molecule on the 
activated intermediate product [GlcNAct oxonium ion. We postulated that these latter 
were formed in the collision cell by fragmentation of the precursor protonated molecule. 
Thus, the formation of this C-glycoside occurs from the net result of breakage of two 
original covalent bonds separated by the polyethoxy chain· spacer in the precursor 
protonated neoglycolipid. This [C-glycosidet reforms by a product ion-molecule 
reaction to produce a new C-1-C-3' covalent bond. 
During the CID-MS/MS of the protonated neoglycolipid molecules, theN-acetyl-
2-deoxy-D-glucosaminyl and the cholesteryl moieties, are both 0-linked, and are 
separated by a variable length polyethoxy spacer arm. Therefore, the formation of the C-
glycoside was not related to any specific conformation in the gas phase. This formation 
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of a C-C linkage by this type of ion-molecule reaction is quite unusual and rather unique, 
and could not involve, under any circumstances, a C-0 intra-molecular rearrangement. 
It should be also noted that most gas-phase ion-molecule reactions involve 
reactive atoms such as oxygen, nitrogen, and sulphur (Eberlin, 2006). The formation of 
carbon-carbon bonds (in non-sugar structures) were, however, observed previously; for 
example, the formation of a characteristic cyclic product, resulting from a selective 
reaction between ethyl vinyl ether and hydroxycarbonyl compounds has been previously 
demonstrated (Kenttamaa & Cooks, 1989). 
In summary, the exact structure and the fragmentation patterns of these synthetic 
neoglycolipids were precisely established, including the elucidation of a unique "in situ" 
C-glycosylation reaction. This fact will be further explored in the future with the aid of 
state-of'-the-art desorption electrospray ionization (DESI), and mass spectrometry may 
eventually serve as a reaction vessel, capable of generating the final products within a 
very short timeframe. 
7.3. Future directions: 
The intact LPS molecule of A. salmonicida will be studied by ESI- and MALDI-
tandem mass spectrometry. This large biomaterial will be evaluated in its native form or 
after chemical manipulation to enhance the MS analysis; e.g. deacetylation of the fatty 
acids from the lipid A and permethylation (Robinson et al., 2005). 
Both liposomes and protein carriers were used to formulate A. salmonicida 
oligosaccharide vaccines (Banoub et al., 1989; Nakhla et al., 1994). Neoglycolipid-
stabilized liposomes and BSA will be used as liposomal and protein carriers, respectively, 
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of the core oligosaccharide so that fish can be challenged with these formulations. It was 
shown recently that 83.5% of carp (Cyprinus carpio) immunized with liposomally-
entrapped A. salmonicida antigens survived infections compared to 62.5% for non-
immunized carp (Irie eta!., 2005). It should also be mentioned that the native structure of 
these oligosaccharides can serve as the basis for synthetic analogs that retain activity, 
reduce side effects and ease the design of pharmaceutical formulations (Asai, 2004; 
Baldridge & Crane, 1999). 
In addition to vaccine-related work associated with LPS, one of the most exciting 
findings, when evaluating neoglycolipdis, is related to the formation of the C-glycoside 
species during ESI-MS and MS/MS analysis. The formation of this ion will be evaluated 
using mass analyzers which "trap" ions, namely IT-MS and FT-MS. Various structures 
will be co-infused (with deuterated species) and the formation of the corresponding C-
glycoside will be monitored. In addition, various neoglycolipids that bear glucosamine 
derivatives that are blocked at one or two variable positions will be synthesized and tested 
for the formation of the [ C-Glycoside t so that additional explanation for the absence of 
this species within the per-0-acetylated neoglycolipids can be established. 
7.4. Closing remarks: 
The fragmentation pattern and the mass spectrometric fingerprints of natural A. 
salmonicida LPS and synthetic cholesteryl neoglycolipids are discussed and established. 
Complex oligosaccharide mixtures are evaluated by MS revealing the formation of ions, 
formed by glycosidic cleavages where bond ruptures occur between different sugar units 
and involve hydrogen migration. In addition, cross-ring fragmentations were also 
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observed, providing concrete information with respect to the sequence and type of 
linkages between monosaccharides and various non-sugar substituents. The MS data can 
assist in predicting the fragmentation patterns of similar structures and may serve as the 
basis for any quantitative or qualitative studies involving the series of glycoconjugates 
evaluated in this project. 
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Appendix 1: Lipid A 
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Figure I~l: Nigative ESI-QhQ-MS showed the major diagnostic ions observed with 
QqToF instrumentation (A). However, the [MB-Hrwere not observed. This 
instrument failed to fragment the precursor mono-phosphorylated ion (B). 
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Figure I-2: Negative QqToF MS scan of the native lipid A extract from wild-type mutant A. salmonicida acquired at 
DP= - 60. The ions observed are identical to those reported for the rough mutant species (Figure 3-2). The assignment 
of the diagnostic ions are shown in Table 3-1. 
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Appendix II: The CID-MS/MS spectra and the fragmentation patterns of the doubly 
charged series ions presented in Table 4-1 
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Figure Il-l: ESI-MS/MS spectra of the permethylated precursor ions [M1+2H]2+ at m/z 
1201.60 and the proposed fragmentation routes and product ions of this precursor. 
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Figure 11-2: ESI-MS/MS spectra of the permethylated precursor ions [M2+2H]2+ at 
mlz 1208.10 and the proposed fragmentation routes and product ions of this precursor. 
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Figure II-3: ESI-MS/MS spectra of the permethylated precursor ions [M3+2Hf+ at 
m/z 1215.60 and the proposed fragmentation routes and product ions of this 
precursor. 
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Figure II-3: ESI-MS/MS spectra of the permethylated precursor ions [M4+2H]2+ at mlz 
1240.60 and the proposed fragmentation routes and product ions of this precursor. 
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Appendix III: ESI-MS/MS and MALDI-MS/MS spectra of the mono-charged series 
of the proptontated molecules shown in Table 4-1 
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Figure 111-1: MALDI-MS/MS (A) and ESI-MS/MS of the precursor [MNHMe+Ht 
observed at 2374.2129. 
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Figure 111-2: MALDI-MS/MS (A) and ESI-MS/MS of the precursor [M+Ht 
observed at 2388.2289. 
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Figure III-3: MALDI-MS/MS (A) and ESI-MS/MS ofthe precursor [Mt+Ht 
observed at 2402.2429. 
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Figure 111-4: MALDI-MS/MS (A) and ESI-MS/MS of the precursor [M2+Ht 
observed at 2416.2315. 
227 
100'/o 
00% 
00% 
70% 
00% 199.00 
&l% 
87.fB 
40% 
246.09 
:D'/o / P5.1 )4 
20% 
10
% _It II 
2429.71 
2!D :ro 4lll roo 600 700 600 600 1ax> 1100 12m 1:ro 141ll 1roo 1600 1700 1600 1600 2ax> 2100 22!D 2:m 2400 2500 
rriZ,anJ 
2430.40 
00% 
70% (A) 
199.04 
ro% 
187.00 
40o/o 
~46.00 
:u'/o 432.09 
.11 
I 
2!D :ro 400 roo 600 700 600 600 1ax> 1100 12m 1:ro 1400 1roo 1600 1700 1600 1600 2ax> 2100 22!D 2:m 2400 2500 
rriZ,anJ 
Figure 111-4: MALDI-MS/MS (A) and ESI-MS/MS of the precursor [M3+Ht 
observed at 2430.2330. 
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Figure III-4: MALDI-MS/MS (A) and ESI-MS/MS of the precursor [M.+Ht 
observed at 2480.2581. 
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Figure III-4: MALDI-MS/MS (A) and ESI-MS/MS of the precursor [Ms+Ht 
observed at 2494.2429. 
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Appendix IV: Additional positive ESI-MS/MS spectra that established the 
fragmentation pattern shown in Figure 5-7 
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Figure IV -1: Product ion scan of m/z 1035.52 by ESI-QqTOF MS/MS using low 
energy CID at two different collision energies (Top: 10eV and Bottom: 15eV). 
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Figure IV-2: Product ion scan ofm/z 1049.53 by ESI-QqTOF MS/MS using low 
energy CID at two different collision energies (Top: lOeV and Bottom: 15eV). 
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Appendix V: Positive QqToF-MS spectra of all tested neoglycolipids (except for the 
ones presented in Figure 6-1) 
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Figure V -1: ESI-QqToF spectrum of the neoglycolipid bearing GlcNH2 with 0-glycoside 
linkage (tO-glycoside). 
233 
OO"A. 
OO'A> 
HO~' 1\ HO~O 0 
[GicNAct 
204.10 
[GicNAc-2H20-COt 
131!.07 
126. 
NHAc 
[Cholestener 
'.m.37 
445.39 
[M+Ht 
634.48 
[M+Nat 
656.46 
[M+Kt 
672.44 
700 
Figure V-2: ESI-QqToF spectrum ofthe neoglycolipid bearing GlcNAcwith CH2CH20 
spacer (2CH2CH20). 
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Figure V -3: ESI-QqToF spectrum of the neoglycolipid bearing GlcNAc with 
(CHzCHzO)z spacer (2(CHzCHzO)z). 
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Figure V-4: ESI-QqToF spectrum of the neoglycolipid bearing GlcNAcwith 
(CHzCHz0)3 spacer (2(CHzCH20)2). 
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Figure V-5: ESI-QqToF spectrum ofthe neoglycolipid bearing GlcNAcwith (CH2CH20)4 
spacer (2(CH2CH20)4). 
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Figure V-6: ESI-QqToF spectrum ofthe neoglycolipid bearing GlcNAcwith 
CH2CH20 CH2CH20 CD2CH20 spacer. 
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Figure V-7: ESI-QqToF spectrum ofthe neoglycolipid bearing GlcNAcwith 
CH2CH20CD2CH20CH2CH20 spacer. 
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Figure V-8: ESI-QqToF spectrum ofthe neoglycolipid bearing GlcNAcwith 
CD2CH20CH2CH20CH2CH20 spacer. 
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Figure V-9: ESI-QqToF spectrum ofthe neoglycolipid bearing LacNAcwith 
(CH2CH20)3 spacer ( 4(CH2CH20)3). 
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Figure V -10: ESI-QqToF spectrum of the neoglycolipid bearing GlcNAloc with 0-
glycoside as spacer (60-glycoside). 
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Figure V-11: ESI-QqToF spectrum ofthe neoglycolipid bearing Fucwith 
(CH2CH20)4 spacer (S(CH2CH20)4). 
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Appendix VI: Positive ESI-QqToF-MS spectra ofthe protected neoglycolipids 
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Figure VI-1: ESI-QqToF-MS spectrum of the neoglycolipids bearing GleN Aloe with a-
glycoside as spacer (60-glycoside). 
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Figure VI-2: ESI-QqToF-MS spectrum ofthe neoglycolipids bearing GlcNAlocwith 
(CH2CH20)4 as spacer (6(CH2CH20)4). 
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Figure VI-3: ESI-QqToF-MS spectrum ofthe neoglycolipids bearing LacNAcwith 
(CH2CH20)3 as spacer (4(CH2CH20)3). 
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Appendix VII: ESI-QqToF-MS/MS spectra of the protonated moleculaes of the 
neoglycolipids, except for the ones presented within Chapter 7 
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Figure VII-I: ESI-MS/MS spectrum of the neoglycolipid bearing GlcNH2 with 0-
glycoside linkage (tO-glycoside). 
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Figure VII-2: ESI-MS/MS spectrum of the neoglycolipid bearing GlcNH2 with 
(CH2CH20)2linkage (l(CH2CH20)2). 
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Figure VII-3: ESI-MS/MS spectrum of the neoglycolipid bearing GlcNAc with 
CH2CH20 linkage (lCH2CH20). 
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Figure VII-4: ESI-MS/MS spectrum of the neoglycolipid bearing GlcNAc with 
(CHzCHzO)z linkage (2(CHzCHzO)z). 
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Figure VII-5: ESI-MS/MS spectrum of the neoglycolipid bearing GlcNAc with 
CHzCHzOCHzCHzOCDzCHzO linkage. 
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Figure VII-6: ESI-MS/MS spectrum of the neoglycolipid bearing GlcNAc with 
CH2CH20CD2CH20CH2CH20 linkage. 
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Figure VII-7: ESI-MS/MS spectrum of the neoglycolipid bearing GlcNAc with 
CDzCHzOCHzCHzOCHzCHzO linkage. 
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Figure VII-8: ESI-MS/MS spectrum of the neoglycolipid bearing Fuc with (CH2CH20)4 
linkage (S(CH2CH20)4). 
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Figure VII-9: ESI-MS/MS spectrum of the neoglycolipid bearing GlcNHCOCD3 with 
(CH2CH20)3 linkage (3(CH2CH20)3). 
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Figure VII-10: ESI-MS/MS spectrum of the neoglycolipid bearing GlcNAloc with 0-
glycoside as spacer (60-glycoside). 
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Figure V -11: ESI-MS/MS spectrum of the neoglycolipid bearing GlcNAloc with 
(CHzCHz0)4 as spacer (6(CHzCHz0)4). 
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Figure VII-12: ESI-MS/MS spectrum of the neoglycolipids bearing GlcNAloc with a-
glycoside as spacer-acetylated form (60-glycoside). 
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Figure VII-13: ESI-MS/MS spectrum of the neoglycolipids bearing GlcNAloc with 
(CH2CH20)4 as spacer-acetylated form (6(CH2CH20)4). 
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Figure VII-14: ESI-MS/MS spectrum ofthe neoglycolipids bearing LacNAcwith 
(CH2CH20)3 as spacer- acetylated form (4(CH2CH20)3). 
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